
<html lang="en"     class="pb-page"  data-request-id="e84836ec-c7ee-482b-8169-c0d8a4196e6e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-11;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.8b00477;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus–Cell Interface" /></meta><meta name="dc.Creator" content="Adel A.  Rashad" /></meta><meta name="dc.Creator" content="Li-Rui  Song" /></meta><meta name="dc.Creator" content="Andrew P.  Holmes" /></meta><meta name="dc.Creator" content="Kriti  Acharya" /></meta><meta name="dc.Creator" content="Shiyu  Zhang" /></meta><meta name="dc.Creator" content="Zhi-Long  Wang" /></meta><meta name="dc.Creator" content="Ebony  Gary" /></meta><meta name="dc.Creator" content="Xin  Xie" /></meta><meta name="dc.Creator" content="Vanessa  Pirrone" /></meta><meta name="dc.Creator" content="Michele A.  Kutzler" /></meta><meta name="dc.Creator" content="Ya-Qiu  Long" /></meta><meta name="dc.Creator" content="Irwin  Chaiken" /></meta><meta name="dc.Description" content="To address the urgent need for new agents to reduce the global occurrence and spread of AIDS, we investigated the underlying hypothesis that antagonists of the HIV-1 envelope (Env) gp120 protein an..." /></meta><meta name="Description" content="To address the urgent need for new agents to reduce the global occurrence and spread of AIDS, we investigated the underlying hypothesis that antagonists of the HIV-1 envelope (Env) gp120 protein an..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 16, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00477" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00477" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00477" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00477" /></link>
        
    
    

<title>Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus–Cell Interface | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00477" /></meta><meta property="og:title" content="Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus–Cell Interface" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0012.jpeg" /></meta><meta property="og:description" content="To address the urgent need for new agents to reduce the global occurrence and spread of AIDS, we investigated the underlying hypothesis that antagonists of the HIV-1 envelope (Env) gp120 protein and the host-cell coreceptor (CoR) protein can be covalently joined into bifunctional synergistic combinations with improved antiviral capabilities. A synthetic protocol was established to covalently combine a CCR5 small-molecule antagonist and a gp120 peptide triazole antagonist to form the bifunctional chimera. Importantly, the chimeric inhibitor preserved the specific targeting properties of the two separate chimera components and, at the same time, exhibited low to subnanomolar potencies in inhibiting cell infection by different pseudoviruses, which were substantially greater than those of a noncovalent mixture of the individual components. The results demonstrate that targeting the virus–cell interface with a single molecule can result in improved potencies and also the introduction of new phenotypes to the chimeric inhibitor, such as the irreversible inactivation of HIV-1." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00477"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00477">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00477&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00477&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00477&amp;href=/doi/10.1021/acs.jmedchem.8b00477" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 5020-5033</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00460" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00499" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus–Cell Interface</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Adel A. Rashad</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adel A. Rashad</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adel+A.++Rashad">Adel A. Rashad</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6113-0333" title="Orcid link">http://orcid.org/0000-0001-6113-0333</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Li-Rui Song</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Li-Rui Song</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Science, Shanghai 201203, China</div><div class="loa-info-affiliations-info">College of Pharmaceutical Sciences, Soochow University Medical College, Suzhou 215123, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Number 19A Yuquan Road, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Li-Rui++Song">Li-Rui Song</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrew P. Holmes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew P. Holmes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+P.++Holmes">Andrew P. Holmes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kriti Acharya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kriti Acharya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kriti++Acharya">Kriti Acharya</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3408-149X" title="Orcid link">http://orcid.org/0000-0002-3408-149X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shiyu Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shiyu Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States</div><div class="loa-info-affiliations-info">School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, Pennsylvania 19104, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shiyu++Zhang">Shiyu Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhi-Long Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhi-Long Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Science, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhi-Long++Wang">Zhi-Long Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ebony Gary</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ebony Gary</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ebony++Gary">Ebony Gary</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xin Xie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xin Xie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Science, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Xie">Xin Xie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vanessa Pirrone</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vanessa Pirrone</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vanessa++Pirrone">Vanessa Pirrone</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michele A. Kutzler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michele A. Kutzler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michele+A.++Kutzler">Michele A. Kutzler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ya-Qiu Long</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ya-Qiu Long</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Science, Shanghai 201203, China</div><div class="loa-info-affiliations-info">College of Pharmaceutical Sciences, Soochow University Medical College, Suzhou 215123, China</div></div><span class="conrtib-corresp"><strong>*</strong>Tel.: +86-512-65882275. E-mail: <a href="/cdn-cgi/l/email-protection#2b4744454c524a5a425e6b585e4f4a054e4f5e054845"><span class="__cf_email__" data-cfemail="fb9794959c829a8a928ebb888e9f9ad59e9f8ed59895">[email protected]</span></a> (Y.-Q.L.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ya-Qiu++Long">Ya-Qiu Long</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Irwin Chaiken</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Irwin Chaiken</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Tel.: +1-215-762-4197. E-mail: <a href="/cdn-cgi/l/email-protection#a0c9cdc39293e0c4d2c5d8c5cc8ec5c4d5"><span class="__cf_email__" data-cfemail="31585c5203027155435449545d1f545544">[email protected]</span></a> (I.C.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Irwin++Chaiken">Irwin Chaiken</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00477&amp;href=/doi/10.1021%2Facs.jmedchem.8b00477" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 5020–5033</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 16, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 March 2018</li><li><span class="item_label"><b>Published</b> online</span>16 May 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 June 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00477" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00477</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5020%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAdel%2BA.%2BRashad%252C%2BLi-Rui%2BSong%252C%2BAndrew%2BP.%2BHolmes%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D11%26contentID%3Dacs.jmedchem.8b00477%26title%3DBifunctional%2BChimera%2BThat%2BCoordinately%2BTargets%2BHuman%2BImmunodeficiency%2BVirus%2B1%2BEnvelope%2Bgp120%2Band%2Bthe%2BHost-Cell%2BCCR5%2BCoreceptor%2Bat%2Bthe%2BVirus%25E2%2580%2593Cell%2BInterface%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5033%26publicationDate%3DJune%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00477"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1157</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00477" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus–Cell Interface&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Adel&quot;,&quot;last_name&quot;:&quot;A. Rashad&quot;},{&quot;first_name&quot;:&quot;Li-Rui&quot;,&quot;last_name&quot;:&quot;Song&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;P. Holmes&quot;},{&quot;first_name&quot;:&quot;Kriti&quot;,&quot;last_name&quot;:&quot;Acharya&quot;},{&quot;first_name&quot;:&quot;Shiyu&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Zhi-Long&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Ebony&quot;,&quot;last_name&quot;:&quot;Gary&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Vanessa&quot;,&quot;last_name&quot;:&quot;Pirrone&quot;},{&quot;first_name&quot;:&quot;Michele&quot;,&quot;last_name&quot;:&quot;A. Kutzler&quot;},{&quot;first_name&quot;:&quot;Ya-Qiu&quot;,&quot;last_name&quot;:&quot;Long&quot;},{&quot;first_name&quot;:&quot;Irwin&quot;,&quot;last_name&quot;:&quot;Chaiken&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;5020-5033&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00477&quot;},&quot;abstract&quot;:&quot;To address the urgent need for new agents to reduce the global occurrence and spread of AIDS, we investigated the underlying hypothesis that antagonists of the HIV-1 envelope (Env) gp120 protein and the host-cell coreceptor (CoR) protein can be covalently joined into bifunctional synergistic combinations with improved antiviral capabilities. A synthetic protocol was established to covalently combine a CCR5 small-molecule antagonist and a gp120 peptide triazole antagonist to form the bifunctional chimera. Importantly, the chimeric inhibitor preserved the specific targeting properties of the two separate chimera components and, at the same time, exhibited low to subnanomolar potencies in inhibiting cell infection by different pseudoviruses, which were substantially greater than those of a noncovalent mixture of the individual components. The results demonstrate that targeting the virus–cell interface with a single molecule can result in improved potencies and also the introduction of new phenotypes to the chime&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00477&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00477" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00477&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00477" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00477&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00477" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00477&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00477&amp;href=/doi/10.1021/acs.jmedchem.8b00477" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00477" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00477" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00477%26sid%3Dliteratum%253Aachs%26pmid%3D29767965%26genre%3Darticle%26aulast%3DRashad%26date%3D2018%26atitle%3DBifunctional%2BChimera%2BThat%2BCoordinately%2BTargets%2BHuman%2BImmunodeficiency%2BVirus%2B1%2BEnvelope%2Bgp120%2Band%2Bthe%2BHost-Cell%2BCCR5%2BCoreceptor%2Bat%2Bthe%2BVirus%25E2%2580%2593Cell%2BInterface%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D11%26spage%3D5020%26epage%3D5033%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=290677" title="Toxicological synergy">Toxicological synergy</a>,</li><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292035" title="Viruses">Viruses</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/jmcmar.2018.61.issue-11/20180614/jmcmar.2018.61.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">To address the urgent need for new agents to reduce the global occurrence and spread of AIDS, we investigated the underlying hypothesis that antagonists of the HIV-1 envelope (Env) gp120 protein and the host-cell coreceptor (CoR) protein can be covalently joined into bifunctional synergistic combinations with improved antiviral capabilities. A synthetic protocol was established to covalently combine a CCR5 small-molecule antagonist and a gp120 peptide triazole antagonist to form the bifunctional chimera. Importantly, the chimeric inhibitor preserved the specific targeting properties of the two separate chimera components and, at the same time, exhibited low to subnanomolar potencies in inhibiting cell infection by different pseudoviruses, which were substantially greater than those of a noncovalent mixture of the individual components. The results demonstrate that targeting the virus–cell interface with a single molecule can result in improved potencies and also the introduction of new phenotypes to the chimeric inhibitor, such as the irreversible inactivation of HIV-1.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76367" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76367" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Inhibition of the initial entry of HIV-1 into host cells remains a compelling yet elusive means to prevent infection and the spread of the virus. HIV-1 cell infection is mediated by concerted interactions at the virus–host-cell interface between trimeric envelope-glycoprotein (Env) spikes on the virus membrane surface and two host-cell receptors, CD4 and a coreceptor that is most commonly either CCR5 or CXCR4.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Each Env trimer consists of two noncovalently associated glycoproteins, a gp41 transmembrane protein and an external gp120 surface protein. During viral infection, the interaction between CD4 and the most exposed Env protein, gp120, causes a conformational rearrangement of the latter, leading to an increased affinity for a coreceptor interaction at an initially cryptic site in gp120. This cascade exposes structural components in gp41 necessary to promote virus- and cell-membrane lipid mixing, fusion, pore formation, and infection. Inhibitors that can potently block virus–cell interactions and cell entry would hold great promise in inhibiting initial HIV-1 infections.</div><div class="NLM_p">Currently approved inhibitors of the entry steps are available clinically but have properties that limit their therapeutic usefulness. Maraviroc is an approved entry-inhibitor that binds to the coreceptor CCR5 and prevents binding to HIV Env gp120 and, as a consequence, prevents the full exposure of gp41 and suppresses virus–cell fusion.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> However, the effectiveness of this drug requires matching the administered therapeutic to the coreceptor used by the viral variants infecting each patient. In most cases, HIV infects cells after binding to the CCR5 receptor in the early stages of disease, but as the disease progresses, the virus can switch to another receptor, CXCR4. Therefore, patients need to be tested for viral tropism before commencing the CCR5-inhibition therapy. In addition, maraviroc induces a tropism switch to CXCR4-expressing cells.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Hence, maraviroc is currently only approved for use in treatment-experienced patients.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Enfuvirtide (T20) is a 36-residue peptide that mimics the part of the C-terminal helix in gp41 that mediates fusion. As such, it blocks the binding of the gp41 N-terminal helix to the C-terminal helix and formation of the six-helix bundle, which is the process that drives fusion between the viral and cellular membranes. Because of its high cost of production, its short half-life, and the need for subcutaneous injections, enfuvirtide is also only approved as salvage therapy in patients who have failed multiple lines of therapy. Moreover, rapid mutations in a 10-residue stretch of the gp41 N-terminal helix were observed to lead to resistance to this drug.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Recently, it also has been shown that HIV-1 can develop resistance to fusion inhibitors and become inhibitor-dependent, because of the critical kinetics required for these inhibitors.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Identifying new entry-targeting inhibitors, in particular those that could function in combination to increase potency and overcome viral resistance, remains an important goal of HIV-1-drug-discovery efforts. To date, delineation of such combinations has been limited mainly to combinations of coreceptor inhibitors and T20.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11">(8−11)</a> Such combinations have demonstrated the potential for the strong synergy between CCR5 (TAK-220, SCH-C, and Aplaviroc) and CXCR4 (AMD-3100) inhibitors in assays of infection of peripheral blood mononuclear cells (PBMCs) with clinical HIV-1 isolates. Synergy between coreceptor inhibitors and Env-gp41 inhibitors has been proposed to be due to a kinetic linkage between the steps of entry that they antagonize.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9−12)</a> This work points to the potential to achieve increased potency through combinations of inhibitors targeting different components of the virus–cell interface. This could be particularly important as researchers develop new small-molecule coreceptor inhibitors that target CXCR4 in addition to CCR5, as well as new inhibitors of the Env protein complex, including the most exposed protein component, gp120.</div><div class="NLM_p last">In the current work, we tested the hypothesis that the covalent fusion of HIV-1 gp120 and coreceptor inhibitors could yield an HIV-1-cell-infection inhibitor with enhanced potency compared with the sum of the potencies of the individual components. New classes of coreceptor inhibitors have been identified that can target either CCR5 or CXCR4 with strong antiviral effects.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17">(13−17)</a> At the same time, a class of gp120-targeting peptide triazoles (PTs) has been identified that blocks both host-cell-receptor interactions and causes irreversible virus inactivation by triggering gp120 shedding.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> We chose the LJC240<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (coreceptor-targeting, see <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> for the structure) and UM15<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (gp120-targeting, see <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> for the structure) inhibitors for the initial prototype-chimera components on the basis of the already-established antiviral efficacies of these components on their own. The conjugation points of LJC240 to UM15 were determined by examining target-binding models as well as their structure–activity relationships, which identified the structural elements of the inhibitors that were tolerant to modification. The protocol for the chimera synthesis was derived from the already-established solid-phase syntheses of the peptide triazoles themselves<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21−24)</a> with follow-up sequential additions of the linker and the free-acid form of LJC240–COOH (<b>10</b>) before the introduction of the triazole by click conjugation. The functional properties of the resulting prototype chimera, LJC240–L4–UM15 (<b>11</b>), were examined by a combination of cellular, virological, and molecular assays. The results demonstrated that the covalent chimera retained the individual components’ functions and, at the same time, a synergistically enhanced antiviral potency compared with that of a noncovalent mixture of the two component inhibitors. The work provides strong support for the hypothesis that a bifunctional chimera could engage and synergistically block the infection-causing functions of host-cell coreceptors and virus envelope gp120 at the HIV-1–cell interface.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27325" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27325" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">1.  Chimera Design and Synthesis</h3><div class="NLM_p">We designed a bifunctional molecule that is able to target both the HIV-1 envelope and the cellular coreceptor (here, CCR5). When the HIV-1 envelope encounters the cell receptors, the released gp120 V3 loop docks into the cellular-coreceptor-binding site. We envisioned that a bifunctional molecule that has gp120- and CCR5-targeting components would be able to bridge the envelope–CCR5-encounter complex. This kind of complex has not been resolved at high resolution. However, structural information is available for the individual components.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> Because PTs target the CD4-binding area of gp120, we measured the distance between the CD4-binding site (residue Asp368) and the tip of the released V3 loop (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QAD">2QAD</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> This distance represents the hypothetical minimal linker length required to tether the gp120 and CCR5 inhibitors together in a way that mimics the encounter complex.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Geometry of the gp120 protein showing the distance between the CD4-binding site and the released V3-loop tip (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QAD">2QAD</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We also examined the possible positions for chemical ligation through modeling of the inhibitors in the context of their individual protein targets (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), in order to avoid any unexpected reduction in potency. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> (left), the UM15 N-terminal (protonated) residue is in a solvent-exposed moiety. On the other hand, the fluorine atom of LJC240 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, right) is well solvated and actually can displace water in the crystal structure of the CCR5 receptor. This docking result, combined with prior structure–function relationships in LJC240-derived CCR5 inhibitors,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> argues that structural variation replacing the fluorine atom should be tolerated.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Interaction maps of UM15 (left) docked within gp120 of the HIV-1 envelope (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NCO">4NCO</a>)<a onclick="showRef(event, 'ref25 ref28'); return false;" href="javascript:void(0);" class="ref ref25 ref28">(25,28)</a> and LJC240<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (right) docked onto the CCR5 structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MBS">4MBS</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The gray circles represent the solvated (solvent-exposed) moieties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the predicted topology presented above (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), we envisioned a linker of approximately 59 Å would be required to tether the UM15 N-terminus to the fluoro-phenyl ring. The hydrophilicity built into the linker was predicted to help keep the two components apart and avoid any nonspecific hydrophobic interactions with either of the target proteins. We chose four units of amino-ethoxy-ethoxy acetic acid as the linker (hereafter referred to as L4) as it would provide the distance on the basis of the bond-length measurements.</div><div class="NLM_p">We employed solid-phase synthesis to build the L4–UM15 precursor. We also synthesized a modified version of LJC240 (compound <b>10</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) in which the fluorine atom (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) was replaced with a carboxylic group to enable ligation with the amino group of the L4–UM15 N-terminus (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The coupling reagents of HBTU/HOBt and DIEA were selected for the amide-coupling, which was followed by an on-resin click reaction to form the triazole component on the UM15-azido-Pro residue (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Synthesis of the coreceptor inhibitor LJC240–COOH (<b>10</b>). Reagents and conditions: (a) NH<sub>2</sub>OH·HCl, NaHCO<sub>3</sub>, EtOH/H<sub>2</sub>O, rt; (b) Na, pentanol, reflux; (c) (Boc)<sub>2</sub>O, TEA, THF, rt; (d) 10% Pd/C, HCO<sub>2</sub>NH<sub>4</sub>, methanol, reflux; (e) 1-bromo-3-chloropropane, KI, TEA, DMF, rt; (f) 1-acetylpiperidine-4-carboxylic acid, SOCl<sub>2</sub>, TEA, DCM, rt; (g) <b>5</b>, KI, K<sub>2</sub>CO<sub>3</sub>, MeCN, reflux; (h) HCl, methanol, rt; (i) 4-(chlorosulfonyl)benzoic acid, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, rt.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Solid-phase synthesis of chimera <b>11</b>. A Liberty blue microwave synthesizer was used for the assembly of the L4–UM15 precursor segment. The latter was joined with the LJC240 free acid (<b>10</b>), which was followed by ferrocenyl triazole formation using a click reaction, leading to the final chimera (<b>11</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.  Potent Neutralization of HIV-1 Infection by the Bifunctional Chimera</h3><div class="NLM_p">We measured the antiviral potency of the bifunctional chimera in a cell-infection-inhibition assay. Pseudotyped viruses bearing the BaL.01, JR-FL, and YU2 envelope proteins and carrying a luciferase reporter gene were incubated with the serially diluted chimera for 30 min at 37 °C and then added to human osteosarcoma (HOS) cells expressing CD4 and CCR5 (HOS.T4.R5). Following the completion of the infection-inhibition assay, the cells were lysed and monitored for luciferase activity. UM15 and LJC240–L4 (with the same L4 linker used for the chimera) served as controls for the experiment because they best represented the parental molecules that made up the chimera. LJC240–L4–UM15 (<b>11</b>) displayed subnanomolar to low-nanomolar inhibition of HIV-1 envelope-pseudotyped viruses (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The chimera had improved potencies that ranged from >2-fold (YU2) to >50-fold (BaL.01) greater than the most potent parental component, LJC240–L4. We also evaluated an additional control of a 1:1 noncovalent mixture of UM15 and LJC240–L4 (against the tier-2 JRFL-pseudotyped virus), which mimicked the molar ratio between the inhibitors in the chimera, to determine whether the covalent attachment resulted in synergy and increased the potency beyond that of the combination of the individual inhibitors. Indeed, the bifunctional chimera was more potent (4 nM) than the 1:1 mixture (34 nM, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B), thus demonstrating the value of the covalent attachment for the potency compared with that of the sum of the parts.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Neutralization of HIV-1 Env-pseudotyped viruses (A) Bal.01, (B) JRFL, (C) YU2, and (D) HxBc2, as examples of X4-tropic viruses, by the bifunctional chimera (red), UM15 (black), LJC240–L4 (blue), and a 1:1 mixture of UM15 and LJC240–L4 (green). ND indicates not determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6">2.1.  Synergistic Effects of the Covalent Chimera</h4><div class="NLM_p">To further define the value of the covalent attachment of UM15 to LJC240–L4 versus that of the noncovalent mixture, we performed a quantitative synergy analysis. Initially, we evaluated the noncovalent mixtures against a Bal.01 HIV-1 strain (because of the ease of virus production and assay handling) on the basis of their individual activities reported in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. Interestingly, both UM15 and LJC240–L4 showed ∼7-fold improved potency in the presence of each other (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A); UM15 showed an IC<sub>50</sub> value of 56 nM in the mixture compared with 378 nM alone (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A), and LJC240–L4 showed an IC<sub>50</sub> value of 2.9 nM in the mixture (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A) compared with 20 nM alone (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). The IC<sub>50</sub> value obtained for the covalent chimera in the same assay (0.86 nM, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A) clearly showed a strong increase in potency versus that of the noncovalent mixture. These results argue for the value of the covalent joining of the two inhibitors, further confirming the difference with the 1:1 noncovalent mixture (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). Representation of the data with an isobologram<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B) shows the synergy in the noncovalent mixture (1:30 molar ratio of UM15/LJC240–L4) when we plotted the 50% inhibition of the mixture (red dot in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B), compared with the individual IC<sub>50</sub> values of the separate inhibitors (connected by the blue line in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). Interestingly, plotting the 50% inhibition by the covalent chimera, <b>11</b>, (green dot in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B) shows the even stronger synergistic effect of the latter.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Synergy-assay results between UM15 and LJC240–L4 against HIV-Bal.01. The IC<sub>50</sub> values (blue for LJC240–L4 and black for UM15) are the effective inhibitory concentrations of the individual components in the mixture. Chimera <b>11</b> (red) was also included in the experiment. (B) Isobologram representation of the UM15–LJC240–L4 combination. The blue line connects the IC<sub>50</sub> values of the two inhibitors; the red dot is the effective concentration of the noncovalent mixture (1:30 ratio which achieved 50% inhibition), whereas the green dot is the effective concentration of the covalent chimera, <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.  Activity Retained by Individual Components of the Chimera</h3><div class="NLM_p">In order to confirm that the covalent attachment of the inhibitors did not interfere with the ability of each molecule to bind to its respective target in the virus–cell interface, we performed a series of experiments to measure the magnitudes of the peptide triazole and coreceptor inhibitor functions of the bifunctional chimera.</div><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8">3.1.  Activity against X4-tropic HIV</h4><div class="NLM_p last">First, we performed an infection-inhibition assay with HxBc2 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D), an X4-tropic virus, on HOS cells expressing CD4 and CXCR4 (HOS.T4.X4). By using an X4-tropic virus on X4-expressing cells, we ruled out the contribution of the coreceptor inhibitor toward the potency of the chimera. As expected, the bifunctional-chimera potency was nearly identical to that of the UM15 control (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D), thereby demonstrating that the UM15 component of the chimera retained full activity.</div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9">3.2.  Full gp120 Dual Antagonism Retained by Chimera <b>11</b></h4><div class="NLM_p">Surface-plasmon-resonance (SPR) analysis was carried out to further confirm the retention of the UM15 part’s gp120-binding efficiency. Both soluble CD4 and 17b (a gp120-targeting antibody that stabilizes the bridging sheet) were immobilized separately on sensor-chip surfaces, and gp120 was flowed across in increasing concentrations of inhibitor to assess binding. The binding of the bifunctional chimera was again equivalent to that of the UM15 control (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Efficacy of the chimeric inhibitor for gp120-protein–ligand binding determined by SPR gp120-competition analyses. (Left) Representative sensorgrams showing dose-dependent inhibition of monomeric-YU2-gp120 binding to the receptors CD4 and 17b by LJC240–L4–UM15. (Right) Dose–response curves derived from the sensorgrams of YU2-gp120-binding inhibition by LJC240–L4–UM15 and UM15 (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">These findings confirm previous observations that N-terminal extensions on the peptide do not interfere with pharmacophore binding<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> and also match the docking model for UM15 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">3.3.  Irreversible Inactivation of HIV by Chimera <b>11</b> via gp120 Shedding</h4><div class="NLM_p">Western-blot analysis was used to detect the gp120-shedding function of the peptide triazole component. As observed in the infection-inhibition (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D) and gp120-binding analyses (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), the shedding ability of UM15 was not affected by the covalent attachment to LJC240, with the chimera and UM15 both inducing gp120 shedding with similar potencies (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). This argues that the unique irreversible-virus-inactivation capacity is still retained by the chimeric inhibitor.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Capacity of the bifunctional chimera, LJC240–L4–UM15, to induce gp120 shedding similarly to UM15.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11">3.4.  Evaluation of Chimera <b>11</b> and Its Individual Components against CD4-Independent HIV</h4><div class="NLM_p">To further validate the bifunctional approach, we evaluated chimera <b>11</b> and the individual components against an adapted HIV-1 pseudovirus, J1HX, and its CD4-independent mutant, N197S. Removal of the glycosylation site at asparagine 197 in the V1–V2 stem was found to be sufficient to enable a conformation that is more primed for CCR5 binding in the absence of CD4 and for HIV-1 entry into CD4-negative cells expressing CCR5.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>, chimera <b>11</b> was functionally active and showed synergy against the parent non-CD4-independent J1HX WT with an IC<sub>50</sub> >16-fold more active than that of LJC240–L4 (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A). With the CD4-independent mutant, the individual components remained active: the potency of the UM15 component did not change compared with that of the WT, arguing that the binding of UM15 to gp120 was not disrupted, whereas the LJC240–L4 component showed ∼3-fold enhanced potency (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B) compared with that of the WT. In contrast with the results of the WT J1HX, chimera <b>11</b> was only slightly more active, if at all, than the LJC240–L4 component alone against the J1HX N197S virus (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B). The reduced synergistic potency of chimera <b>11</b> observed with J1HX N197S could be due to either (1) the masking of the chimera effect by the enhanced LJC240–L4 potency or (2) an altered dual Env–CCR5 encounter by the chimera components due to rearrangements in the gp120 V1–V2 region. Further investigation will be required to better define the mechanism causing reduced synergy.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Evaluation of chimera <b>11</b> (red) and the individual components, UM15 (black) and LJC240–L4 (blue), against J1HX (A) and the CD4-independent J1HX mutant, N197S (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">3.5.  Coreceptor-Binding Efficiency Retained by Chimera <b>11</b></h4><div class="NLM_p">The coreceptor-inhibitory function of the chimera was assessed, initially using a calcium-mobilization assay to determine the extent of antagonism of RANTES function (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>, top panel). A comparison of LJC240<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) and LJC240–L4 was included to determine whether the linker would negatively impact antagonistic ability. Indeed, the added linker appeared to interfere with the potency of the molecule, as judged by an activity decrease from 1.59 nM with LJC240 to 27.44 nM with LJC240–L4. No further decrease of function was observed with LJC240–L4–UM15 (<b>11</b>), as judged by the IC<sub>50</sub> value of 22.09 nM.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Dose-dependent CCR5 antagonism by the bifunctional chimera and the parent small-molecule inhibitors. (Top) Dose–response curves of the extent of the inhibition of RANTES (10 nM) stimulation of calcium mobilization measured for LJC240-containing compounds. Maraviroc was included as a control. (Bottom) Chemotaxis inhibition of CEM CCR5 cells to RANTES by LJC240–L4–UM15. One million CEM CCR5 cells were seeded in the apical chambers of 8 μm transwell inserts, and chemoattraction was induced using RANTES (10 ng/mL) in the presence or absence (control, No Chemokine) of the inhibitors maraviroc (MRVC); LJC240; LJC240–L4; or the peptide triazole chimera, LJC240–L4–UM15, at the IC<sub>50</sub> value for each compound. Data are presented as cells recovered in the basolateral chamber postincubation normalized to cells migrating to RANTES in the absence of inhibitor. Two-way ANOVA was used to compare the inhibitor-treated groups to the RANTES-only control group, and Student’s <i>t</i>-test was used to compare individual groups. Error bars represent means ± SEM; *<i>p</i> ≤ 0.05, **<i>p</i> ≤ 0.01. These data are representative of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Antagonism of the coreceptor was confirmed using chemotaxis assays with the parent molecules, the linker-containing inhibitor, and the bifunctional chimera. As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> (bottom panel), the compounds containing the coreceptor-inhibitor component at the IC<sub>50</sub> values determined in the calcium-mobilization assay all prevented chemotaxis of CEM CCR5 cells to the RANTES chemokine in a transwell assay. The in vitro cell toxicity was measured postincubation, and the inhibitors did not lead to cell death as measured in the apical and basolateral chambers post-treatment (data not shown). These results support the finding that the bifunctional chimera retains the function of antagonizing the CCR5 coreceptor.</div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">4.  Cytotoxicity and HIV Specificity</h3><div class="NLM_p">To assess cellular safety and HIV specificity, we evaluated the chimera (<b>11</b>) in a WST cytotoxicity assay as well as its activity against acute murine leukemia virus (AMLV). As shown in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>, chimera <b>11</b> did not show any cytotoxicity nor any activity against AMLV at the concentration range used.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Cytotoxicity evaluation of chimera <b>11</b> (left) and evaluation of chimera <b>11</b> against AMLV (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04651" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04651" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this work, we engineered a covalent bifunctional chimera capable of inhibiting HIV cell infection through a combination of effects on both sides of the virus–host-cell interface. A linker designed to span the distance between the Env and the coreceptor was utilized to join the peptide triazole and the CCR5 antagonist. The first prototype bifunctional chimera generated, namely, LJC240–L4–UM15 (<b>11</b>), not only displays enhanced inhibitory potency compared with that of a 1:1 (mol/mol) noncovalent mixture of the parent molecules that make up the chimera, but also shows a better synergistic effect compared with that of the noncovalent mixture in a quantitative synergy analysis. This potency was made possible because each component of the chimera is able to function coordinately despite the covalent attachment to the other.</div><div class="NLM_p">The observed synergistic function of the two inhibitory components of the CoRI–PT chimera argues that both components can function at the same time. This in turn implies spatial proximity of the gp120- and coreceptor-binding sites upon the virus–cell encounter. Several hypotheses can be surmised to explain this synergy, based on the modes of action of the chimera components. Because PTs inhibit binding to the coreceptor site likely via affecting the release of the V3 loop,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> we envision that as the virus approaches the cell in the presence of the chimera, the PT part of the chimera can dock onto the virion Env, inhibiting CD4 attachment and altering the V3-loop–CCR5-epitope-release mechanism. However, the chimera has another exposed scaffold, which is the CCR5 blocker. This CCR5 blocker brings the Env–chimera complex closer to the cell to dock onto the CCR5 protein. The net result of this mechanism is the locking of the virus–cell complex in an arrested configuration, leading to the blocking of the infection and later on causing gp120 shedding by the PT-domain function. In other words, the chimera CCR5-inhibitor–L4 part can act as a false V3 loop, bringing the virus closer to the cell not for initiating infection but rather to be blocked. On the other hand, the entropic advantage of the tethered hybrid over the two separate components might be one cause of the synergistic effect.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> When the chimera binds to one site (protein) at the cell–virus interface, much of the entropy cost of binding to the second site (protein) has already been paid. Thus, the free energy of binding for the chimera is not the sum of the free energies of the two components because of entropy, leading to a synergistic potency. Importantly, the shedding function of the chimera was demonstrated in this work. Nonetheless, the sequence of bifunctional-chimera-binding events at the cell–virus interface remains speculative at present.</div><div class="NLM_p">Although other covalent chimeras have been designed that target HIV-1 infection,<a onclick="showRef(event, 'ref35 ref36 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38 ref39 ref40">(35−40)</a> the prototype chimera LJC240–L4–UM15 (<b>11</b>) is unique in the added value of the irreversible inactivation of the virus. Previously, chimeric inhibitors have been reported that target (1) two sites on the HIV-1 Env protein alone,<a onclick="showRef(event, 'ref36 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref36 ref38 ref39">(36,38,39)</a> (2) CD4 and Env gp41,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and (3) Env gp41 and a coreceptor.<a onclick="showRef(event, 'ref37 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref40">(37,40)</a> The latter two findings have demonstrated the feasibility of the bifunctional engagement of both virus Env and host-cell receptors. Because the CCR5 and CXCR4 coreceptors can heterodimerize with each other,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> the CCR5-targeting CoRI–PT chimera reported in the current work has the additional potential to bind to CCR5 in the heterodimer and neutralize the X4-tropic virus by Env inactivation through the PT domain (which is active against both X4- and R5-viruses) before the CXCR4 encounter.</div><div class="NLM_p">Bifunctional chimeras of the CoRI–PT type have an important advantage in avoiding virus resistance by combining components that can function synergistically or separately against evolving viruses and hence challenging the virus to combine escapes to two different inhibitory functions coordinately. Analogously with most if not all virus-protein-targeting antagonists, mutational escape of the Env-binding PT component can occur.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Further, even though CoRIs target a host-cell protein rather than a virus protein, HIV-1 resistance mutations to coreceptor antagonists have been observed to occur by the formation of binding sites on the virus Env protein that can bind the antagonist-bound form of the coreceptor and in this way infect cells in the presence of CoRIs.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> We envision that, because the CCR5 antagonist in the LJC240–L4–UM15 chimera (<b>11</b>) is attached to a relatively large peptide and linker moiety, it would be difficult for the virus to bind the chimera-armed coreceptor because of the increased spatial blockade. However, even if the virus could overcome this blockade, the added challenge of escaping the PT component of the chimera would improve the ability of the chimera to avoid overall inhibitor escape.</div><div class="NLM_p last">The results of the current work open up both future chimera-design opportunities and the potential for expanded functional utility. The chimeric inhibitor presented in this work (<b>11</b>) serves as a prototype for advancing more druglike chimeric inhibitors. The recent discovery of macrocyclic PTs (cPTs),<a onclick="showRef(event, 'ref19 ref43'); return false;" href="javascript:void(0);" class="ref ref19 ref43">(19,43)</a> combined with existing<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and newly discovered CXCR4-targeting small molecules,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> provides the potential to develop druglike and protease-resistant CoRI–cPT variants that target both CCR5 and CXCR4 cellular infections with improved bioavailability. Increased understanding of the structural mechanisms of action of the chimeras will be helpful to guide future chimera design. As the latter is progressing, the relatively small sizes of such chimeras will make it feasible to investigate whether these could inhibit not only virus–cell infections but also cell-to-cell transmission.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16484" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16484" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have designed and produced a fully synthetic bifunctional chimeric inhibitor that can target both sides of the HIV–cell interface. One component blocks the viral envelope, and the second component blocks the cellular coreceptor CCR5. The chimera showed synergistic potency, compared with that of the noncovalent mixture of the individual components. This result demonstrates the ability to make potent, fully synthetic HIV-1 inhibitors by simultaneously targeting the virus Env and its cellular chemokine receptors.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26162" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26162" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Docking of LJC240 onto the CCR5 Receptor</h3><div class="NLM_p last">The recently solved crystal structure of CCR5 bound to the inhibitor maraviroc was used (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MBS">4MBS</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The PDB file was downloaded from the Protein Data Bank and prepared with the protein-preparation wizard in Maestro 9.9 (Schrödinger Suite 2015; Schrödinger, LLC). Before docking LJC240, the docking procedures were validated; the cocrystallized maraviroc was docked onto the receptor structure using the Glide-XP docking protocol, and it showed a similar pose to that of the crystallographically solved bound state (heavy atoms RMSD = 0.31 Å, data not shown) and had a calculated receptor–maraviroc-interaction-energy value of ca. −33.2 kcal/mol as calculated using Szybki 1.8.0.2 (OpenEye Scientific Software).<a onclick="showRef(event, 'link1'); return false;" href="javascript:void(0);" class="ref link1">(46)</a> LJC240 was built and prepared using the builder and LigPrep tools in Maestro 9.9.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(47)</a> The inhibitor LJC240 was then docked onto the CCR5 receptor using the same Glide-XP protocol. This yielded a stable low-energy pose (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) with a calculated receptor–ligand-interaction energy of ca. −27.1 kcal/mol (calculated using Szybki 1.8.0.2, OpenEye Scientific Software).<a onclick="showRef(event, 'link1'); return false;" href="javascript:void(0);" class="ref link1">(46)</a> The docking showed the fluorophenyl moiety of the inhibitor to be the most-solvent-exposed part, with the least-important interaction. This was in agreement with the results of the SAR studies that changes in this part of the molecule can be tolerated.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Docking of UM15 onto the gp120 Protein</h3><div class="NLM_p last">Peptide UM15 was built and docked onto gp120 chain A of the SOSIP Env trimer (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NCO">4NCO</a>,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> structure as previously described)<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(48)</a> using the InducedFit docking protocol.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(49)</a> The N-terminus of UM15 was shown to be well solvated (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) and could be used as an extension point for the chimera synthesis.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemical Synthesis</h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Information</h4><div class="NLM_p">The starting materials were obtained from commercial sources, such as Adamas-Beta, Sigma-Aldrich, J&K, TCI, and Chem-Impex, and were used without further purification. Unless otherwise specified, all reactions were carried out in oven-dried glassware with magnetic stirring. All reagents were weighed and handled in air at room temperature. Column chromatography was performed on silica gel (200–300 mesh). The column output was monitored by TLC on silica gel (100–200 mesh) precoated on glass plates (15 × 50 mm), and spots were visualized by UV light at 254 nm. All new compounds were characterized by <sup>1</sup>H NMR, <sup>13</sup>C NMR, and low- or high-resolution mass spectroscopy. NMR spectra were recorded on a Bruker AVANCE III 400 NMR spectrometer. Chemical shifts for the proton-magnetic-resonance spectra (<sup>1</sup>H NMR) were quoted in parts per million (ppm) and referenced to the signals of residual chloroform (7.26 ppm) or methanol (3.30 ppm). All <sup>13</sup>C NMR spectra were reported in ppm relative to deuterochloroform (77.23 ppm) or methanol (49.00 ppm). The following abbreviations were used to describe peak-splitting patterns when appropriate: br, broad; s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; and dd, doublet of doublets. Coupling constants, <i>J</i>, were reported in hertz units (Hz). Mass spectra were recorded using an ESI ion source unless stated otherwise. All melting points were measured using a BÜCHI 510 melting-point apparatus. The yields in this paper refer to the isolated yields of compounds estimated to be ≥95% pure as determined by <sup>1</sup>H NMR. Unless otherwise specified, the purities of all new compounds were determined by analytical HPLC on an Agilent Technologies 1260 Infinity with an Agilent ZORBAX 3.5 μM SB-phenyl column (4.6 × 75 mm) in one solvent system (solvent A was 0.02% TFA in water, and solvent B was 0.02% TFA in acetonitrile). The flow rate was 1.5 mL/min, the UV detector was at 210 or 254 nm, and the gradient was 5–90% B in 12 min and then 90% B for 3 min.</div><div id="sec5_3_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> Synthesis of 8-Benzyl-8-aza-bicyclo[3.2.1]octan-3-one Oxime (<b>2</b>)<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(50)</a></h5><div class="NLM_p last">A mixture of 8-benzyl-8-aza-bicyclo[3.2.1]octan-3-one (5.00 g, 23.2 mmol), hydroxylamine hydrochloride (1.78 g, 25.6 mmol), and NaHCO<sub>3</sub> (2.54 g, 30.2 mmol) was stirred in EtOH/H<sub>2</sub>O (60 mL; 1:1, v/v) for 18 h. The reaction mixture was filtered, and the residue was washed with water and dried to afford compound <b>2</b> as a white solid (3.24 g, 61% yield, mp 118–120 °C). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.43 (d, <i>J</i> = 7.2 Hz, 2H), 7.38–7.32 (m, 2H), 7.32–7.29 (m, 1H), 3.70 (s, 2H), 3.43–3.34 (m, 2H), 3.02 (d, <i>J</i> = 15.5 Hz, 1H), 2.66–2.59 (m, 1H), 2.31–2.23 (m, 1H), 2.18–2.05 (m, 1H), 2.10–2.00 (m, 2H), 1.66 (t, <i>J</i> = 7.9 Hz, 1H), 1.56 (t, <i>J</i> = 7.6 Hz, 1H). <sup>13</sup>C NMR (151 MHz, CDCl3) δ 157.0, 139.3, 128.6, 128.3, 127.0, 58.5, 57.8, 55.6, 37.3, 31.3, 27.6, 26.7. HRMS (ESI) calcd for C<sub>14</sub>H<sub>19</sub>N<sub>2</sub>O [M + H]<sup>+</sup>: 231.1492, found 231.1489.</div></div><div id="sec5_3_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> Synthesis of <i>exo</i>-8-Benzyl-8-aza-bicyclo[3.2.1]oct-3-ylamine (<b>3</b>)<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(51)</a></h5><div class="NLM_p last">A solution of compound <b>2</b> (3.00 g, 13.0 mmol) in pentanol (50 mL) was heated under reflux. Sodium (3.59 g, 156.3 mmol) was added portionwise over 2.5 h. The reaction was then heated under reflux for 2 h further and then cooled in an ice bath. Water was added until no more hydrogen gas was evolved. The mixture was acidified using 6 N aqueous hydrochloric acid, and the phases were separated. The organic layer was extracted with 6 N aqueous hydrochloric acid, the combined aqueous extracts were basified to pH 12 with sodium hydroxide pellets, and the aqueous solution was extracted with ethyl acetate. The combined organic solutions were dried with MgSO<sub>4</sub>, filtered, and evaporated under reduced pressure to afford compound <b>3</b> as a colorless oil (1.91 g, 68% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.45–7.36 (m, 2H), 7.30–7.25 (m, 2H), 7.26–7.19 (m, 1H), 3.63 (s, 2H), 3.38–3.23 (m, 3H), 2.09–1.97 (m, 2H), 1.96–1.80 (m, 4H), 1.67–1.53 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl3) δ 138.2, 128.4, 127.9, 126.7, 57.5, 54.5, 43.6, 35.7, 26.1. HRMS (ESI) calcd for C<sub>14</sub>H<sub>21</sub>N<sub>2</sub> [M + H]<sup>+</sup>: 217.1699, found 217.1704.</div></div><div id="sec5_3_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> Synthesis of <i>exo</i>-(8-Benzyl-8-aza-bicyclo[3.2.1]oct-3-yl)-carbamic Acid <i>tert</i>-Butyl Ester (<b>4</b>)<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(52)</a></h5><div class="NLM_p last">A mixture of compound <b>3</b> (3.00 g, 13.9 mmol), Boc<sub>2</sub>O (3.33 g, 15.3 mmol), and TEA (3.9 mL, 27.7 mmol) was stirred in THF (52 mL) for 18 h. The reaction mixture was evaporated under reduced pressure. The residue was purified by recrystallization, affording compound <b>4</b> as a white solid (4.19 g, 95% yield, mp 174–175 °C). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.38 (d, <i>J</i> = 7.3 Hz, 2H), 7.32 (t, <i>J</i> = 7.4 Hz, 2H), 7.26- 7.23 (m, 1H), 3.56 (s, 2H), 3.31–3.14 (m, 2H), 2.05–2.00 (m, 2H), 1.84–1.78 (m, 2H), 1.73–1.69 (m, 2H), 1.58–1.50 (m, 3H), 1.43 (s, 9H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 155.3, 140.0, 128.5, 128.2, 126.8, 79.2, 58.7, 56.1, 42.8, 38.7, 28.4, 26.5. HRMS (ESI) calcd for C<sub>19</sub>H<sub>29</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>: 317.2224, found 317.2224.</div></div><div id="sec5_3_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> Synthesis of <i>exo</i>-(8-Aza-bicyclo[3.2.1]oct-3-yl)-carbamic Acid <i>tert</i>-Butyl Ester (<b>5</b>)<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(53)</a></h5><div class="NLM_p last">To a solution of compound <b>4</b> (2.73 g, 8.6 mmol) in methanol (40 mL) were added 10% Pd/C (273 mg, ca. 50% water) and HCO<sub>2</sub>NH<sub>4</sub> (3.81 g, 60.4 mmol), and the above mixture was heated under reflux for 15 min. After it cooled to room temperature, the reaction mixture was evaporated under reduced pressure. Purification by flash chromatography on silica gel (10:1 DCM/methanol) afforded compound <b>5</b> as a white solid (1.43 g, 73% yield, mp 271–272 °C). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.80–4.76 (m, 1H), 4.08–4.02 (m, 2H), 2.29–2.20 (m, 2H), 2.05–1.93 (m, 6H), 1.42 (s, 9H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 169.0, 79.8, 54.7, 41.1, 35.4, 28.3, 26.3. HRMS (ESI) calcd for C<sub>12</sub>H<sub>23</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>: 227.1754, found 227.1748.</div></div><div id="sec5_3_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> Synthesis of (3-Chloro-4-methyl-phenyl)-(3-chloro-propyl)-amine (<b>7</b>)<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(54)</a></h5><div class="NLM_p last">To a mixture of 1-bromo-3-chloropropane (10.5 mL, 105.9 mmol) in DMF was added KI (586 mg, 3.5 mmol), and the mixture was stirred at room temperature for 30 min; then, TEA (19.6 mL, 141.2 mmol) and 3-chloro-4-methyl-phenylamine (5.00 g, 35.3 mmol) were added, and the solution was stirred at room temperature for 72 h further. The reaction mixture was filtered, and the filtrate was concentrated in a vacuum. The residue was diluted with EtOAc, washed with water and brine, dried with MgSO<sub>4</sub>, filtered, and concentrated in a vacuum. Purification by flash chromatography on silica gel (25:1 petroleum ether/ethyl acetate) afforded compound <b>7</b> as a yellow oil (5.20 g, 68% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.01 (d, <i>J</i> = 8.2 Hz, 1H), 6.63 (d, <i>J</i> = 2.4 Hz, 1H), 6.44 (dd, <i>J</i> = 8.2, 2.5 Hz, 1H), 3.65 (t, <i>J</i> = 6.2 Hz, 2H), 3.30 (t, <i>J</i> = 6.6 Hz, 2H), 2.25 (s, 3H), 2.05 (p, <i>J</i> = 6.5 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 147.0, 134.9, 131.4, 124.4 113.1, 111.7, 42.5, 41.1, 31.8, 18.9. HRMS (ESI) calcd for C<sub>10</sub>H<sub>14</sub>Cl<sub>2</sub>N [M + H]<sup>+</sup>: 218.0498, found 218.0497.</div></div><div id="sec5_3_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> Synthesis of 1-Acetyl-piperidine-4-carboxylic Acid (3-Chloro-4-methyl-phenyl)-(3-chloro-propyl)-amide (<b>8</b>)<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(54)</a></h5><div class="NLM_p last">A solution of 1-acetylpiperidine-4-carboxylic acid (6.75 g, 39.4 mmol) in SOCl<sub>2</sub> (40 mL) was stirred for 2 h at room temperature. The reaction mixture was diluted with petroleum ether and filtered to afford the acyl chloride as a white solid. Compound <b>7</b> (2.87 g, 13.1 mmol) was dissolved in DCM (50 mL), TEA (5.5 mL, 39.4 mmol) and the acyl chloride were added, and then the mixture was stirred at room temperature for 2 h further. The residue was diluted with DCM, washed with water and brine, dried with MgSO<sub>4</sub>, filtered, and concentrated in a vacuum. Purification by flash chromatography on silica gel (1:1 petroleum ether/ethyl acetate) afforded compound <b>8</b> as a white solid (3.74 g, 77% yield, mp 101–103 °C). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.31 (d, <i>J</i> = 8.0 Hz, 1H), 7.18 (d, <i>J</i> = 2.0 Hz, 1H), 6.97 (dd, <i>J</i> = 8.0, 2.1 Hz, 1H), 4.51 (d, <i>J</i> = 13.3 Hz, 1H), 3.78–3.75 (m, 2H), 3.53 (t, <i>J</i> = 6.6 Hz, 2H), 2.87–2.81 (m, 1H), 2.43 (s, 3H), 2.39–2.28 (m, 2H), 2.05 (s, 3H), 2.02–1.96 (m, 2H), 1.67–1.55 (m, 5H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 174.2, 168.8, 140.9, 136.7, 135.4, 132.1, 128.4, 126.2, 47.7, 45.5, 42.3, 40.7, 39.3, 30.8, 28.8, 28.3, 21.4, 19.8. HRMS (ESI) calcd for C<sub>18</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>: 371.1288, found 371.1281.</div></div><div id="sec5_3_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> Synthesis of <i>exo</i>-1-Acetyl-piperidine-4-carboxylic Acid [3-(3-Amino-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-(3-chloro-4-methyl-phenyl)-amide (<b>9</b>)</h5><div class="NLM_p last">To a mixture of compound <b>8</b> (1.70 g, 4.6 mmol), compound <b>5</b> (1.04 g, 4.6 mmol), and KI (760 mg, 4.6 mmol) in acetonitrile was added NaHCO<sub>3</sub> (1.15 g, 13.7 mmol), and the mixture was stirred at reflux for 12 h. After cooling to room temperature, the mixture was filtered, and the filtrate was concentrated in a vacuum. The residue was diluted with EtOAc, washed with water and brine, dried with MgSO<sub>4</sub>, filtered, and concentrated in a vacuum. Purification by flash chromatography on silica gel (25:1 DCM/methanol) afforded the product as a white foam (1.72 g, 67% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.31 (d, <i>J</i> = 8.1 Hz, 1H), 7.20 (d, <i>J</i> = 1.4 Hz, 1H), 7.08 (d, <i>J</i> = 7.7 Hz, 1H), 4.65–4.46 (m, 2H), 3.88–3.60 (m, 4H), 3.49–3.38 (m, 2H), 2.82 (t, <i>J</i> = 13.7 Hz, 1H), 2.57–2.50 (m, 2H), 2.40 (s, 3H), 2.36–2.25 (m, 2H), 2.03 (s, 3H), 2.00–1.95 (m, 2H), 1.84–1.79 (m, 8H), 1.67–1.54 (m, 3H), 1.41 (s, 9H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 174.3, 168.8, 155.3, 140.7, 136.7, 135.3, 132.1, 128.4, 126.6, 79.5, 59.7, 54.7, 48.9, 47.5, 45.5, 41.8, 40.7, 39.4, 36.8, 28.9, 28.4, 28.3, 25.8, 21.4, 19.8. HRMS (ESI) calcd for C<sub>30</sub>H<sub>46</sub>ClN<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup>: 561.3202, found 561.3214. Purity: 99.8% (<i>t</i><sub>R</sub> = 6.63).</div></div><div id="sec5_3_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> Synthesis of 4-8-(3-(1-Acetyl-<i>N</i>-(3-chloro-4-methylphenyl)piperidine-4-carboxamido)propyl)-8-azabicyclo[3.2.1]octan-3-yl)sulfamoyl)benzoic Acid (<b>10</b>)</h5><div class="NLM_p last">To a solution of compound <b>9</b> (2.62 g, 4.7 mmol) in methanol, HCl (4.8 M, in methanol) was added, and the mixture was stirred at room temperature for 4 h. After the reaction mixture was concentrated in a vacuum, the residue (1.57 g, 3.4 mmol) was dissolved in 1,4-dioxane (40 mL); then, 4-(chlorosulfonyl)benzoic acid (1.50 g, 6.8 mmol) and a solution of Na<sub>2</sub>CO<sub>3</sub> (1.08 g, 10.2 mmol) in H<sub>2</sub>O (20 mL) were added, and the mixture was stirred at room temperature for 12 h. The residue was evaporated in a vacuum, washed with a mixture of methanol and DCM (9:1 DCM/methanol), and filtered, and the filtrate was concentrated in a vacuum. Purification by flash chromatography on silica gel (10:1 DCM/methanol) afforded compound <b>10</b> as a white solid (1.22 g, 40% yield for two steps, mp 182–184 °C). <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.01 (d, <i>J</i> = 8.5 Hz, 2H), 7.82 (d, <i>J</i> = 8.5 Hz, 2H), 7.35 (dd, <i>J</i> = 8.5, 5.1 Hz, 2H), 7.11 (dd, <i>J</i> = 8.1, 2.1 Hz, 1H), 4.35–4.26 (m, 1H), 3.86–3.79 (m, 2H), 3.78–3.70 (m, 1H), 3.67–3.60 (m, 2H), 3.56–3.46 (m, 1H), 2.95–2.87 (m, 2H), 2.78 (t, <i>J</i> = 11.4 Hz, 1H), 2.42–2.36 (m, 1H), 2.31 (s, 3H), 2.29–2.24 (m, 1H), 2.16–2.08 (m, 2H), 1.95 (s, 3H), 1.86–1.74 (m, 8H), 1.59 (d, <i>J</i> = 15.2 Hz, 3H), 1.45 (d, <i>J</i> = 16.2 Hz, 1H). <sup>13</sup>C NMR (126 MHz, MeOD) δ176.0 (2), 169.7, 143.2, 139.6, 139.0, 136.7, 134.7, 131.9, 129.4, 127.7, 125.9, 125.7, 60.8, 45.9, 44.8, 43.1, 40.0, 38.9, 28.0, 27.5, 23.5, 22.3, 19.3, 18.0. HRMS (ESI) calcd for C<sub>32</sub>H<sub>42</sub>ClN<sub>4</sub>O<sub>6</sub>S [M + H]<sup>+</sup>: 645.2508, found 645.2506. Purity: 99.5% (<i>t</i><sub>R</sub> = 5.61).</div></div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Solid-Phase Synthesis of LJC240–L4</h3><div class="NLM_p">Rink amide resin (0.1 mmol, 200–400 mesh) was swollen in 10 mL of DMF/DCM (1:1). Fmoc deprotection was achieved using a solution of 20% piperidine in DMF. The Fmoc-protected linker (116 mg, 0.3 mmol) was dissolved in DMF, and DIEA (124 μL, 0.75 mmol) and HBTU (110 mg, 0.29 mmol) were added. The mixture was vibrated for 30 min at room temperature and then added to the reaction vessel, which was vibrated at room temperature for 4 h. Four units of the linker were installed. LJC240–COOH (<b>10</b>, 193 mg, 0.3 mmol) was dissolved in DMF. Then, DIEA (124 μL, 0.75 mmol), HOBt (41 mg, 0.3 mmol), and HBTU (110 mg, 0.29 mmol) were added, and the mixture was vibrated for 30 min and then added to the (linker)<sub>4</sub>–resin vessel. The reaction vessel was vibrated at room temperature for 12 h. Cleavage was carried out using a cocktail of trifluoroacetic acid/ethanedithiol/H<sub>2</sub>O (4.75:0.125:0.125, v/v) for 2 h at room temperature. The cleaved-compound solution was concentrated under a gentle N<sub>2</sub> stream, and then dissolved in ACN/H<sub>2</sub>O. The crude product was purified by semipreparative HPLC on an EasySep-1050 with an XBridge Prep C18 reversed-phase column (19 × 150 mm, ACN/H<sub>2</sub>O/0.1% TFA, <i>t</i><sub>R</sub> = 17.7 min, gradient: 10–90% ACN over 30 min, flow rate of 4 mL/min) and finally evaporated in a vacuum to yield the ideal product. <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.06–7.99 (m, 4H), 7.51–7.46 (m, 2H), 7.24 (dd, <i>J</i> = 7.9, 2.0 Hz, 1H), 4.45 (d, <i>J</i> = 13.9 Hz, 1H), 4.02 (s, 4H), 3.99 (s, 3H), 3.91–3.75 (m, 3H), 3.75–3.64 (m, 17H), 3.62–3.55 (m, 6H), 3.51–3.39 (m, 5H), 3.06–2.98 (m, 2H), 2.95–2.82 (m, 2H), 2.72 (s, 2H), 2.57–2.49 (m, 1H), 2.44 (s, 3H), 2.43–2.38 (m, 1H), 2.29–2.21 (m, 2H), 2.08 (s, 3H), 2.06 (s, 1H), 2.02–1.87 (m, 7H), 1.77–1.54 (m, 5H), 1.38–1.28 (m, 4H). <sup>13</sup>C NMR (126 MHz, MeOD) δ 176.0, 174.0, 171.0, 169.6, 166.9, 143.8, 139.6, 137.8, 136.7, 134.7, 131.8, 127.7, 127.6, 126.2, 125.9, 70.1 (4), 69.7–69.1 (8), 68.9–68.5 (4), 61.2, 45.8, 44.8, 43.1, 40.0, 39.2, 38.9, 37.9, 36.4, 33.5, 28.1, 27.5, 23.4, 22.2, 19.3, 18.0. HRMS (ESI) calcd for C<sub>56</sub>H<sub>87</sub>ClN<sub>9</sub>O<sub>17</sub>S [M + H]<sup>+</sup>: 1224.5624, found 1224.5627. Purity: 99.0% (<i>t</i><sub>R</sub> = 8.47).</div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Solid-Phase Synthesis of LJC240–L4–UM15 (<b>11</b>)</h4><div id="sec5_4_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Solid-Phase Synthesis of Resin-Bound Linker–PT</h5><div class="NLM_p last">Using an Fmoc-based synthesis strategy, the following sequence was assembled using microwave-assisted coupling: (linker)<sub>4</sub>–ile–asn–asn–ile–AzidoPro–trp–resin. The resin is the rink amide resin (100–200 mesh size), and the synthesis scale was 0.25 mM. An activation scheme (1 mL of 0.5 M DIC/0.5 mL of 0.5 M Oxyma) was used. Deprotection of the Fmoc groups was performed with 5 mL of 20% piperidine and 0.1 M HOBt in DMF.</div></div><div id="sec5_4_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Coupling LJC240–COOH to the Linker–PT–Resin</h5><div class="NLM_p last">The (linker)<sub>4</sub>–peptide–resin was swollen by soaking it in 10 mL of DMF/DCM (1:1). LJC240–COOH (<b>10</b>, 1.1 equiv), HBTU (2.2 equiv), HOBt (2.2 equiv), and DIPEA (4.4 equiv) were added to the reaction vessel. The vessel was vibrated for 10 h at room temperature, and the reaction was monitored by the Kaiser test until negative (no blue color) results were observed. The resin-bound complex was then filtered, and the resin was washed thoroughly with DMF, methanol, and DCM.</div></div><div id="sec5_4_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Click Reaction of the Alkyne (Ethynylferrocene) with the Azide Group on the Pro Residue</h5><div class="NLM_p last">The resin-bound fusion was mixed with 5 mL of ACN, 4 mL of H<sub>2</sub>O, 1.06 mL of DIPEA, and 0.53 mL of pyridine with 5 equiv of ethynylferrocene, and the reaction vessel was vibrated at room temperature for 12 h. The resin-bound product was washed thoroughly with 5% HCl (2 × 50 mL), DMF (2 × 50 mL), and DCM (2 × 50 mL).</div></div><div id="sec5_4_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> Cleavage of the Fusion from the Resin and Deprotection of the Peptide Side Chains</h5><div class="NLM_p last">The resin-bound product was mixed with 20 mL of a chilled cleavage mixture (95% TFA, 2.5% H<sub>2</sub>0, and 2.5% TIPS) and vibrated for 2.5 h at room temperature. The reaction mixture was filtered, and the leftover resin was washed with 10 mL of the cleavage mixture. The acidic filtrate was concentrated under a gentle N<sub>2</sub> stream. Precooled ether (30 mL) was added to the residue, and after rigorous vortexing and centrifugation, the ether layer was decanted. This ether-washing step was repeated two to three times until the ether layer was no longer colored. The residue was then vacuum-dried, redissolved in an ACN/H<sub>2</sub>0/0.1% TFA mixture for RP-HPLC purification (Waters HPLC, absorption at 210 nm) using a Waters C18 prep column. The pure HPLC fractions (≥97% purity as judged by analytical HPLC; 5–95% ACN with 0.1% TFA in 40 min) were lyophilized to give the chimera, <b>11</b>, as a pale-yellow powder (65% yield calculated on the basis of the cleavage of 0.5 g of resin). The MALDI-TOF-determined mass of the purified chimera was found to be 2212.75 Da, comparable to the calculated mass of 2211.96 Da.</div></div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Production of the HIV-1 Envelope-Pseudotyped Virus</h3><div class="NLM_p last">Recombinant envelope-pseudotyped viruses were prepared by cotransfection of an envelope-expression plasmid, either JR-FL (R5-tropic) or HxBc2 (X4-tropic), with an HIV-1-viral-backbone plasmid encoded with a luciferase gene and lacking Env, pNL Luc AM.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(55)</a> A combination of 4 mg of Env and 8 mg of backbone DNA were transfected into 293T cells using PEI (Fisher Scientific) as a transfection reagent. Cell supernatant containing the recombinant viruses was collected after 48–72 h and purified through a 6–20% iodixanol (Sigma-Aldrich) gradient to remove free viral proteins and exosomes. The gradient was performed at 4 °C for 2 h at 30 000 rpm (SW41 rotor, Beckman ultracentrifuge). The fractions were collected following the spin, validated as previously described, and stored at −80 °C until needed.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Infection-Inhibition Assay</h3><div class="NLM_p last">The LJC240–L4–UM15 (<b>11</b>) bifunctional chimera was evaluated for potency using a standard pseudoviral assay.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(55,56)</a> Briefly, envelope-pseudotyped viruses were treated for 30 min at 37 °C with the inhibitor and then added to HOS cells expressing both CD4 and an appropriate coreceptor depending on the assay. The infection was carried out for 24 h before a medium change was performed to remove any residual virus or inhibitor. The production of the reporter luciferase was allowed to continue for an additional 24 h before the cells were lysed with passive-lysis buffer (Promega). Cell lysates were transferred to a white well plate and mixed with 1 mM luciferin salt (Anaspec) diluted in 0.1 M potassium phosphate buffer containing 0.1 M magnesium sulfate. The luminescence was measured using a Wallace 1450 Microbeta luminescence reader at a wavelength of 490 nM.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Synergy Analysis</h3><div class="NLM_p last">For the synergy analysis, the cell-infection-inhibition assay was set up as described above with LJC240–L4, UM15, chimera <b>11</b>, and the combination of LJC240–L4 and UM15 at a 1:30 ratio based on the initially derived IC<sub>50</sub> values. The values of percent Bal.01 infection were plotted against the concentration of each inhibitor used in the combination, and the IC<sub>50</sub> values were calculated and compared with the IC<sub>50</sub> values of the chimera derived from the same experiment. The IC<sub>50</sub> values so determined were plotted in an isobologram to assess the synergistic effects of both the noncovalent mixture and the chimera.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> HIV Specificity and Cytotoxicity</h3><div class="NLM_p">HIV specificity was observed by performing an infection-inhibition analysis of the bifunctional chimera against amyotrophic leukemia virus (AMLV) along with pseudotyped HIV-1. In addition, infection-inhibition activities were evaluated with the functionally CD4-independent virus mutant J1HX N197S and compared with those of the nonmutated, CD4-dependent parent virus (J1HX).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Briefly, the viruses were treated for 30 min at 37 °C with the inhibitor and then added to HOS cells. The infection was carried out for 24 h before a media change was performed to remove any residual virus or inhibitor. The production of the reporter luciferase was allowed to continue for an additional 24 h before the cells were lysed with passive-lysis buffer (Promega), and a luciferase assay was performed to quantify the signal.</div><div class="NLM_p last">The cytotoxicity of the bifunctional chimera, <b>11</b>, was measured by performing a colorimetric assay designed to measure the relative proliferation rates of cells in culture. Briefly, the cells were treated with the serially diluted bifunctional chimera for 24 h, after which a tetrazolium salt, WST-1, was added to the cells. The viability of the cells was measured by detecting the conversion of the tetrazolium salt, WST-1, into a colored dye (Optical density measurement at 400 nM) by mitochondrial dehydrogenase enzymes functional only in live cells.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Shedding Protocol</h3><div class="NLM_p last">HIV-1 shedding was determined by performing a Western-blot analysis to observe the amount of shed gp120 when the viruses were treated with the bifunctional chimera, <b>11</b>, and UM15. Pseudovirus BaL.01 was produced and purified as described above. Aliquots (90 μL) of purified BaL.01 pseudovirus were mixed with 10 μL of the compounds (UM15 or LJC240–L4–UM15) at various dilutions or PBS, which served as the negative control. The mixtures were incubated for 18 h at 37 °C and then spun at 15 000 rpm at 4 °C for 2 h. The supernatants (80 μL) of the mixtures were taken and separated by 10% SDS-PAGE gel electrophoresis. Then, Western blotting was used to determine the gp120 contents in the supernatants with a primary anti-gp120 antibody, D7324, and a secondary antibody, anti-sheep HRP. ImageJ was used to determine the Western-blot band densities.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Surface-Plasmon-Resonance-Interaction Analysis</h3><div class="NLM_p last">SPR experiments were performed on a BIACORE 3000 optical biosensor (GE) at 25 °C using standard PBS buffer containing 0.005% tween 20 and 2% DMSO. Three flow cells in a CM5 chip were used for the amine coupling of different ligands using standard 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide (EDC)–<i>N</i>-hydroxysuccinamide (NHS) chemistry. Flow cell 1, containing ∼2000 RU of immobilized 2B6R antibody, served as a control for flow cells 2 and 3, which contained 2000 RU of CD4 and 17b antibodies, respectively. The protein gp120 (200 nM) in the presence of increasing concentrations of LJC240–L4–UM15 (<b>11</b>) and UM15 was injected over flow cells 1, 2, and 3. After each sample run, bound gp120 was removed with 10 mM HCl (two pulses of 10 s). All experiments were done in sets of three. Data analysis was performed using BIAevaluation V4.1.1 software (GE). To correct for nonspecific binding, response signals from the buffer injection and from the control flow cell were subtracted from all sensorgrams. Inhibition data were determined by calculating the inhibitor concentration required for 50% inhibition of maximal binding (IC<sub>50</sub>). The inhibition curve was plotted and then fitted using the four-parameter <a class="ref internalNav" href="#ueq1" aria-label="eq 1">eq 1</a>, as shown below, using Origin Pro 8 graphing software.<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_m001.gif" alt="" id="_i41" /></img><span class="labelSpan">(1)</span></span>where <i>R</i><sub>high</sub> is the response at the highest inhibitor concentration, <i>R</i><sub>low</sub> is the response at the low inhibitor concentration, concn is the concentration of the inhibitor, and <i>A</i><sub>1</sub> and <i>A</i><sub>2</sub> are the fitting parameters.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Calcium-Mobilization Assay</h3><div class="NLM_p last">CHO cells stably expressing CCR5 and Gα16 were loaded with 2 μmol/L Fluo-4 AM in Hanks’ balanced salt solution (HBSS, containing 5.4 mM KCl, 0.3 mM Na<sub>2</sub>HPO<sub>4</sub>, 0.4 mM KH<sub>2</sub>PO<sub>4</sub>, 4.2 mM NaHCO<sub>3</sub>, 1.3 mM CaCl<sub>2</sub>, 0.5 mM MgCl<sub>2</sub>, 0.6 mM Mg<sub>2</sub>SO<sub>4</sub>, 137 mM NaCl, 5 g/L BSA, 5.6 mM glucose, 250 μM sulfinpyrazone, pH 7.4) at 37 °C for 45 min. After the cells were rinsed with the reaction buffer, HBSS (50 μL) containing known antagonists (the positive control), the compounds of interest, or DMSO (the negative control, final concentration of 1%) were added. After an incubation at room temperature for 10 min, RANTES (25 μL, final concentration 30 nM) was dispensed into the well using a FlexStation II microplate reader (Molecular Devices), and the intracellular calcium change was recorded with an excitation wavelength of 485 nm and an emission wavelength of 525 nm. The half-maximal inhibitory concentrations (IC<sub>50</sub>) of the compounds were determined with GraphPad Prism software by constructing their dose–response curves.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Cellular-Chemotaxis Assay</h3><div class="NLM_p last">CEM CCR5 cells were resuspended to a density of 2.0 × 10<sup>6</sup> cells/mL in RPMI-1640 medium containing 0.1% BSA and 10% FBS. The cells were preincubated with maraviroc, LJC240, LJC240–L4, and LJC240–L4–UM15 (<b>11</b>) at the IC<sub>50</sub> values indicated in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> for 15 min at room temperature. The cells (500 μL, 1.0 × 10<sup>6</sup> cells) were seeded in smooth-walled inserts containing polycarbonate membranes with 8 μm pores in a 24-well tissue-culture plate (BrandTech). Complete medium (1 mL) containing RANTES (10 ng/mL) was added to the lower chamber, and the plate was incubated for 6 h at 37 °C in 5% CO<sub>2</sub>. The well with complete media only served as a control for RANTES-induced migration. Migrated cells that adhered to the basolateral surface of the insert were dissociated by incubating the inserts in 1 mL of HBSS with 1 mM EDTA for 30 min at 37 °C in 5% CO<sub>2</sub>. A 1:1 mixture (10 μL) of cells from the basolateral chamber and dissociated cells was then mixed with 10 μL of trypan blue, and the live cells were counted using the Countess automated cell counter (Thermo Scientific). Two-way ANOVA was used to compare the inhibitor-treated groups with the RANTES-only control group, and Student’s <i>t</i>-test was used to compare individual groups. Error bars represent means ± SEM; *<i>p</i> ≤ 0.05, **<i>p</i> ≤ 0.01.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00477" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18725" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18725" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00477" class="ext-link">10.1021/acs.jmedchem.8b00477</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">UM15–SOSIP (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00477/suppl_file/jm8b00477_si_001.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">LJC240–CCR5 complex (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00477/suppl_file/jm8b00477_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular-formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00477/suppl_file/jm8b00477_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00477/suppl_file/jm8b00477_si_001.pdb">jm8b00477_si_001.pdb (571.37 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00477/suppl_file/jm8b00477_si_002.pdb">jm8b00477_si_002.pdb (459.4 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00477/suppl_file/jm8b00477_si_003.csv">jm8b00477_si_003.csv (0.93 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00477" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02234" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02234" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ya-Qiu Long</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai Institute of Materia
Medica, Chinese Academy of Science, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">College
of Pharmaceutical Sciences, Soochow University
Medical College, Suzhou 215123, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#34585b5a534d55455d4174474150551a5150411a575a"><span class="__cf_email__" data-cfemail="caa6a5a4adb3abbba3bf8ab9bfaeabe4afaebfe4a9a4">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irwin Chaiken</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, , , Drexel University College
of Medicine, Philadelphia, Pennsylvania 19102, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5930343a6b6a193d2b3c213c35773c3d2c"><span class="__cf_email__" data-cfemail="99f0f4faabaad9fdebfce1fcf5b7fcfdec">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adel A. Rashad</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, , , Drexel University College
of Medicine, Philadelphia, Pennsylvania 19102, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6113-0333" title="Orcid link">http://orcid.org/0000-0001-6113-0333</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li-Rui Song</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai Institute of Materia
Medica, Chinese Academy of Science, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">College
of Pharmaceutical Sciences, Soochow University
Medical College, Suzhou 215123, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Number 19A Yuquan Road, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew P. Holmes</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, , , Drexel University College
of Medicine, Philadelphia, Pennsylvania 19102, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kriti Acharya</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, , , Drexel University College
of Medicine, Philadelphia, Pennsylvania 19102, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3408-149X" title="Orcid link">http://orcid.org/0000-0002-3408-149X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shiyu Zhang</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, 
    , , , Drexel University College
of Medicine, Philadelphia, Pennsylvania 19102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, Pennsylvania 19104, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhi-Long Wang</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai Institute of Materia
Medica, Chinese Academy of Science, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ebony Gary</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine, , , Drexel University College
of Medicine, Philadelphia, Pennsylvania 19102, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Xie</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai Institute of Materia
Medica, Chinese Academy of Science, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vanessa Pirrone</span> - <span class="hlFld-Affiliation affiliation">Department of Microbiology
and Immunology, , , Drexel University College
of Medicine, Philadelphia, Pennsylvania 19102, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michele A. Kutzler</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine, , , Drexel University College
of Medicine, Philadelphia, Pennsylvania 19102, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.A.R., L.S., and A.P.H. contributed equally to this work. A.A.R., A.P.H., Y.Q.L., and I.C. wrote the main manuscript text. A.A.R. designed, synthesized, and purified the LJC240–L4–UM15 bifunctional chimera and managed the experimental path of the chimera evaluation. A.A.R. and L.S. designed and synthesized the component inhibitors. A.P.H. and K.A. designed and performed the virological studies that demonstrated the infection-inhibition functions and synergistic activities. K.A. performed the SPR experiments. S.Z. performed the gp120-shedding assays. Z.L.W. and X.X. performed the calcium-mobilization assays. E.G. and M.A.K. performed the chemotaxis assays. V.P. helped with the synergy analysis. Y.Q.L. and I.C. jointly directed the project. All authors reviewed the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24425" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24425" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Y.Q.L. received funding from the National Natural Science Foundation of China (81761128022, 81361120410, and 81325020), and I.C. received funding from the National Institutes of Health (R01AI106633 and P01GM56550). We thank Openeye Scientific Software (Santa Fe, NM; <a href="http://www.eyesopen.com" class="extLink">http://www.eyesopen.com</a>) for providing a complementary academic license of their software package.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ACN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">DIC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-diisopropylcarbodiimide</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">Env</td><td class="NLM_def"><p class="first last">HIV envelope gp160</p></td></tr><tr><td class="NLM_term">Fmoc</td><td class="NLM_def"><p class="first last">9-fluorenylmethoxycarbonyl</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HOBT</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">PT</td><td class="NLM_def"><p class="first last">peptide triazole</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">tBu</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyl</p></td></tr><tr><td class="NLM_term">TIPS</td><td class="NLM_def"><p class="first last">triisoproylsilane</p></td></tr><tr><td class="NLM_term">Trt</td><td class="NLM_def"><p class="first last">triphenylmethyl</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild type.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88022" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88022" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 56 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilen, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilton, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doms, R. W.</span></span> <span> </span><span class="NLM_article-title">Hiv: Cell binding and entry</span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">a006866</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a006866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1101%2Fcshperspect.a006866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=22908191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlemtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a006866&author=C.+B.+Wilenauthor=J.+C.+Tiltonauthor=R.+W.+Doms&title=Hiv%3A+Cell+binding+and+entry&doi=10.1101%2Fcshperspect.a006866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">HIV: cell binding and entry</span></div><div class="casAuthors">Wilen, Craig B.; Tilton, John C.; Doms, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">a006866/1-a006866/13</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  The first step of the human immunodeficiency virus (HIV) replication cycle-binding and entry into the host cell-plays a major role in detg. viral tropism and the ability of HIV to degrade the human immune system.  HIV uses a complex series of steps to deliver its genome into the host cell cytoplasm while simultaneously evading the host immune response.  To infect cells, the HIV protein envelope (Env) binds to the primary cellular receptor CD4 and then to a cellular coreceptor.  This sequential binding triggers fusion of the viral and host cell membranes, initiating infection.  Revealing the mechanism of HIV entry has profound implications for viral tropism, transmission, pathogenesis, and therapeutic intervention.  Here, we provide an overview into the mechanism of HIV entry, provide historical context to key discoveries, discuss recent advances, and speculate on future directions in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTFIru0CcC0LVg90H21EOLACvtfcHk0liUfkZb8hqBoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlemtL0%253D&md5=08e66975badc489e248c1ada616a86e7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006866%26sid%3Dliteratum%253Aachs%26aulast%3DWilen%26aufirst%3DC.%2BB.%26aulast%3DTilton%26aufirst%3DJ.%2BC.%26aulast%3DDoms%26aufirst%3DR.%2BW.%26atitle%3DHiv%253A%2520Cell%2520binding%2520and%2520entry%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da006866%26doi%3D10.1101%2Fcshperspect.a006866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macartney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickett, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Burchnell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armour, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros, M.</span></span> <span> </span><span class="NLM_article-title">Maraviroc (uk-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4721</span>– <span class="NLM_lpage">4732</span>, <span class="refDoi"> DOI: 10.1128/AAC.49.11.4721-4732.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FAAC.49.11.4721-4732.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=16251317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Siu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=4721-4732&author=P.+Dorrauthor=M.+Westbyauthor=S.+Dobbsauthor=P.+Griffinauthor=B.+Irvineauthor=M.+Macartneyauthor=J.+Moriauthor=G.+Rickettauthor=C.+Smith-Burchnellauthor=C.+Napierauthor=R.+Websterauthor=D.+Armourauthor=D.+Priceauthor=B.+Stammenauthor=A.+Woodauthor=M.+Perros&title=Maraviroc+%28uk-427%2C857%29%2C+a+potent%2C+orally+bioavailable%2C+and+selective+small-molecule+inhibitor+of+chemokine+receptor+CCR5+with+broad-spectrum+anti-human+immunodeficiency+virus+type+1+activity&doi=10.1128%2FAAC.49.11.4721-4732.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity</span></div><div class="casAuthors">Dorr, Patrick; Westby, Mike; Dobbs, Susan; Griffin, Paul; Irvine, Becky; Macartney, Malcolm; Mori, Julie; Rickett, Graham; Smith-Burchnell, Caroline; Napier, Carolyn; Webster, Rob; Armour, Duncan; Price, David; Stammen, Blanda; Wood, Anthony; Perros, Manos</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4721-4732</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Maraviroc (UK-427,857) is a selective CCR5 antagonist with potent antihuman immunodeficiency virus type 1 (HIV-1) activity and favorable pharmacol. properties.  Maraviroc is the product of a medicinal chem. effort initiated following identification of an imidazopyridine CCR5 ligand from a high-throughput screen of the Pfizer compd. file.  Maraviroc demonstrated potent antiviral activity against all CCR5-tropic HIV-1 viruses tested, including 43 primary isolates from various clades and diverse geog. origin (geometric mean 90% inhibitory concn. of 2.0 nM).  Maraviroc was active against 200 clin. derived HIV-1 envelope-recombinant pseudoviruses, 100 of which were derived from viruses resistant to existing drug classes.  There was little difference in the sensitivity of the 200 viruses to maraviroc, as illustrated by the biol. cutoff in this assay (= geometric mean plus two std. deviations [SD] of 1.7-fold).  The mechanism of action of maraviroc was established using cell-based assays, where it blocked binding of viral envelope, gp120, to CCR5 to prevent the membrane fusion events necessary for viral entry.  Maraviroc did not affect CCR5 cell surface levels or assocd. intracellular signaling, confirming it as a functional antagonist of CCR5.  Maraviroc has no detectable in vitro cytotoxicity and is highly selective for CCR5, as confirmed against a wide range of receptors and enzymes, including the hERG ion channel (50% inhibitory concn., > 10 μM), indicating potential for an excellent clin. safety profile.  Studies in preclin. in vitro and in vivo models predicted maraviroc to have human pharmacokinetics consistent with once- or twice-daily dosing following oral administration.  Clin. trials are ongoing to further investigate the potential of using maraviroc for the treatment of HIV-1 infection and AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN0Z8KdsHODrVg90H21EOLACvtfcHk0liUfkZb8hqBoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Siu7rM&md5=561aea68490f7c6d3ec0f65676450155</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.11.4721-4732.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.11.4721-4732.2005%26sid%3Dliteratum%253Aachs%26aulast%3DDorr%26aufirst%3DP.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DDobbs%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DIrvine%26aufirst%3DB.%26aulast%3DMacartney%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DJ.%26aulast%3DRickett%26aufirst%3DG.%26aulast%3DSmith-Burchnell%26aufirst%3DC.%26aulast%3DNapier%26aufirst%3DC.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DArmour%26aufirst%3DD.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DStammen%26aufirst%3DB.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DPerros%26aufirst%3DM.%26atitle%3DMaraviroc%2520%2528uk-427%252C857%2529%252C%2520a%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520selective%2520small-molecule%2520inhibitor%2520of%2520chemokine%2520receptor%2520CCR5%2520with%2520broad-spectrum%2520anti-human%2520immunodeficiency%2520virus%2520type%25201%2520activity%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D4721%26epage%3D4732%26doi%3D10.1128%2FAAC.49.11.4721-4732.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman-Blum, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandres, J. C.</span></span> <span> </span><span class="NLM_article-title">Maraviroc: A CCR5-receptor antagonist for the treatment of hiv-1 infection</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1228</span>– <span class="NLM_lpage">1250</span>, <span class="refDoi"> DOI: 10.1016/S0149-2918(08)80048-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1016%2FS0149-2918%2808%2980048-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=18691983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVyitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=1228-1250&author=S.+S.+Lieberman-Blumauthor=H.+B.+Fungauthor=J.+C.+Bandres&title=Maraviroc%3A+A+CCR5-receptor+antagonist+for+the+treatment+of+hiv-1+infection&doi=10.1016%2FS0149-2918%2808%2980048-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection</span></div><div class="casAuthors">Lieberman-Blum, Sharon S.; Fung, Horatio B.; Bandres, Juan C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1228-1250</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Background: The emergence of viral resistance is one of the greatest challenges in the treatment of HIV infection.  Maraviroc is the first member of a new class of antiretroviral medications, the CCR5-receptor antagonists.  It is approved by the US Food and Drug Administration (FDA) for use in combination with other antiretroviral agents in treatment-experienced patients infected with multidrug-resistant, CCR5-tropic HIV-1.  Objective: This article provides an overview of the pharmacol., efficacy, and tolerability of maraviroc in the treatment of HIV-1 infection.  Methods: Relevant information was identified through a search of MEDLINE (Jan. 2000-May 2008) using the terms maraviroc, UK-427,857, and CCR5-receptor antagonist.  Also consulted were abstrs. from the International AIDS Society Conference, the Conference on Retroviruses and Opportunistic Infections, and other relevant scientific meetings.  Addnl. publications were found by searching the ref. lists of the identified articles and the FDA Web site.  Results: Maraviroc is a selective, reversible, small-mol. CCR5-receptor antagonist.  In vitro, it has potent anti-HIV-1 activity, with a mean 90% inhibitory concn. of 2.0 nmol/L.  It is widely distributed, with a Vd of ∼194 L.  Maraviroc is moderately metabolized in the liver (65.3%), primarily via the cytochrome P 450 3A4 isoenzyme.  It has an elimination t1/2 of 15.9 to 22.9 h.  Until more data are available, maraviroc should be avoided in patients with severe hepatic insufficiency; dose adjustment does not appear to be necessary on the basis of age, sex, or renal function.  In 2 Phase IIb/III studies, maraviroc 300 mg PO QD or BID was found to be more efficacious than placebo in reducing the viral load at 48 wk in treatment-experienced, CCR5-tropic HIV-1-infected patients receiving an optimized background regimen (difference vs placebo-QD arm: -0.89 log10 copies/mL [97.5% CI, -1.17 to -0.62]; BID arm: -1.05 log10 copies/mL [97.5% CI, -1.33 to -0.78]).  The proportion of patients with a viral load <50 copies/mL was 43.2% in the QD arm and 45.5% in the BID arm, compared with 16.7% in the placebo arm (P < 0.001, both treatment arms vs placebo).  In treatment-naive patients infected with CCR5-tropic virus only, maraviroc 300 mg PO BID was not noninferior to oral efavirenz 600 mg QD (difference = -4.2%; lower bound of the 1-sided 97.5% CI, -10.9 [predefined statistical cutoff for noninferiority, -10]).  Maraviroc was generally well tolerated in clin. trials.  The most frequently reported (≥5%) adverse events were upper respiratory tract infection (20.0%), cough (12.7%), pyrexia (12.0%), rash (9.6%), musculoskeletal complaints (8.7%), gastrointestinal and abdominal pain (8.2%), dizziness (8.2%), appetite disorders (7.3%), insomnia (7.0%), herpes infection (6.8%), sinusitis (6.3%), joint complaints (6.1%), bronchitis (5.9%), and constipation (5.4%).  The recommended dose of maraviroc differs based on concomitant medications, ranging from 150 to 600 mg BID.  Conclusion: When used in combination with other antiretroviral agents, maraviroc appears to be a promising agent for treatment-experienced patients infected with multidrug-resistant, CCR5-tropic HIV-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo73dWGTL6Me7Vg90H21EOLACvtfcHk0ljg0z_3xXl17g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVyitL0%253D&md5=f0923816dd986856a3dd6c3e11a3c45d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0149-2918%2808%2980048-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-2918%252808%252980048-3%26sid%3Dliteratum%253Aachs%26aulast%3DLieberman-Blum%26aufirst%3DS.%2BS.%26aulast%3DFung%26aufirst%3DH.%2BB.%26aulast%3DBandres%26aufirst%3DJ.%2BC.%26atitle%3DMaraviroc%253A%2520A%2520CCR5-receptor%2520antagonist%2520for%2520the%2520treatment%2520of%2520hiv-1%2520infection%26jtitle%3DClin.%2520Ther.%26date%3D2008%26volume%3D30%26spage%3D1228%26epage%3D1250%26doi%3D10.1016%2FS0149-2918%2808%2980048-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Este, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telenti, A.</span></span> <span> </span><span class="NLM_article-title">Hiv entry inhibitors</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(07)61052-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1016%2FS0140-6736%2807%2961052-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2007&pages=81-88&author=J.+A.+Esteauthor=A.+Telenti&title=Hiv+entry+inhibitors&doi=10.1016%2FS0140-6736%2807%2961052-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2807%2961052-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252807%252961052-6%26sid%3Dliteratum%253Aachs%26aulast%3DEste%26aufirst%3DJ.%2BA.%26aulast%3DTelenti%26aufirst%3DA.%26atitle%3DHiv%2520entry%2520inhibitors%26jtitle%3DLancet%26date%3D2007%26volume%3D370%26spage%3D81%26epage%3D88%26doi%3D10.1016%2FS0140-6736%2807%2961052-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yost, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquale, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahloff, E. G.</span></span> <span> </span><span class="NLM_article-title">Maraviroc: A coreceptor CCR5 antagonist for management of hiv infection</span>. <i>Am. J. Health-Syst. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.2146/ajhp080206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.2146%2Fajhp080206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=19336831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Gmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=715-726&author=R.+Yostauthor=T.+R.+Pasqualeauthor=E.+G.+Sahloff&title=Maraviroc%3A+A+coreceptor+CCR5+antagonist+for+management+of+hiv+infection&doi=10.2146%2Fajhp080206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Maraviroc: a coreceptor CCR5 antagonist for management of HIV infection</span></div><div class="casAuthors">Yost, Raymond; Pasquale, Timothy R.; Sahloff, Eric G.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Health-System Pharmacy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">715-726</span>CODEN:
                <span class="NLM_cas:coden">AHSPEK</span>;
        ISSN:<span class="NLM_cas:issn">1079-2082</span>.
    
            (<span class="NLM_cas:orgname">American Society of Health-System Pharmacists</span>)
        </div><div class="casAbstract">A review.  Purpose: The mechanism of action, pharmacol., pharmacokinetics, clin. efficacy, drug interactions, adverse effects, dosage and administration, cost, and role in therapy of maraviroc are reviewed.  Summary: Maraviroc is the first CCR5 coreceptor antagonist to receive marketing approval from the Food and Drug Administration (FDA) for the treatment of CCR5-tropic human immunodeficiency virus (HIV) infection as part of an optimized antiretroviral regimen in treatment-experienced patients.  As 50% or more of treatment-experienced patients may be infected with CXCR4-tropic virus, a tropism assay should be performed before initiating maraviroc therapy.  The majority of evidence supporting maraviroc's use comes from two studies of HIV-infected, treatment-experienced patients.  Pooled anal. from these two studies revealed that twice-daily maraviroc decreased HIV-1 RNA by 1.84 log copies/mL, compared with 0.78 log copy/mL with placebo.  Forty-six percent of subjects attained an HIV-1 RNA concn. of <50 copies/mL, compared with only 17% with placebo.  In a trial of treatment-naive HIV-infected individuals, maraviroc failed to show noninferiority to efavirenz.  Maraviroc is metabolized by cytochrome P 450 isoenzyme 3A4 and is subject to interactions with inhibitors and inducers of that isoenzyme, such as the protease inhibitors (except tipranavir), efavirenz, and rifampin.  Resistance has been reported with maraviroc, but specific mechanisms are still poorly understood.  The most common adverse effects reported with maraviroc were diarrhea, nausea, fatigue, and headache.  Conclusion: Available data support the use of maraviroc, the first CCR5 antagonist to receive FDA marketing approval, as part of an optimized antiretroviral regimen in treatment-experienced patients infected with CCR5-tropic HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfd1R_payHC7Vg90H21EOLACvtfcHk0ljg0z_3xXl17g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Gmsrw%253D&md5=7005b19eba32dd044a039532ade0d5bb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2146%2Fajhp080206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2146%252Fajhp080206%26sid%3Dliteratum%253Aachs%26aulast%3DYost%26aufirst%3DR.%26aulast%3DPasquale%26aufirst%3DT.%2BR.%26aulast%3DSahloff%26aufirst%3DE.%2BG.%26atitle%3DMaraviroc%253A%2520A%2520coreceptor%2520CCR5%2520antagonist%2520for%2520management%2520of%2520hiv%2520infection%26jtitle%3DAm.%2520J.%2520Health-Syst.%2520Pharm.%26date%3D2009%26volume%3D66%26spage%3D715%26epage%3D726%26doi%3D10.2146%2Fajhp080206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, M.
L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, N.</span></span> <span> </span><span class="NLM_article-title">Resistance to enfuvirtide, the first hiv fusion inhibitor</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.1093/jac/dkh330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1093%2Fjac%2Fdkh330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=15231762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1Wis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=333-340&author=M.%0AL.+Greenbergauthor=N.+Cammack&title=Resistance+to+enfuvirtide%2C+the+first+hiv+fusion+inhibitor&doi=10.1093%2Fjac%2Fdkh330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to enfuvirtide, the first HIV fusion inhibitor</span></div><div class="casAuthors">Greenberg, Michael L.; Cammack, Nick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">333-340</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Fusion inhibitors are a new class of antiretroviral drugs (ARVs) for the treatment of human immunodeficiency virus infection.  Enfuvirtide is the first in this class to reach market approval.  Fusion inhibitors block the last step in the three-step viral entry process consisting of attachment, co-receptor binding and fusion, thereby preventing viral capsid entry into the host cell.  Enfuvirtide has a unique mechanism of action and high viral target specificity, and in clin. trials has been shown to exhibit both high efficacy and low toxicity.  Enfuvirtide is a peptide mimetic of an essential region within viral envelope glycoprotein gp41 that functions by blocking gp41 structural rearrangements at a transitional pre-fusion conformation.  Although different clin. isolates show variation in susceptibility to enfuvirtide, primary resistance has not been obsd., and thus enfuvirtide-naive isolates remain clin. sensitive.  Acquired resistance centers round a 10 amino acid motif between residues 36 and 45 in gp41 that forms part of the binding site of enfuvirtide.  The 10 amino acid motif is crit. for viral fusion, and enfuvirtide-resistant mutants show poor replicative capacity compared with wild type.  Reversion to a wild-type, drug-sensitive state has been reported following enfuvirtide withdrawal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowrBuVp5AuRrVg90H21EOLACvtfcHk0ljg0z_3xXl17g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1Wis7k%253D&md5=0e61296ea9dcaa671883f5d4a37f34db</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkh330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkh330%26sid%3Dliteratum%253Aachs%26aulast%3DGreenberg%26aufirst%3DM.%2BL.%26aulast%3DCammack%26aufirst%3DN.%26atitle%3DResistance%2520to%2520enfuvirtide%252C%2520the%2520first%2520hiv%2520fusion%2520inhibitor%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2004%26volume%3D54%26spage%3D333%26epage%3D340%26doi%3D10.1093%2Fjac%2Fdkh330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eggink, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Taeye, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bontjer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klasse, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langedijk, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkhout, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, R. W.</span></span> <span> </span><span class="NLM_article-title">Hiv-1 escape from a peptidic anchor inhibitor through stabilization of the envelope glycoprotein spike</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">10587</span>– <span class="NLM_lpage">10599</span>, <span class="refDoi"> DOI: 10.1128/JVI.01616-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FJVI.01616-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=27654295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVWmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=10587-10599&author=D.+Egginkauthor=S.+W.+de+Taeyeauthor=I.+Bontjerauthor=P.+J.+Klasseauthor=J.+P.+Langedijkauthor=B.+Berkhoutauthor=R.+W.+Sanders&title=Hiv-1+escape+from+a+peptidic+anchor+inhibitor+through+stabilization+of+the+envelope+glycoprotein+spike&doi=10.1128%2FJVI.01616-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 escape from a peptidic anchor inhibitor through stabilization of the envelope glycoprotein spike</span></div><div class="casAuthors">Eggink, Dirk; de Taeye, Steven W.; Bontjer, Ilja; Klasse, Per Johan; Langedijk, Johannes P. M.; Berkhout, Ben; Sanders, Rogier W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10587-10599</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The trimeric HIV-1 envelope glycoprotein spike (Env) mediates viral entry into cells by using a spring-loaded mechanism that allows for the controlled insertion of the Env fusion peptide into the target membrane, followed by membrane fusion.  Env is the focus of vaccine research aimed at inducing protective immunity by antibodies as well as efforts to develop drugs that inhibit the viral entry process.  The mol. factors contributing to Env stability and decay need to be understood better in order to optimally design vaccines and therapeutics.  We generated viruses with resistance to VIR165, a peptidic inhibitor that binds the fusion peptide of the gp41 subunit and prevents its insertion into the target membrane.  Interestingly, a no. of escape viruses acquired substitutions in the C1 domain of the gp120 subunit (A60E, E64K, and H66R) that rendered these viruses dependent on the inhibitor.  These viruses could infect target cells only when VIR165 was present after CD4 binding.  Furthermore, the VIR165- dependent viruses were resistant to sol. CD4-induced Env destabilization and decay.  These data suggest that VIR165-dependent Env proteins are kinetically trapped in the unliganded state and require the drug to negotiate CD4-induced conformational changes.  These studies provide mechanistic insight into the action of the gp41 fusion peptide and its inhibitors and provide new ways to stabilize Env trimer vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyvuZVMr27jLVg90H21EOLACvtfcHk0ljBpUgGw4VkEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVWmsLo%253D&md5=03ee07cf829f06bef7415b47626271b4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FJVI.01616-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01616-16%26sid%3Dliteratum%253Aachs%26aulast%3DEggink%26aufirst%3DD.%26aulast%3Dde%2BTaeye%26aufirst%3DS.%2BW.%26aulast%3DBontjer%26aufirst%3DI.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DLangedijk%26aufirst%3DJ.%2BP.%26aulast%3DBerkhout%26aufirst%3DB.%26aulast%3DSanders%26aufirst%3DR.%2BW.%26atitle%3DHiv-1%2520escape%2520from%2520a%2520peptidic%2520anchor%2520inhibitor%2520through%2520stabilization%2520of%2520the%2520envelope%2520glycoprotein%2520spike%26jtitle%3DJ.%2520Virol.%26date%3D2016%26volume%3D90%26spage%3D10587%26epage%3D10599%26doi%3D10.1128%2FJVI.01616-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span> <span> </span><span class="NLM_article-title">Potent synergistic anti-human immunodeficiency virus (hiv) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-hiv drugs</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2111</span>– <span class="NLM_lpage">2119</span>, <span class="refDoi"> DOI: 10.1128/AAC.01299-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FAAC.01299-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=18378711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVaitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=2111-2119&author=H.+Nakataauthor=S.+M.+Steinbergauthor=Y.+Kohauthor=K.+Maedaauthor=Y.+Takaokaauthor=H.+Tamamuraauthor=N.+Fujiiauthor=H.+Mitsuya&title=Potent+synergistic+anti-human+immunodeficiency+virus+%28hiv%29+effects+using+combinations+of+the+CCR5+inhibitor+aplaviroc+with+other+anti-hiv+drugs&doi=10.1128%2FAAC.01299-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Potent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugs</span></div><div class="casAuthors">Nakata, Hirotomo; Steinberg, Seth M.; Koh, Yasuhiro; Maeda, Kenji; Takaoka, Yoshikazu; Tamamura, Hirokazu; Fujii, Nobutaka; Mitsuya, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2111-2119</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Aplaviroc (AVC), an exptl. CCR5 inhibitor, potently blocks in vitro the infection of R5-tropic human immunodeficiency virus type 1 (R5-HIV-1) at subnanomolar 50% inhibitory concns.  Although maraviroc is presently clin. available, further studies are required to det. the role of CCR5 inhibitors in combinations with other drugs.  Here we detd. anti-HIV-1 activity using combinations of AVC with various anti-HIV-1 agents, including four U.S. Food and Drug Administration-approved drugs, two CCR5 inhibitors (TAK779 and SCH-C) and two CXCR4 inhibitors (AMD3100 and TE14011).  Combination effects were defined as synergistic or antagonistic when the activity of drug A combined with B was statistically greater or less, resp., than the additive effects of drugs A and A combined and drugs B and B combined by using the Combo method, described in this paper, which provides (i) a flexible choice of interaction models and (ii) the use of nonparametric statistical methods.  Synergistic effects against R5-HIV-1Ba-L and a 50:50 mixt. of R5-HIV-1Ba-L and X4-HIV-1ERS104pre (HIV-1Ba-L/104pre) were seen when AVC was combined with zidovudine, nevirapine, indinavir, or enfuvirtide.  Mild synergism and additivity were obsd. when AVC was combined with TAK779 and SCH-C, resp.  We also obsd. more potent synergism against HIV-1Ba-L/104pre when AVC was combined with AMD3100 or TE14011.  The data demonstrate a tendency toward greater synergism with AVC plus either of the two CXCR4 inhibitors compared to the synergism obtained with combinations of AVC and other drugs, suggesting that the development of effective CXCR4 inhibitors may be important for increasing the efficacies of CCR5 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ZzHdzM1OULVg90H21EOLACvtfcHk0ljBpUgGw4VkEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVaitr4%253D&md5=afb4091cdb73b2f8568183da302a59fa</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FAAC.01299-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01299-07%26sid%3Dliteratum%253Aachs%26aulast%3DNakata%26aufirst%3DH.%26aulast%3DSteinberg%26aufirst%3DS.%2BM.%26aulast%3DKoh%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DTakaoka%26aufirst%3DY.%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DPotent%2520synergistic%2520anti-human%2520immunodeficiency%2520virus%2520%2528hiv%2529%2520effects%2520using%2520combinations%2520of%2520the%2520CCR5%2520inhibitor%2520aplaviroc%2520with%2520other%2520anti-hiv%2520drugs%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D2111%26epage%3D2119%26doi%3D10.1128%2FAAC.01299-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, M. S.</span></span> <span> </span><span class="NLM_article-title">Tak-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitro</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3483</span>– <span class="NLM_lpage">3485</span>, <span class="refDoi"> DOI: 10.1128/AAC.49.8.3483-3485.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FAAC.49.8.3483-3485.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=16048964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntFCgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=3483-3485&author=C.+L.+Tremblayauthor=F.+Giguelauthor=Y.+Guanauthor=T.+C.+Chouauthor=K.+Takashimaauthor=M.+S.+Hirsch&title=Tak-220%2C+a+novel+small-molecule+CCR5+antagonist%2C+has+favorable+anti-human+immunodeficiency+virus+interactions+with+other+antiretrovirals+in+vitro&doi=10.1128%2FAAC.49.8.3483-3485.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">TAK-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitro</span></div><div class="casAuthors">Tremblay, Cecile L.; Giguel, Francoise; Guan, Yongbiao; Chou, Ting-Chao; Takashima, Katsunori; Hirsch, Martin S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3483-3485</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">TAK-220 is a CCR5 antagonist, part of the new class of anti-human immunodeficiency virus type 1 (anti-HIV-1) entry inhibitors.  The authors evaluated the anti-HIV-1 interactions between TAK-220 and various antiretrovirals in vitro.  Synergy was obsd. with all drugs at the 90 and 95% inhibitory concns.  The favorable drug interactions obsd. suggest that further clin. evaluation is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQE1EHC3eXQ7Vg90H21EOLACvtfcHk0ljBpUgGw4VkEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntFCgsr4%253D&md5=6ca61dc2aed93ac6ac904a6eda731290</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.8.3483-3485.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.8.3483-3485.2005%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay%26aufirst%3DC.%2BL.%26aulast%3DGiguel%26aufirst%3DF.%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DChou%26aufirst%3DT.%2BC.%26aulast%3DTakashima%26aufirst%3DK.%26aulast%3DHirsch%26aufirst%3DM.%2BS.%26atitle%3DTak-220%252C%2520a%2520novel%2520small-molecule%2520CCR5%2520antagonist%252C%2520has%2520favorable%2520anti-human%2520immunodeficiency%2520virus%2520interactions%2520with%2520other%2520antiretrovirals%2520in%2520vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D3483%26epage%3D3485%26doi%3D10.1128%2FAAC.49.8.3483-3485.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baroudy, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, M. S.</span></span> <span> </span><span class="NLM_article-title">Anti-human immunodeficiency virus interactions of sch-c (sch 351125), a CCR5 antagonist, with other antiretroviral agents in vitro</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1336</span>– <span class="NLM_lpage">1339</span>, <span class="refDoi"> DOI: 10.1128/AAC.46.5.1336-1339.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FAAC.46.5.1336-1339.2002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=1336-1339&author=C.+L.+Tremblayauthor=F.+Giguelauthor=C.+Kollmannauthor=Y.+Guanauthor=T.+C.+Chouauthor=B.+M.+Baroudyauthor=M.+S.+Hirsch&title=Anti-human+immunodeficiency+virus+interactions+of+sch-c+%28sch+351125%29%2C+a+CCR5+antagonist%2C+with+other+antiretroviral+agents+in+vitro&doi=10.1128%2FAAC.46.5.1336-1339.2002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FAAC.46.5.1336-1339.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.46.5.1336-1339.2002%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay%26aufirst%3DC.%2BL.%26aulast%3DGiguel%26aufirst%3DF.%26aulast%3DKollmann%26aufirst%3DC.%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DChou%26aufirst%3DT.%2BC.%26aulast%3DBaroudy%26aufirst%3DB.%2BM.%26aulast%3DHirsch%26aufirst%3DM.%2BS.%26atitle%3DAnti-human%2520immunodeficiency%2520virus%2520interactions%2520of%2520sch-c%2520%2528sch%2520351125%2529%252C%2520a%2520CCR5%2520antagonist%252C%2520with%2520other%2520antiretroviral%2520agents%2520in%2520vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26spage%3D1336%26epage%3D1339%26doi%3D10.1128%2FAAC.46.5.1336-1339.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, M. S.</span></span> <span> </span><span class="NLM_article-title">Strong in vitro synergy between the fusion inhibitor t-20 and the CXCR4 blocker amd-3100</span>. <i>JAIDS, J. Acquired Immune Defic. Syndr.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1097/00126334-200010010-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1097%2F00126334-200010010-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=11103038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVekt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2000&pages=99-102&author=C.+L.+Tremblayauthor=C.+Kollmannauthor=F.+Giguelauthor=T.+C.+Chouauthor=M.+S.+Hirsch&title=Strong+in+vitro+synergy+between+the+fusion+inhibitor+t-20+and+the+CXCR4+blocker+amd-3100&doi=10.1097%2F00126334-200010010-00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100</span></div><div class="casAuthors">Tremblay, Cecile L.; Kollmann, Christopher; Giguel, Francoise; Chou, Ting-Chao; Hirsch, Martin S.</div><div class="citationInfo"><span class="NLM_cas:title">JAIDS, Journal of Acquired Immune Deficiency Syndromes</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-102</span>CODEN:
                <span class="NLM_cas:coden">JJASFJ</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Attachment and entry of HIV-1 into CD4 cells involve a series of events in which different viral envelope proteins interact with specific cell receptors, culminating in fusion of viral and cell membranes.  AMD-3100 is a small mol. inhibitor of HIV-1 attachment to the CXCR4 chemokine receptor, and T-20 is a synthetic peptide corresponding to a region of HIV-1 gp41 that blocks fusion to cell membranes.  To evaluate the interaction between agents acting at 2 different steps of the entry process, the authors conducted in vitro studies of the combination of T-20 and AMD-3100 against an X4 HIV-1 isolate.  Single drugs or multiply dild. fixed ratio combinations of drugs were added to peripheral blood mononuclear cells infected with a clin. isolate, 14aPre.  Drug interactions were evaluated using the median-effect principle and the combination index technique.  The 50% inhibitory concn. (IC50) for T-20 was 0.10 μg/mL and for AMD-3100 was 0.19 μg/mL.  Synergy was obsd. between T-20 and AMD-3100 and this increased with higher inhibitory concns., with combination indexes ranging from 0.62 at IC50 to 0.02 at IC95.  Whether these synergistic interactions translate into clin. benefit will need to be addressed in the context of clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGnKF3mFZTbLVg90H21EOLACvtfcHk0lh-kwE4zF-TeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVekt7o%253D&md5=d618afa60b738f4d09a8a6fe7641db9f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1097%2F00126334-200010010-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00126334-200010010-00001%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay%26aufirst%3DC.%2BL.%26aulast%3DKollmann%26aufirst%3DC.%26aulast%3DGiguel%26aufirst%3DF.%26aulast%3DChou%26aufirst%3DT.%2BC.%26aulast%3DHirsch%26aufirst%3DM.%2BS.%26atitle%3DStrong%2520in%2520vitro%2520synergy%2520between%2520the%2520fusion%2520inhibitor%2520t-20%2520and%2520the%2520CXCR4%2520blocker%2520amd-3100%26jtitle%3DJAIDS%252C%2520J.%2520Acquired%2520Immune%2520Defic.%2520Syndr.%26date%3D2000%26volume%3D25%26spage%3D99%26epage%3D102%26doi%3D10.1097%2F00126334-200010010-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doms, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peiper, S. C.</span></span> <span> </span><span class="NLM_article-title">Unwelcomed guests with master keys: How hiv uses chemokine receptors for cellular entry</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>235</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1006/viro.1997.8703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1006%2Fviro.1997.8703" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1997&pages=179-190&author=R.+W.+Domsauthor=S.+C.+Peiper&title=Unwelcomed+guests+with+master+keys%3A+How+hiv+uses+chemokine+receptors+for+cellular+entry&doi=10.1006%2Fviro.1997.8703"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1006%2Fviro.1997.8703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fviro.1997.8703%26sid%3Dliteratum%253Aachs%26aulast%3DDoms%26aufirst%3DR.%2BW.%26aulast%3DPeiper%26aufirst%3DS.%2BC.%26atitle%3DUnwelcomed%2520guests%2520with%2520master%2520keys%253A%2520How%2520hiv%2520uses%2520chemokine%2520receptors%2520for%2520cellular%2520entry%26jtitle%3DVirology%26date%3D1997%26volume%3D235%26spage%3D179%26epage%3D190%26doi%3D10.1006%2Fviro.1997.8703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Efficient synthesis and identification of novel propane-1,3-diamino bridged CCR5 antagonists with variation on the basic center carrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">2827</span>– <span class="NLM_lpage">2840</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2010.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1016%2Fj.ejmech.2010.03.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=2827-2840&author=X.+Fanauthor=H.+S.+Zhangauthor=L.+Chenauthor=Y.+Q.+Long&title=Efficient+synthesis+and+identification+of+novel+propane-1%2C3-diamino+bridged+CCR5+antagonists+with+variation+on+the+basic+center+carrier&doi=10.1016%2Fj.ejmech.2010.03.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%2BS.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DEfficient%2520synthesis%2520and%2520identification%2520of%2520novel%2520propane-1%252C3-diamino%2520bridged%2520CCR5%2520antagonists%2520with%2520variation%2520on%2520the%2520basic%2520center%2520carrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D2827%26epage%3D2840%26doi%3D10.1016%2Fj.ejmech.2010.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Forward- and reverse-synthesis of piperazinopiperidine amide analogs: A general access to structurally diverse 4-piperazinopiperidine-based CCR5 antagonists</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2690</span>– <span class="NLM_lpage">2697</span>, <span class="refDoi"> DOI: 10.1039/b707175b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1039%2Fb707175b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=2690-2697&author=D.+Z.+Fengauthor=Y.+L.+Songauthor=X.+H.+Jiangauthor=L.+Chenauthor=Y.+Q.+Long&title=Forward-+and+reverse-synthesis+of+piperazinopiperidine+amide+analogs%3A+A+general+access+to+structurally+diverse+4-piperazinopiperidine-based+CCR5+antagonists&doi=10.1039%2Fb707175b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2Fb707175b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb707175b%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DD.%2BZ.%26aulast%3DSong%26aufirst%3DY.%2BL.%26aulast%3DJiang%26aufirst%3DX.%2BH.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DForward-%2520and%2520reverse-synthesis%2520of%2520piperazinopiperidine%2520amide%2520analogs%253A%2520A%2520general%2520access%2520to%2520structurally%2520diverse%25204-piperazinopiperidine-based%2520CCR5%2520antagonists%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2007%26volume%3D5%26spage%3D2690%26epage%3D2697%26doi%3D10.1039%2Fb707175b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. Q.</span>; <span class="NLM_string-name">Feng, D. Z.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Chen, R.
H.</span></span> <span> </span><span class="NLM_article-title">1-(3-Amino-Propyl)-Piperidin-4-yl-Amides, Pharmaceutical Compositions, Processes For Their Preparation And Uses</span>. <span class="NLM_patent">WO2009052708A1</span>, April 30, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+Q.+Long&author=D.+Z.+Feng&author=L.+Chen&author=R.%0AH.+Chen&title=1-%283-Amino-Propyl%29-Piperidin-4-yl-Amides%2C+Pharmaceutical+Compositions%2C+Processes+For+Their+Preparation+And+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3D1-%25283-Amino-Propyl%2529-Piperidin-4-yl-Amides%252C%2520Pharmaceutical%2520Compositions%252C%2520Processes%2520For%2520Their%2520Preparation%2520And%2520Uses%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel (s)-alpha-phenyl-gamma-amino butanamide containing CCR5 antagonists via functionality inversion approach</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2219</span>– <span class="NLM_lpage">2223</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1016%2Fj.bmcl.2010.02.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2219-2223&author=H.+S.+Zhangauthor=D.+Z.+Fengauthor=L.+Chenauthor=Y.+Q.+Long&title=Discovery+of+novel+%28s%29-alpha-phenyl-gamma-amino+butanamide+containing+CCR5+antagonists+via+functionality+inversion+approach&doi=10.1016%2Fj.bmcl.2010.02.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BS.%26aulast%3DFeng%26aufirst%3DD.%2BZ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DDiscovery%2520of%2520novel%2520%2528s%2529-alpha-phenyl-gamma-amino%2520butanamide%2520containing%2520CCR5%2520antagonists%2520via%2520functionality%2520inversion%2520approach%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2219%26epage%3D2223%26doi%3D10.1016%2Fj.bmcl.2010.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span>; <span class="NLM_string-name">Long, Y.
Q.</span>; <span class="NLM_string-name">Wei, W.</span>; <span class="NLM_string-name">Xie, X.</span></span> <span> </span><span class="NLM_article-title">New Imidazopyridine Compound Useful In Pharmaceutical Composition and In Preparation Of Medicine For Treating Dieseases From Hiv Virus Infection, Rheumatoid Arthritis, Inflammation, and Cancer</span>. <span class="NLM_patent">CN 102675305 B</span>, March 08, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=B.+Cao&author=Y.%0AQ.+Long&author=W.+Wei&author=X.+Xie&title=New+Imidazopyridine+Compound+Useful+In+Pharmaceutical+Composition+and+In+Preparation+Of+Medicine+For+Treating+Dieseases+From+Hiv+Virus+Infection%2C+Rheumatoid+Arthritis%2C+Inflammation%2C+and+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DB.%26atitle%3DNew%2520Imidazopyridine%2520Compound%2520Useful%2520In%2520Pharmaceutical%2520Composition%2520and%2520In%2520Preparation%2520Of%2520Medicine%2520For%2520Treating%2520Dieseases%2520From%2520Hiv%2520Virus%2520Infection%252C%2520Rheumatoid%2520Arthritis%252C%2520Inflammation%252C%2520and%2520Cancer%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bastian, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantharaju</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contarino, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papazoglou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Cell-free hiv-1 virucidal action by modified peptide triazole inhibitors of env gp120</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1335</span>– <span class="NLM_lpage">1339</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1002%2Fcmdc.201100177" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1335-1339&author=A.+R.+Bastianauthor=+Kantharajuauthor=K.+McFaddenauthor=C.+Duffyauthor=S.+Rajagopalauthor=M.+R.+Contarinoauthor=E.+Papazoglouauthor=I.+Chaiken&title=Cell-free+hiv-1+virucidal+action+by+modified+peptide+triazole+inhibitors+of+env+gp120&doi=10.1002%2Fcmdc.201100177"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100177%26sid%3Dliteratum%253Aachs%26aulast%3DBastian%26aufirst%3DA.%2BR.%26aulast%3DKantharaju%26aulast%3DMcFadden%26aufirst%3DK.%26aulast%3DDuffy%26aufirst%3DC.%26aulast%3DRajagopal%26aufirst%3DS.%26aulast%3DContarino%26aufirst%3DM.%2BR.%26aulast%3DPapazoglou%26aufirst%3DE.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DCell-free%2520hiv-1%2520virucidal%2520action%2520by%2520modified%2520peptide%2520triazole%2520inhibitors%2520of%2520env%2520gp120%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1335%26epage%3D1339%26doi%3D10.1002%2Fcmdc.201100177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rashad, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyana Sundaram, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aneja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic envelope glycoprotein antagonists that irreversibly inactivate hiv-1 before host cell encounter</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7603</span>– <span class="NLM_lpage">7608</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7603-7608&author=A.+A.+Rashadauthor=R.+V.+Kalyana+Sundaramauthor=R.+Anejaauthor=C.+Duffyauthor=I.+Chaiken&title=Macrocyclic+envelope+glycoprotein+antagonists+that+irreversibly+inactivate+hiv-1+before+host+cell+encounter&doi=10.1021%2Facs.jmedchem.5b00935"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00935%26sid%3Dliteratum%253Aachs%26aulast%3DRashad%26aufirst%3DA.%2BA.%26aulast%3DKalyana%2BSundaram%26aufirst%3DR.%2BV.%26aulast%3DAneja%26aufirst%3DR.%26aulast%3DDuffy%26aufirst%3DC.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DMacrocyclic%2520envelope%2520glycoprotein%2520antagonists%2520that%2520irreversibly%2520inactivate%2520hiv-1%2520before%2520host%2520cell%2520encounter%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7603%26epage%3D7608%26doi%3D10.1021%2Facs.jmedchem.5b00935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aneja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashad, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyana Sundaram, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Peptide triazole inactivators of hiv-1 utilize a conserved two-cavity binding site at the junction of the inner and outer domains of env gp120</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3843</span>– <span class="NLM_lpage">3858</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00073</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00073" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3843-3858&author=R.+Anejaauthor=A.+A.+Rashadauthor=H.+Liauthor=R.+V.+Kalyana+Sundaramauthor=C.+Duffyauthor=L.+D.+Baileyauthor=I.+Chaiken&title=Peptide+triazole+inactivators+of+hiv-1+utilize+a+conserved+two-cavity+binding+site+at+the+junction+of+the+inner+and+outer+domains+of+env+gp120&doi=10.1021%2Facs.jmedchem.5b00073"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00073%26sid%3Dliteratum%253Aachs%26aulast%3DAneja%26aufirst%3DR.%26aulast%3DRashad%26aufirst%3DA.%2BA.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DKalyana%2BSundaram%26aufirst%3DR.%2BV.%26aulast%3DDuffy%26aufirst%3DC.%26aulast%3DBailey%26aufirst%3DL.%2BD.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DPeptide%2520triazole%2520inactivators%2520of%2520hiv-1%2520utilize%2520a%2520conserved%2520two-cavity%2520binding%2520site%2520at%2520the%2520junction%2520of%2520the%2520inner%2520and%2520outer%2520domains%2520of%2520env%2520gp120%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3843%26epage%3D3858%26doi%3D10.1021%2Facs.jmedchem.5b00073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gopi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umashankara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirrone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaLonde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuzer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zentner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocklin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jawanda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodroski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Structural determinants for affinity enhancement of a dual antagonist peptide entry inhibitor of human immunodeficiency virus type-1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2638</span>– <span class="NLM_lpage">2647</span>, <span class="refDoi"> DOI: 10.1021/jm070814r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070814r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2638-2647&author=H.+Gopiauthor=M.+Umashankaraauthor=V.+Pirroneauthor=J.+LaLondeauthor=N.+Madaniauthor=F.+Tuzerauthor=S.+Baxterauthor=I.+Zentnerauthor=S.+Cocklinauthor=N.+Jawandaauthor=S.+R.+Millerauthor=A.+Schonauthor=J.+C.+Kleinauthor=E.+Freireauthor=F.+C.+Krebsauthor=A.+B.+Smithauthor=J.+Sodroskiauthor=I.+Chaiken&title=Structural+determinants+for+affinity+enhancement+of+a+dual+antagonist+peptide+entry+inhibitor+of+human+immunodeficiency+virus+type-1&doi=10.1021%2Fjm070814r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm070814r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070814r%26sid%3Dliteratum%253Aachs%26aulast%3DGopi%26aufirst%3DH.%26aulast%3DUmashankara%26aufirst%3DM.%26aulast%3DPirrone%26aufirst%3DV.%26aulast%3DLaLonde%26aufirst%3DJ.%26aulast%3DMadani%26aufirst%3DN.%26aulast%3DTuzer%26aufirst%3DF.%26aulast%3DBaxter%26aufirst%3DS.%26aulast%3DZentner%26aufirst%3DI.%26aulast%3DCocklin%26aufirst%3DS.%26aulast%3DJawanda%26aufirst%3DN.%26aulast%3DMiller%26aufirst%3DS.%2BR.%26aulast%3DSchon%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DJ.%2BC.%26aulast%3DFreire%26aufirst%3DE.%26aulast%3DKrebs%26aufirst%3DF.%2BC.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DSodroski%26aufirst%3DJ.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DStructural%2520determinants%2520for%2520affinity%2520enhancement%2520of%2520a%2520dual%2520antagonist%2520peptide%2520entry%2520inhibitor%2520of%2520human%2520immunodeficiency%2520virus%2520type-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2638%26epage%3D2647%26doi%3D10.1021%2Fjm070814r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gopi, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirupula, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I. M.</span></span> <span> </span><span class="NLM_article-title">Click chemistry on azidoproline: High-affinity dual antagonist for hiv-1 envelope glycoprotein gp120</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">54</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200500037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1002%2Fcmdc.200500037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=54-57&author=H.+N.+Gopiauthor=K.+C.+Tirupulaauthor=S.+Baxterauthor=S.+Ajithauthor=I.+M.+Chaiken&title=Click+chemistry+on+azidoproline%3A+High-affinity+dual+antagonist+for+hiv-1+envelope+glycoprotein+gp120&doi=10.1002%2Fcmdc.200500037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200500037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200500037%26sid%3Dliteratum%253Aachs%26aulast%3DGopi%26aufirst%3DH.%2BN.%26aulast%3DTirupula%26aufirst%3DK.%2BC.%26aulast%3DBaxter%26aufirst%3DS.%26aulast%3DAjith%26aufirst%3DS.%26aulast%3DChaiken%26aufirst%3DI.%2BM.%26atitle%3DClick%2520chemistry%2520on%2520azidoproline%253A%2520High-affinity%2520dual%2520antagonist%2520for%2520hiv-1%2520envelope%2520glycoprotein%2520gp120%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D54%26epage%3D57%26doi%3D10.1002%2Fcmdc.200500037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamanna, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aneja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubinski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigo
Moreira, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuzer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contarino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I. M.</span></span> <span> </span><span class="NLM_article-title">Non-natural peptide triazole antagonists of hiv-1 envelope gp120</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1002%2Fcmdc.201200422" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=322-328&author=K.+Kamannaauthor=R.+Anejaauthor=C.+Duffyauthor=P.+Kubinskiauthor=D.+Rodrigo%0AMoreiraauthor=L.+D.+Baileyauthor=K.+McFaddenauthor=A.+Schonauthor=A.+Holmesauthor=F.+Tuzerauthor=M.+Contarinoauthor=E.+Freireauthor=I.+M.+Chaiken&title=Non-natural+peptide+triazole+antagonists+of+hiv-1+envelope+gp120&doi=10.1002%2Fcmdc.201200422"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200422%26sid%3Dliteratum%253Aachs%26aulast%3DKamanna%26aufirst%3DK.%26aulast%3DAneja%26aufirst%3DR.%26aulast%3DDuffy%26aufirst%3DC.%26aulast%3DKubinski%26aufirst%3DP.%26aulast%3DRodrigo%2BMoreira%26aufirst%3DD.%26aulast%3DBailey%26aufirst%3DL.%2BD.%26aulast%3DMcFadden%26aufirst%3DK.%26aulast%3DSchon%26aufirst%3DA.%26aulast%3DHolmes%26aufirst%3DA.%26aulast%3DTuzer%26aufirst%3DF.%26aulast%3DContarino%26aufirst%3DM.%26aulast%3DFreire%26aufirst%3DE.%26aulast%3DChaiken%26aufirst%3DI.%2BM.%26atitle%3DNon-natural%2520peptide%2520triazole%2520antagonists%2520of%2520hiv-1%2520envelope%2520gp120%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D322%26epage%3D328%26doi%3D10.1002%2Fcmdc.201200422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Umashankara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zentner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuzer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriakose, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contarino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalonde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">The active core in a triazole peptide dual-site antagonist of hiv-1 gp120</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1871</span>– <span class="NLM_lpage">1879</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1002%2Fcmdc.201000222" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1871-1879&author=M.+Umashankaraauthor=K.+McFaddenauthor=I.+Zentnerauthor=A.+Schonauthor=S.+Rajagopalauthor=F.+Tuzerauthor=S.+A.+Kuriakoseauthor=M.+Contarinoauthor=J.+Lalondeauthor=E.+Freireauthor=I.+Chaiken&title=The+active+core+in+a+triazole+peptide+dual-site+antagonist+of+hiv-1+gp120&doi=10.1002%2Fcmdc.201000222"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000222%26sid%3Dliteratum%253Aachs%26aulast%3DUmashankara%26aufirst%3DM.%26aulast%3DMcFadden%26aufirst%3DK.%26aulast%3DZentner%26aufirst%3DI.%26aulast%3DSchon%26aufirst%3DA.%26aulast%3DRajagopal%26aufirst%3DS.%26aulast%3DTuzer%26aufirst%3DF.%26aulast%3DKuriakose%26aufirst%3DS.%2BA.%26aulast%3DContarino%26aufirst%3DM.%26aulast%3DLalonde%26aufirst%3DJ.%26aulast%3DFreire%26aufirst%3DE.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DThe%2520active%2520core%2520in%2520a%2520triazole%2520peptide%2520dual-site%2520antagonist%2520of%2520hiv-1%2520gp120%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1871%26epage%3D1879%26doi%3D10.1002%2Fcmdc.201000222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanfield, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyumkis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deller, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klasse, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a soluble cleaved hiv-1 envelope trimer</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">1477</span>– <span class="NLM_lpage">1483</span>, <span class="refDoi"> DOI: 10.1126/science.1245625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1126%2Fscience.1245625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=24179159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFemu7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=1477-1483&author=J.+P.+Julienauthor=A.+Cupoauthor=D.+Sokauthor=R.+L.+Stanfieldauthor=D.+Lyumkisauthor=M.+C.+Dellerauthor=P.+J.+Klasseauthor=D.+R.+Burtonauthor=R.+W.+Sandersauthor=J.+P.+Mooreauthor=A.+B.+Wardauthor=I.+A.+Wilson&title=Crystal+structure+of+a+soluble+cleaved+hiv-1+envelope+trimer&doi=10.1126%2Fscience.1245625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer</span></div><div class="casAuthors">Julien, Jean-Philippe; Cupo, Albert; Sok, Devin; Stanfield, Robyn L.; Lyumkis, Dmitry; Deller, Marc C.; Klasse, Per-Johan; Burton, Dennis R.; Sanders, Rogier W.; Moore, John P.; Ward, Andrew B.; Wilson, Ian A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">6165</span>),
    <span class="NLM_cas:pages">1477-1483</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">HIV-1 entry into CD4+ target cells is mediated by cleaved envelope glycoprotein (Env) trimers that have been challenging to characterize structurally.  Here, we describe the crystal structure at 4.7 angstroms of a sol., cleaved Env trimer that is stabilized and antigenically near-native (termed the BG505 SOSIP.664 gp140 trimer) in complex with a potent broadly neutralizing antibody, PGT122.  The structure shows a prefusion state of gp41, the interaction between the component gp120 and gp41 subunits, and how a close assocn. between the gp120 V1/V2/V3 loops stabilizes the trimer apex around the threefold axis.  The complete epitope of PGT122 on the trimer involves gp120 V1, V3, and several surrounding glycans.  This trimer structure advances our understanding of how Env functions and is presented to the immune system, and provides a blueprint for structure-based vaccine design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYmAaUYZVlYbVg90H21EOLACvtfcHk0lgsutTxc9ILOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFemu7zI&md5=30ec4fffcf1264eb668261f1640d7609</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscience.1245625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1245625%26sid%3Dliteratum%253Aachs%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DCupo%26aufirst%3DA.%26aulast%3DSok%26aufirst%3DD.%26aulast%3DStanfield%26aufirst%3DR.%2BL.%26aulast%3DLyumkis%26aufirst%3DD.%26aulast%3DDeller%26aufirst%3DM.%2BC.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DSanders%26aufirst%3DR.%2BW.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520a%2520soluble%2520cleaved%2520hiv-1%2520envelope%2520trimer%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D1477%26epage%3D1483%26doi%3D10.1126%2Fscience.1245625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenalti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span> <span> </span><span class="NLM_article-title">Structure of the CCR5 chemokine receptor-hiv entry inhibitor maraviroc complex</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">1387</span>– <span class="NLM_lpage">1390</span>, <span class="refDoi"> DOI: 10.1126/science.1241475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1126%2Fscience.1241475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=24030490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2013&pages=1387-1390&author=Q.+Tanauthor=Y.+Zhuauthor=J.+Liauthor=Z.+Chenauthor=G.+W.+Hanauthor=I.+Kufarevaauthor=T.+Liauthor=L.+Maauthor=G.+Fenaltiauthor=J.+Liauthor=W.+Zhangauthor=X.+Xieauthor=H.+Yangauthor=H.+Jiangauthor=V.+Cherezovauthor=H.+Liuauthor=R.+C.+Stevensauthor=Q.+Zhaoauthor=B.+Wu&title=Structure+of+the+CCR5+chemokine+receptor-hiv+entry+inhibitor+maraviroc+complex&doi=10.1126%2Fscience.1241475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex</span></div><div class="casAuthors">Tan, Qiuxiang; Zhu, Ya; Li, Jian; Chen, Zhuxi; Han, Gye Won; Kufareva, Irina; Li, Tingting; Ma, Limin; Fenalti, Gustavo; Li, Jing; Zhang, Wenru; Xie, Xin; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Liu, Hong; Stevens, Raymond C.; Zhao, Qiang; Wu, Beili</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6152</span>),
    <span class="NLM_cas:pages">1387-1390</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The CCR5 chemokine receptor acts as a co-receptor for HIV-1 viral entry.  Here we report the 2.7 angstrom-resoln. crystal structure of human CCR5 bound to the marketed HIV drug maraviroc.  The structure reveals a ligand-binding site that is distinct from the proposed major recognition sites for chemokines and the viral glycoprotein gp120, providing insights into the mechanism of allosteric inhibition of chemokine signaling and viral entry.  A comparison between CCR5 and CXCR4 crystal structures, along with models of co-receptor-gp120-V3 complexes, suggests that different charge distributions and steric hindrances caused by residue substitutions may be major determinants of HIV-1 co-receptor selectivity.  These high-resoln. insights into CCR5 can enable structure-based drug discovery for the treatment of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt5VKeO5Hmb7Vg90H21EOLACvtfcHk0lgVa88NWqSKQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ&md5=730ee5644a2a144cd49cd0e9a15eba2e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscience.1241475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1241475%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DStructure%2520of%2520the%2520CCR5%2520chemokine%2520receptor-hiv%2520entry%2520inhibitor%2520maraviroc%2520complex%26jtitle%3DScience%26date%3D2013%26volume%3D341%26spage%3D1387%26epage%3D1390%26doi%3D10.1126%2Fscience.1241475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanfield, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodroski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bewley, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, P. D.</span></span> <span> </span><span class="NLM_article-title">Structures of the CCR5 n terminus and of a tyrosine-sulfated antibody with hiv-1 gp120 and CD4</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">1930</span>– <span class="NLM_lpage">1934</span>, <span class="refDoi"> DOI: 10.1126/science.1145373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1126%2Fscience.1145373" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=1930-1934&author=C.+C.+Huangauthor=S.+N.+Lamauthor=P.+Acharyaauthor=M.+Tangauthor=S.+H.+Xiangauthor=S.+S.+Hussanauthor=R.+L.+Stanfieldauthor=J.+Robinsonauthor=J.+Sodroskiauthor=I.+A.+Wilsonauthor=R.+Wyattauthor=C.+A.+Bewleyauthor=P.+D.+Kwong&title=Structures+of+the+CCR5+n+terminus+and+of+a+tyrosine-sulfated+antibody+with+hiv-1+gp120+and+CD4&doi=10.1126%2Fscience.1145373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscience.1145373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1145373%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DLam%26aufirst%3DS.%2BN.%26aulast%3DAcharya%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DS.%2BH.%26aulast%3DHussan%26aufirst%3DS.%2BS.%26aulast%3DStanfield%26aufirst%3DR.%2BL.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DSodroski%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DWyatt%26aufirst%3DR.%26aulast%3DBewley%26aufirst%3DC.%2BA.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26atitle%3DStructures%2520of%2520the%2520CCR5%2520n%2520terminus%2520and%2520of%2520a%2520tyrosine-sulfated%2520antibody%2520with%2520hiv-1%2520gp120%2520and%2520CD4%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D1930%26epage%3D1934%26doi%3D10.1126%2Fscience.1145373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moraca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melillo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, C. F.</span></span> <span> </span><span class="NLM_article-title">Computational evaluation of hiv-1 gp120 conformations of soluble trimeric gp140 structures as targets for de novo docking of first- and second-generation small-molecule cd4 mimics</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2069</span>– <span class="NLM_lpage">2079</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.6b00393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.6b00393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOrt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2016&pages=2069-2079&author=F.+Moracaauthor=K.+Acharyaauthor=B.+Melilloauthor=A.+B.+Smithauthor=I.+Chaikenauthor=C.+F.+Abrams&title=Computational+evaluation+of+hiv-1+gp120+conformations+of+soluble+trimeric+gp140+structures+as+targets+for+de+novo+docking+of+first-+and+second-generation+small-molecule+cd4+mimics&doi=10.1021%2Facs.jcim.6b00393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Computational Evaluation of HIV-1 gp120 Conformations of Soluble Trimeric gp140 Structures as Targets for de Novo Docking of First- and Second-Generation Small-Molecule CD4 Mimics</span></div><div class="casAuthors">Moraca, Francesca; Acharya, Kriti; Melillo, Bruno; Smith, Amos B.; Chaiken, Irwin; Abrams, Cameron F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2069-2079</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. CD4 mimics (SMCM's) bind to the gp120 subunit of the HIV-1 envelope glycoprotein (Env) and have been optimized to block cell infection in vitro.  The lack of the V1/2 and V3 loops and the presence of the β2/3 and β20/21 strands (bridging sheet) in the available structures of the monomeric gp120 core may limit its applicability as a target for further synthetic optimization of SMCM potency and/or breadth.  Here, we employ a combination of binding-site search, docking, estn. of protein-ligand interaction energy, all-atom mol. dynamics, and ELISA-based CD4-binding competition assays to create, characterize, and rationalize models of first- and second-generation of SMCM's bound to the distinct, trimeric BG505 SOSIP.664 structures 4NCO and 4TVP contg. V1/2 and V3 loops with no bridging sheet.  We demonstrate that the in silico neutralization of the highly conserved D368 is necessary to obtain the correct orientation of SMCM in their binding site when docking against the monomeric gp120 core.  The computational results correlate with IC50's measured in CD4 binding competition ELISA and with KD's measured on gp120 core monomer.  This supports the hypothesis that the 4NCO trimeric structure represents a viable target for further SMCM's optimization with advantages over both the 4TVP trimer and gp120 core monomer.  Finally, the docking protocol has been optimized to screen compds. that can clearly interact with the highly conserved residue D368, increasing the likelihood of future optimizations to arrive at SMCM's with a broader spectrum of activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp155xyNFo1YLVg90H21EOLACvtfcHk0lgVa88NWqSKQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOrt73P&md5=4fe4c0ee8faa7f3bdd9b018f1cfa2f74</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.6b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.6b00393%26sid%3Dliteratum%253Aachs%26aulast%3DMoraca%26aufirst%3DF.%26aulast%3DAcharya%26aufirst%3DK.%26aulast%3DMelillo%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DChaiken%26aufirst%3DI.%26aulast%3DAbrams%26aufirst%3DC.%2BF.%26atitle%3DComputational%2520evaluation%2520of%2520hiv-1%2520gp120%2520conformations%2520of%2520soluble%2520trimeric%2520gp140%2520structures%2520as%2520targets%2520for%2520de%2520novo%2520docking%2520of%2520first-%2520and%2520second-generation%2520small-molecule%2520cd4%2520mimics%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2016%26volume%3D56%26spage%3D2069%26epage%3D2079%26doi%3D10.1021%2Facs.jcim.6b00393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tallarida, R. J.</span></span> <span> </span><span class="NLM_article-title">An overview of drug combination analysis with isobolograms</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>319</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.104117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1124%2Fjpet.106.104117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=16670349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCksL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=1-7&author=R.+J.+Tallarida&title=An+overview+of+drug+combination+analysis+with+isobolograms&doi=10.1124%2Fjpet.106.104117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of drug combination analysis with isobolograms</span></div><div class="casAuthors">Tallarida, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review with refs.  Drugs given in combination may produce effects that are greater than or less than the effect predicted from their individual potencies.  The historical basis for predicting the effect of a combination is based on the concept of dose equivalence; i.e., an equally ED (a) of one will add to the dose (b) of the other in the combination situation.  For drugs with a const. relative potency, this leads to linear additive isoboles (a-b curves of const. effect), whereas a varying potency ratio produces nonlinear additive isoboles.  Detn. of the additive isobole is a necessary procedure for assessing both synergistic and antagonistic interactions of the combination.  This review discusses both variable and const. relative potency situations and provides the math. formulas needed to distinguish these cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFzemT-mANgrVg90H21EOLACvtfcHk0lgVa88NWqSKQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCksL%252FO&md5=dc5254bd4348e2704599f41947f273fc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.104117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.104117%26sid%3Dliteratum%253Aachs%26aulast%3DTallarida%26aufirst%3DR.%2BJ.%26atitle%3DAn%2520overview%2520of%2520drug%2520combination%2520analysis%2520with%2520isobolograms%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D1%26epage%3D7%26doi%3D10.1124%2Fjpet.106.104117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emileh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuzer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umashankara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalonde, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bewley, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I. M.</span></span> <span> </span><span class="NLM_article-title">A model of peptide triazole entry inhibitor binding to hiv-1 gp120 and the mechanism of bridging sheet disruption</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2245</span>– <span class="NLM_lpage">2261</span>, <span class="refDoi"> DOI: 10.1021/bi400166b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi400166b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=2245-2261&author=A.+Emilehauthor=F.+Tuzerauthor=H.+Yehauthor=M.+Umashankaraauthor=D.+R.+Moreiraauthor=J.+M.+Lalondeauthor=C.+A.+Bewleyauthor=C.+F.+Abramsauthor=I.+M.+Chaiken&title=A+model+of+peptide+triazole+entry+inhibitor+binding+to+hiv-1+gp120+and+the+mechanism+of+bridging+sheet+disruption&doi=10.1021%2Fbi400166b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fbi400166b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400166b%26sid%3Dliteratum%253Aachs%26aulast%3DEmileh%26aufirst%3DA.%26aulast%3DTuzer%26aufirst%3DF.%26aulast%3DYeh%26aufirst%3DH.%26aulast%3DUmashankara%26aufirst%3DM.%26aulast%3DMoreira%26aufirst%3DD.%2BR.%26aulast%3DLalonde%26aufirst%3DJ.%2BM.%26aulast%3DBewley%26aufirst%3DC.%2BA.%26aulast%3DAbrams%26aufirst%3DC.%2BF.%26aulast%3DChaiken%26aufirst%3DI.%2BM.%26atitle%3DA%2520model%2520of%2520peptide%2520triazole%2520entry%2520inhibitor%2520binding%2520to%2520hiv-1%2520gp120%2520and%2520the%2520mechanism%2520of%2520bridging%2520sheet%2520disruption%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D2245%26epage%3D2261%26doi%3D10.1021%2Fbi400166b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tuzer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamanna, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zentner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaLonde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contarino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodroski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Hiv-1 env gp120 structural determinants for peptide triazole dual receptor site antagonism</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1002/prot.24184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1002%2Fprot.24184" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=271-290&author=F.+Tuzerauthor=N.+Madaniauthor=K.+Kamannaauthor=I.+Zentnerauthor=J.+LaLondeauthor=A.+Holmesauthor=E.+Uptonauthor=S.+Rajagopalauthor=K.+McFaddenauthor=M.+Contarinoauthor=J.+Sodroskiauthor=I.+Chaiken&title=Hiv-1+env+gp120+structural+determinants+for+peptide+triazole+dual+receptor+site+antagonism&doi=10.1002%2Fprot.24184"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fprot.24184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.24184%26sid%3Dliteratum%253Aachs%26aulast%3DTuzer%26aufirst%3DF.%26aulast%3DMadani%26aufirst%3DN.%26aulast%3DKamanna%26aufirst%3DK.%26aulast%3DZentner%26aufirst%3DI.%26aulast%3DLaLonde%26aufirst%3DJ.%26aulast%3DHolmes%26aufirst%3DA.%26aulast%3DUpton%26aufirst%3DE.%26aulast%3DRajagopal%26aufirst%3DS.%26aulast%3DMcFadden%26aufirst%3DK.%26aulast%3DContarino%26aufirst%3DM.%26aulast%3DSodroski%26aufirst%3DJ.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DHiv-1%2520env%2520gp120%2520structural%2520determinants%2520for%2520peptide%2520triazole%2520dual%2520receptor%2520site%2520antagonism%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2013%26volume%3D81%26spage%3D271%26epage%3D290%26doi%3D10.1002%2Fprot.24184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolchinsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiprilov, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodroski, J.</span></span> <span> </span><span class="NLM_article-title">Loss of a single n-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 v1/v2 variable loops</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">3435</span>– <span class="NLM_lpage">3443</span>, <span class="refDoi"> DOI: 10.1128/JVI.75.7.3435-3443.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FJVI.75.7.3435-3443.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=11238869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVGiu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2001&pages=3435-3443&author=P.+Kolchinskyauthor=E.+Kiprilovauthor=P.+Bartleyauthor=R.+Rubinsteinauthor=J.+Sodroski&title=Loss+of+a+single+n-linked+glycan+allows+CD4-independent+human+immunodeficiency+virus+type+1+infection+by+altering+the+position+of+the+gp120+v1%2Fv2+variable+loops&doi=10.1128%2FJVI.75.7.3435-3443.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops</span></div><div class="casAuthors">Kolchinsky, Peter; Kiprilov, Enko; Bartley, Peter; Rubinstein, Roee; Sodroski, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3435-3443</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The gp120 envelope glycoprotein of primary human immunodeficiency virus type 1 (HIV-1) promotes virus entry by sequentially binding CD4 and the CCR5 chemokine receptor on the target cell.  Previously, we adapted a primary HIV-1 isolate, ADA, to replicate in CD4-neg. canine cells expressing human CCR5.  The gp120 changes responsible for CD4-independent replication were limited to the V2 loop-V1/V2 stem.  Here we show that elimination of a single glycosylation site at asparagine 197 in the V1/V2 stem is sufficient for CD4-independent gp120 binding to CCR5 and for HIV-1 entry into CD4-neg. cells expressing CCR5.  Deletion of the V1/V2 loops also allowed CD4-independent viral entry and gp120 binding to CCR5.  The binding of the wild-type ADA gp120 to CCR5 was less dependent upon CD4 at 4°C than at 37°C.  In the absence of the V1/V2 loops, neither removal of the N-linked carbohydrate at asparagine 197 nor lowering of the temp. increased the CD4-independent phenotypes.  A CCR5-binding conformation of gp120, achieved by CD4 interaction or by modification of temp., glycosylation, or variable loops, was preferentially recognized by the monoclonal antibody 48d.  These results suggest that the CCR5-binding region of gp120 is occluded by the V1/V2 variable loops, the position of which can be modulated by temp., CD4 binding, or an N-linked glycan in the V1/V2 stem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Zyjp5wv_V7Vg90H21EOLACvtfcHk0li4ZxrMwroeJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVGiu7Y%253D&md5=247af9cce61ae5e742fa4116cf5747c9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FJVI.75.7.3435-3443.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.75.7.3435-3443.2001%26sid%3Dliteratum%253Aachs%26aulast%3DKolchinsky%26aufirst%3DP.%26aulast%3DKiprilov%26aufirst%3DE.%26aulast%3DBartley%26aufirst%3DP.%26aulast%3DRubinstein%26aufirst%3DR.%26aulast%3DSodroski%26aufirst%3DJ.%26atitle%3DLoss%2520of%2520a%2520single%2520n-linked%2520glycan%2520allows%2520CD4-independent%2520human%2520immunodeficiency%2520virus%2520type%25201%2520infection%2520by%2520altering%2520the%2520position%2520of%2520the%2520gp120%2520v1%252Fv2%2520variable%2520loops%26jtitle%3DJ.%2520Virol%26date%3D2001%26volume%3D75%26spage%3D3435%26epage%3D3443%26doi%3D10.1128%2FJVI.75.7.3435-3443.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pancera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiev, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofek, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart-Jones, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailer, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louder, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumba, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascola, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munro, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mothes, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connors, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, P. D.</span></span> <span> </span><span class="NLM_article-title">Structure and immune recognition of trimeric pre-fusion hiv-1 env</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>514</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1038/nature13808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1038%2Fnature13808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=25296255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSmurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=514&publication_year=2014&pages=455-461&author=M.+Panceraauthor=T.+Zhouauthor=A.+Druzauthor=I.+S.+Georgievauthor=C.+Sotoauthor=J.+Gormanauthor=J.+Huangauthor=P.+Acharyaauthor=G.+Y.+Chuangauthor=G.+Ofekauthor=G.+B.+Stewart-Jonesauthor=J.+Stuckeyauthor=R.+T.+Bailerauthor=M.+G.+Joyceauthor=M.+K.+Louderauthor=N.+Tumbaauthor=Y.+Yangauthor=B.+Zhangauthor=M.+S.+Cohenauthor=B.+F.+Haynesauthor=J.+R.+Mascolaauthor=L.+Morrisauthor=J.+B.+Munroauthor=S.+C.+Blanchardauthor=W.+Mothesauthor=M.+Connorsauthor=P.+D.+Kwong&title=Structure+and+immune+recognition+of+trimeric+pre-fusion+hiv-1+env&doi=10.1038%2Fnature13808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and immune recognition of trimeric pre-fusion HIV-1 Env</span></div><div class="casAuthors">Pancera, Marie; Zhou, Tongqing; Druz, Aliaksandr; Georgiev, Ivelin S.; Soto, Cinque; Gorman, Jason; Huang, Jinghe; Acharya, Priyamvada; Chuang, Gwo-Yu; Ofek, Gilad; Stewart-Jones, Guillaume B. E.; Stuckey, Jonathan; Bailer, Robert T.; Joyce, M. Gordon; Louder, Mark K.; Tumba, Nancy; Yang, Yongping; Zhang, Baoshan; Cohen, Myron S.; Haynes, Barton F.; Mascola, John R.; Morris, Lynn; Munro, James B.; Blanchard, Scott C.; Mothes, Walther; Connors, Mark; Kwong, Peter D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">514</span>
        (<span class="NLM_cas:issue">7523</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human immunodeficiency virus type 1 (HIV-1) envelope (Env) spike, comprising three gp120 and three gp41 subunits, is a conformational machine that facilitates HIV-1 entry by rearranging from a mature unliganded state, through receptor-bound intermediates, to a post-fusion state.  As the sole viral antigen on the HIV-1 virion surface, Env is both the target of neutralizing antibodies and a focus of vaccine efforts.  Here we report the structure at 3.5 Å resoln. for an HIV-1 Env trimer captured in a mature closed state by antibodies PGT122 and 35O22.  This structure reveals the pre-fusion conformation of gp41, indicates rearrangements needed for fusion activation, and defines parameters of immune evasion and immune recognition.  Pre-fusion gp41 encircles amino- and carboxy-terminal strands of gp120 with four helixes that form a membrane-proximal collar, fastened by insertion of a fusion peptide-proximal methionine into a gp41-tryptophan clasp.  Spike rearrangements required for entry involve opening the clasp and expelling the termini.  N-linked glycosylation and sequence-variable regions cover the pre-fusion closed spike; we used chronic cohorts to map the prevalence and location of effective HIV-1-neutralizing responses, which were distinguished by their recognition of N-linked glycan and tolerance for epitope-sequence variation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-_ounjxrWarVg90H21EOLACvtfcHk0li4ZxrMwroeJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSmurnE&md5=2bfc5d3cc8a8577a33ac5f31adbb9015</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnature13808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13808%26sid%3Dliteratum%253Aachs%26aulast%3DPancera%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DDruz%26aufirst%3DA.%26aulast%3DGeorgiev%26aufirst%3DI.%2BS.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DGorman%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DAcharya%26aufirst%3DP.%26aulast%3DChuang%26aufirst%3DG.%2BY.%26aulast%3DOfek%26aufirst%3DG.%26aulast%3DStewart-Jones%26aufirst%3DG.%2BB.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DBailer%26aufirst%3DR.%2BT.%26aulast%3DJoyce%26aufirst%3DM.%2BG.%26aulast%3DLouder%26aufirst%3DM.%2BK.%26aulast%3DTumba%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DCohen%26aufirst%3DM.%2BS.%26aulast%3DHaynes%26aufirst%3DB.%2BF.%26aulast%3DMascola%26aufirst%3DJ.%2BR.%26aulast%3DMorris%26aufirst%3DL.%26aulast%3DMunro%26aufirst%3DJ.%2BB.%26aulast%3DBlanchard%26aufirst%3DS.%2BC.%26aulast%3DMothes%26aufirst%3DW.%26aulast%3DConnors%26aufirst%3DM.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26atitle%3DStructure%2520and%2520immune%2520recognition%2520of%2520trimeric%2520pre-fusion%2520hiv-1%2520env%26jtitle%3DNature%26date%3D2014%26volume%3D514%26spage%3D455%26epage%3D461%26doi%3D10.1038%2Fnature13808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borsi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchinat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarti, N.</span></span> <span> </span><span class="NLM_article-title">Entropic contribution to the linking coefficient in fragment based drug design: A case study</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4285</span>– <span class="NLM_lpage">4289</span>, <span class="refDoi"> DOI: 10.1021/jm901723z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901723z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFChsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4285-4289&author=V.+Borsiauthor=V.+Calderoneauthor=M.+Fragaiauthor=C.+Luchinatauthor=N.+Sarti&title=Entropic+contribution+to+the+linking+coefficient+in+fragment+based+drug+design%3A+A+case+study&doi=10.1021%2Fjm901723z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Entropic Contribution to the Linking Coefficient in Fragment Based Drug Design: A Case Study</span></div><div class="casAuthors">Borsi, Valentina; Calderone, Vito; Fragai, Marco; Luchinat, Claudio; Sarti, Niko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4285-4289</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">For several drug leads obtained by tethering weak binding ligands, the dissocn. const. is smaller than the product of those of the individual fragments by a factor named the linking coeff., E.  This favorable contribution is attributed to the entropic gain that is realized when two weak binding ligands are tethered.  Here we show a case study where the linking coeff. is strikingly small (E = 2.1 × 10-3 M-1) and its totally entropic nature is demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzdSoYwKSiDbVg90H21EOLACvtfcHk0ljFAvmfr1OccA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFChsb4%253D&md5=3f33ad95e5443545871184726ba43e4a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm901723z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901723z%26sid%3Dliteratum%253Aachs%26aulast%3DBorsi%26aufirst%3DV.%26aulast%3DCalderone%26aufirst%3DV.%26aulast%3DFragai%26aufirst%3DM.%26aulast%3DLuchinat%26aufirst%3DC.%26aulast%3DSarti%26aufirst%3DN.%26atitle%3DEntropic%2520contribution%2520to%2520the%2520linking%2520coefficient%2520in%2520fragment%2520based%2520drug%2520design%253A%2520A%2520case%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4285%26epage%3D4289%26doi%3D10.1021%2Fjm901723z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopetzki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jekle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubenrauch, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlothauer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilek, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ries, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankuratri, S.</span></span> <span> </span><span class="NLM_article-title">CD4-anchoring hiv-1 fusion inhibitor with enhanced potency and in vivo stability</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">5175</span>– <span class="NLM_lpage">5185</span>, <span class="refDoi"> DOI: 10.1074/jbc.M808745200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1074%2Fjbc.M808745200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=5175-5185&author=C.+Jiauthor=E.+Kopetzkiauthor=A.+Jekleauthor=K.+G.+Stubenrauchauthor=X.+Liuauthor=J.+Zhangauthor=E.+Raoauthor=T.+Schlothauerauthor=S.+Fischerauthor=N.+Cammackauthor=G.+Heilekauthor=S.+Riesauthor=S.+Sankuratri&title=CD4-anchoring+hiv-1+fusion+inhibitor+with+enhanced+potency+and+in+vivo+stability&doi=10.1074%2Fjbc.M808745200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M808745200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M808745200%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DC.%26aulast%3DKopetzki%26aufirst%3DE.%26aulast%3DJekle%26aufirst%3DA.%26aulast%3DStubenrauch%26aufirst%3DK.%2BG.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DE.%26aulast%3DSchlothauer%26aufirst%3DT.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DHeilek%26aufirst%3DG.%26aulast%3DRies%26aufirst%3DS.%26aulast%3DSankuratri%26aufirst%3DS.%26atitle%3DCD4-anchoring%2520hiv-1%2520fusion%2520inhibitor%2520with%2520enhanced%2520potency%2520and%2520in%2520vivo%2520stability%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D5175%26epage%3D5185%26doi%3D10.1074%2Fjbc.M808745200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kagiampakis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharibi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankowski, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alatas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LiWang, P. J.</span></span> <span> </span><span class="NLM_article-title">Potent strategy to inhibit hiv-1 by binding both gp120 and gp41</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1128/AAC.00376-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FAAC.00376-10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=264-275&author=I.+Kagiampakisauthor=A.+Gharibiauthor=M.+K.+Mankowskiauthor=B.+A.+Snyderauthor=R.+G.+Ptakauthor=K.+Alatasauthor=P.+J.+LiWang&title=Potent+strategy+to+inhibit+hiv-1+by+binding+both+gp120+and+gp41&doi=10.1128%2FAAC.00376-10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1128%2FAAC.00376-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00376-10%26sid%3Dliteratum%253Aachs%26aulast%3DKagiampakis%26aufirst%3DI.%26aulast%3DGharibi%26aufirst%3DA.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DSnyder%26aufirst%3DB.%2BA.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DAlatas%26aufirst%3DK.%26aulast%3DLiWang%26aufirst%3DP.%2BJ.%26atitle%3DPotent%2520strategy%2520to%2520inhibit%2520hiv-1%2520by%2520binding%2520both%2520gp120%2520and%2520gp41%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D264%26epage%3D275%26doi%3D10.1128%2FAAC.00376-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopetzki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jekle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankuratri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilek, G.</span></span> <span> </span><span class="NLM_article-title">Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of hiv-1</span>. <i>Virol. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">56</span>, <span class="refDoi"> DOI: 10.1186/1743-422X-5-56</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1186%2F1743-422X-5-56" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=18452606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A280%3ADC%252BD1czktlOrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=56&author=E.+Kopetzkiauthor=A.+Jekleauthor=C.+Jiauthor=E.+Raoauthor=J.+Zhangauthor=S.+Fischerauthor=N.+Cammackauthor=S.+Sankuratriauthor=G.+Heilek&title=Closing+two+doors+of+viral+entry%3A+Intramolecular+combination+of+a+coreceptor-+and+fusion+inhibitor+of+hiv-1&doi=10.1186%2F1743-422X-5-56"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Closing two doors of viral entry: intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1</span></div><div class="casAuthors">Kopetzki Erhard; Jekle Andreas; Ji Changhua; Rao Eileen; Zhang Jun; Fischer Stephan; Cammack Nick; Sankuratri Surya; Heilek Gabrielle</div><div class="citationInfo"><span class="NLM_cas:title">Virology journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We describe a novel strategy in which two inhibitors of HIV viral entry were incorporated into a single molecule.  This bifunctional fusion inhibitor consists of an antibody blocking the binding of HIV to its co-receptor CCR5, and a covalently linked peptide which blocks envelope mediated virus-cell fusion.  This novel bifunctional molecule is highly active on CCR5- and X4-tropic viruses in a single cycle assay and a reporter cell line with IC50 values of 0.03-0.05 nM.  We demonstrated that both inhibitors contribute to the antiviral activity.  In the natural host peripheral blood mononuclear cells (PBMC) the inhibition of CXCR4-tropic viruses is dependant on the co-expression of CCR5 and CXCR4 receptors.  This bifunctional inhibitor may offer potential for improved pharmacokinetic parameters for a fusion inhibitor in humans and the combination of two active antiviral agents in one molecule may provide better durability in controlling the emergence of resistant viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQRY3cZ5prrYbGbPKh4T9eAfW6udTcc2eZeOwU32qbXm7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czktlOrsg%253D%253D&md5=757aadc315dcc9f4b4a2bdff7f7c2e6d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1186%2F1743-422X-5-56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1743-422X-5-56%26sid%3Dliteratum%253Aachs%26aulast%3DKopetzki%26aufirst%3DE.%26aulast%3DJekle%26aufirst%3DA.%26aulast%3DJi%26aufirst%3DC.%26aulast%3DRao%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DSankuratri%26aufirst%3DS.%26aulast%3DHeilek%26aufirst%3DG.%26atitle%3DClosing%2520two%2520doors%2520of%2520viral%2520entry%253A%2520Intramolecular%2520combination%2520of%2520a%2520coreceptor-%2520and%2520fusion%2520inhibitor%2520of%2520hiv-1%26jtitle%3DVirol.%2520J.%26date%3D2008%26volume%3D5%26spage%3D56%26doi%3D10.1186%2F1743-422X-5-56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parajuli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashad, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I. M.</span></span> <span> </span><span class="NLM_article-title">Lytic inactivation of human immunodeficiency virus by dual engagement of gp120 and gp41 domains in the virus env protein trimer</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6100</span>– <span class="NLM_lpage">6114</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.6b00570</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.6b00570" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1GrurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=6100-6114&author=B.+Parajuliauthor=K.+Acharyaauthor=R.+Yuauthor=B.+Ngoauthor=A.+A.+Rashadauthor=C.+F.+Abramsauthor=I.+M.+Chaiken&title=Lytic+inactivation+of+human+immunodeficiency+virus+by+dual+engagement+of+gp120+and+gp41+domains+in+the+virus+env+protein+trimer&doi=10.1021%2Facs.biochem.6b00570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Lytic inactivation of human immunodeficiency virus by dual engagement of gp120 and gp41 domains in the virus Env protein trimer</span></div><div class="casAuthors">Parajuli, Bibek; Acharya, Kriti; Yu, Reina; Ngo, Brendon; Rashad, Adel A.; Abrams, Cameron F.; Chaiken, Irwin M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">6100-6114</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors recently reported the discovery of a recombinant chimera, denoted DAVEI (dual-acting virucidal entry inhibitor), which was able to selectively cause specific and potent lytic inactivation of both pseudotyped and fully infectious human immunodeficiency virus (HIV-1) virions.  The chimera was composed of the lectin cyanovirin-N (CVN) fused to the 20-residue membrane-proximal external region (MPER) of HIV-1 gp41.  Because the Env gp120-binding CVN domain on its own is not lytic, the authors sought here to det. how the MPER(DAVEI) domain is able to endow the chimera with virolytic activity.  The authors used a protein engineering strategy to identify mol. determinants of MPER(DAVEI) that were important for function.  Recombinant mutagenesis and truncation demonstrated that the MPER(DAVEI) domain could be significantly minimized without loss of function.  The dependence of lysis on specific MPER sequences of DAVEI, detn. of minimal linker length, and competition by a simplified MPER surrogate peptide suggested that the MPER domain of DAVEI interacts with the Env spike trimer, likely with the gp41 region.  This conclusion was further supported by observations from binding of the biotinylated MPER surrogate peptide to Env protein expressed on cells, monoclonal antibody competition, a direct binding ELISA on viruses with varying nos. of trimeric spikes on their surfaces, and comparison of maximal interdomain spacing in DAVEI to that in high-resoln. structures of Env.  The finding that MPER(DAVEI) in CVN-MPER linker sequences could be minimized without loss of virolytic function provides an improved exptl. path for constructing size-minimized DAVEI chimeras and mol. tools for detg. how simultaneous engagement of gp120 and gp41 by these chimeras can disrupt the metastable virus Env spike.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBDfNfVUqtC7Vg90H21EOLACvtfcHk0lg0CQ1VZnwraA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1GrurjK&md5=649cf20617e6d9aa6ad8ba33e87a4266</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.6b00570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.6b00570%26sid%3Dliteratum%253Aachs%26aulast%3DParajuli%26aufirst%3DB.%26aulast%3DAcharya%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DNgo%26aufirst%3DB.%26aulast%3DRashad%26aufirst%3DA.%2BA.%26aulast%3DAbrams%26aufirst%3DC.%2BF.%26aulast%3DChaiken%26aufirst%3DI.%2BM.%26atitle%3DLytic%2520inactivation%2520of%2520human%2520immunodeficiency%2520virus%2520by%2520dual%2520engagement%2520of%2520gp120%2520and%2520gp41%2520domains%2520in%2520the%2520virus%2520env%2520protein%2520trimer%26jtitle%3DBiochemistry%26date%3D2016%26volume%3D55%26spage%3D6100%26epage%3D6114%26doi%3D10.1021%2Facs.biochem.6b00570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quinlan, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebrahimi, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farzan, M.</span></span> <span> </span><span class="NLM_article-title">A double-mimetic peptide efficiently neutralizes hiv-1 by bridging the CD4- and coreceptor-binding sites of gp120</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">3353</span>– <span class="NLM_lpage">3358</span>, <span class="refDoi"> DOI: 10.1128/JVI.03800-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FJVI.03800-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=24390333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVOqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2014&pages=3353-3358&author=B.+D.+Quinlanauthor=V.+R.+Joshiauthor=M.+R.+Gardnerauthor=K.+H.+Ebrahimiauthor=M.+Farzan&title=A+double-mimetic+peptide+efficiently+neutralizes+hiv-1+by+bridging+the+CD4-+and+coreceptor-binding+sites+of+gp120&doi=10.1128%2FJVI.03800-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A double-mimetic peptide efficiently neutralizes HIV-1 by bridging the CD4- and coreceptor-binding sites of gp120</span></div><div class="casAuthors">Quinlan, Brian D.; Joshi, Vinita R.; Gardner, Matthew R.; Ebrahimi, Kourosh H.; Farzan, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3353-3358, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The HIV-1 envelope glycoprotein binds cooperatively to its cellular receptor CD4 and a coreceptor, principally CXCR4 or CCR5.  The authors have previously improved a natural amino-acid form of a scorpion toxin-derived CD4-mimetic peptide and in parallel generated sulfopeptide mimetics of the CCR5 amino terminus.  Here the authors show that some fusions of these CCR5- and CD4-mimetic peptides, expressed as immunoadhesins, neutralize HIV-1 more efficiently than CD4-Fc or equimolar mixts. of immunoadhesin forms of each peptide.  Specifically, double-mimetic peptides with linkers of 11 amino acids or greater, and with the CCR5-mimetic component preceding the CD4-mimetic component, were more efficient than constructs with shorter linkers or in a reverse orientation.  The potency of these constructs derives from (i) their ability to simultaneously and cooperatively bind the CD4- and CCR5-binding sites of a single gp120 monomer of the HIV-1 envelope glycoprotein trimer and (ii) the ability of the CCR5-mimetic component to prevent the CD4-mimetic peptide from promoting infection when cellular CD4 is limiting.  Thus, there is a significant advantage to simultaneously targeting both conserved regions of the HIV-1 envelope glycoprotein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr88wqaM8jg0bVg90H21EOLACvtfcHk0lg0CQ1VZnwraA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVOqsrY%253D&md5=f28889bd475cb5d560782ee46d44a0a7</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1128%2FJVI.03800-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.03800-13%26sid%3Dliteratum%253Aachs%26aulast%3DQuinlan%26aufirst%3DB.%2BD.%26aulast%3DJoshi%26aufirst%3DV.%2BR.%26aulast%3DGardner%26aufirst%3DM.%2BR.%26aulast%3DEbrahimi%26aufirst%3DK.%2BH.%26aulast%3DFarzan%26aufirst%3DM.%26atitle%3DA%2520double-mimetic%2520peptide%2520efficiently%2520neutralizes%2520hiv-1%2520by%2520bridging%2520the%2520CD4-%2520and%2520coreceptor-binding%2520sites%2520of%2520gp120%26jtitle%3DJ.%2520Virol%26date%3D2014%26volume%3D88%26spage%3D3353%26epage%3D3358%26doi%3D10.1128%2FJVI.03800-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankowski, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liwang, P. J.</span></span> <span> </span><span class="NLM_article-title">Highly potent chimeric inhibitors targeting two steps of hiv cell entry</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">28370</span>– <span class="NLM_lpage">28381</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.234799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1074%2Fjbc.M111.234799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=21659523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsl2msb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=28370-28381&author=B.+Zhaoauthor=M.+K.+Mankowskiauthor=B.+A.+Snyderauthor=R.+G.+Ptakauthor=P.+J.+Liwang&title=Highly+potent+chimeric+inhibitors+targeting+two+steps+of+hiv+cell+entry&doi=10.1074%2Fjbc.M111.234799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry</span></div><div class="casAuthors">Zhao, Bo; Mankowski, Marie K.; Snyder, Beth A.; Ptak, Roger G.; LiWang, Patricia J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">28370-28381, S28370/1-S28370/5</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Blocking HIV-1 cell entry has long been a major goal of anti-HIV drug development.  Here, we report a successful design of two highly potent chimeric HIV entry inhibitors composed of one CCR5-targeting RANTES (regulated on activation normal T cell expressed and secreted) variant (5P12-RANTES or 5P14-RANTES (Gaertner, H., Cerini, F., Escola, J. M., Kuenzi, G., Melotti, A., Offord, R., Rossitto-Borlat, I., Nedellec, R., Salkowitz, J., Gorochov, G., Mosier, D., and Hartley, O. (2008) PROC: Natl. Acad. Sci. U.S.A. 105, 17706-17711)) linked to a gp41 fusion inhibitor, C37.  Chimeric inhibitors 5P12-linker-C37 and 5P14-linker-C37 showed extremely high antiviral potency in single cycle and replication-competent viral assays against R5-tropic viruses, with IC50 values as low as 0.004 nM.  This inhibition was somewhat strain-dependent and was up to 100-fold better than the RANTES variant alone or in combination with unlinked C37.  The chimeric inhibitors also fully retained the antiviral activity of C37 against X4-tropic viruses, and this inhibition can be further enhanced significantly if the target cell co-expresses CCR5 receptor.  On human peripheral blood mononuclear cells, the inhibitors showed very strong inhibition against R5-tropic Ba-L strain and X4-tropic IIIB strain, with IC50 values as low as 0.015 and 0.44 nM, which are 45- and 16-fold better than the parent inhibitors, resp.  A clear delivery mechanism requiring a covalent linkage between the two segments of the chimera was obsd. and characterized.  Furthermore, the two chimeric inhibitors are fully recombinant and are easily produced at low cost.  These attributes make them excellent candidates for anti-HIV microbicides.  The results of this study also suggest a potent approach for optimizing existing HIV entry inhibitors or designing new inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_mgPhkmOu-bVg90H21EOLACvtfcHk0lgMi4xgcIatrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsl2msb4%253D&md5=b8599136ca194462a3332b9b8b91495d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.234799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.234799%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DSnyder%26aufirst%3DB.%2BA.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DLiwang%26aufirst%3DP.%2BJ.%26atitle%3DHighly%2520potent%2520chimeric%2520inhibitors%2520targeting%2520two%2520steps%2520of%2520hiv%2520cell%2520entry%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D28370%26epage%3D28381%26doi%3D10.1074%2Fjbc.M111.234799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Munoz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyrhaug, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vega, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Fernandez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santiago, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frade, J. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellado, M.</span></span> <span> </span><span class="NLM_article-title">CCR5/CD4/CXCR4 oligomerization prevents hiv-1 gp120iiib binding to the cell surface</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">E1960</span>– <span class="NLM_lpage">E1969</span>, <span class="refDoi"> DOI: 10.1073/pnas.1322887111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1073%2Fpnas.1322887111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=24778234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntFGisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E1960-E1969&author=L.+Martinez-Munozauthor=R.+Barrosoauthor=S.+Y.+Dyrhaugauthor=G.+Navarroauthor=P.+Lucasauthor=S.+F.+Sorianoauthor=B.+Vegaauthor=C.+Costasauthor=M.+A.+Munoz-Fernandezauthor=C.+Santiagoauthor=J.+M.+R.+Fradeauthor=R.+Francoauthor=M.+Mellado&title=CCR5%2FCD4%2FCXCR4+oligomerization+prevents+hiv-1+gp120iiib+binding+to+the+cell+surface&doi=10.1073%2Fpnas.1322887111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">CCR5/CD4/CXCR4 oligomerization prevents HIV-1 gp120IIIB binding to the cell surface</span></div><div class="casAuthors">Martinez-Munoz, Laura; Barroso, Ruben; Dyrhaug, Sunniva Y.; Navarro, Gemma; Lucas, Pilar; Soriano, Silvia F.; Vega, Beatriz; Costas, Coloma; Munoz-Fernandez, M. Angeles; Santiago, Cesar; Rodriguez Frade, Jose Miguel; Franco, Rafael; Mellado, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">E1960-E1969</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">CCR5 and CXCR4, the resp. cell surface coreceptors of R5 and X4 HIV-1 strains, both form heterodimers with CD4, the principal HIV-1 receptor.  Using several resonance energy transfer techniques, the authors detd. that CD4, CXCR4, and CCR5 formed heterotrimers, and that CCR5 coexpression altered the conformation of both CXCR4/CXCR4 homodimers and CD4/CXCR4 heterodimers.  As a result, binding of the HIV-1 envelope protein gp120IIIB to the CD4/CXCR4/CCR5 heterooligomer was negligible, and the gp120-induced cytoskeletal rearrangements necessary for HIV-1 entry were prevented.  CCR5 reduced HIV-1 envelope-induced CD4/CXCR4-mediated cell-cell fusion.  In nucleofected Jurkat CD4 cells and primary human CD4+ T cells, CCR5 expression led to a redn. in X4 HIV-1 infectivity.  These findings can help to understand why X4 HIV-1 strains infection affect T-cell types differently during AIDS development and indicate that receptor oligomerization might be a target for previously unidentified therapeutic approaches for AIDS intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQPlvOBqnKq7Vg90H21EOLACvtfcHk0lgMi4xgcIatrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntFGisrg%253D&md5=c701d21034823dd22e9cf14cc1839a38</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1322887111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1322887111%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Munoz%26aufirst%3DL.%26aulast%3DBarroso%26aufirst%3DR.%26aulast%3DDyrhaug%26aufirst%3DS.%2BY.%26aulast%3DNavarro%26aufirst%3DG.%26aulast%3DLucas%26aufirst%3DP.%26aulast%3DSoriano%26aufirst%3DS.%2BF.%26aulast%3DVega%26aufirst%3DB.%26aulast%3DCostas%26aufirst%3DC.%26aulast%3DMunoz-Fernandez%26aufirst%3DM.%2BA.%26aulast%3DSantiago%26aufirst%3DC.%26aulast%3DFrade%26aufirst%3DJ.%2BM.%2BR.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DMellado%26aufirst%3DM.%26atitle%3DCCR5%252FCD4%252FCXCR4%2520oligomerization%2520prevents%2520hiv-1%2520gp120iiib%2520binding%2520to%2520the%2520cell%2520surface%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3DE1960%26epage%3DE1969%26doi%3D10.1073%2Fpnas.1322887111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feyertag, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meehan, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travers, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, D. L.</span></span> <span> </span><span class="NLM_article-title">Characterizing the diverse mutational pathways associated with r5-tropic maraviroc resistance: Hiv-1 that uses the drug-bound CCR5 coreceptor</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">11457</span>– <span class="NLM_lpage">11472</span>, <span class="refDoi"> DOI: 10.1128/JVI.01384-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FJVI.01384-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=26339063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslymtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=11457-11472&author=X.+Jiangauthor=F.+Feyertagauthor=C.+J.+Meehanauthor=G.+P.+McCormackauthor=S.+A.+Traversauthor=C.+Craigauthor=M.+Westbyauthor=M.+Lewisauthor=D.+L.+Robertson&title=Characterizing+the+diverse+mutational+pathways+associated+with+r5-tropic+maraviroc+resistance%3A+Hiv-1+that+uses+the+drug-bound+CCR5+coreceptor&doi=10.1128%2FJVI.01384-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Characterizing the diverse mutational pathways associated with R5-tropic maraviroc resistance: HIV-1 that uses the drug-bound CCR5 coreceptor</span></div><div class="casAuthors">Jiang, Xiaowei; Feyertag, Felix; Meehan, Conor J.; McCormack, Grace P.; Travers, Simon A.; Craig, Charles; Westby, Mike; Lewis, Marilyn; Robertson, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">11457-11472</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Entry inhibitors represent a potent class of antiretroviral drugs that target a host cell protein, CCR5, an HIV-1 entry coreceptor, and not viral protein.  Lack of sensitivity can occur due to preexisting virus that uses the CXCR4 coreceptor, while true resistance occurs through viral adaptation to use a drug-bound CCR5 coreceptor.  To understand this R5 resistance pathway, we analyzed >500 envelope protein sequences and phenotypes from viruses of 20 patients from the clin. trials MOTIVATE 1 and 2, in which treatment-experienced patients received maraviroc plus optimized background therapy.  The resistant viral population was phylogenetically distinct and assocd. with a genetic bottleneck in each patient, consistent with de novo emergence of resistance.  Recombination anal. showed that the C2-V3-C3 region tends to genotypically correspond to the recombinant's phenotype, indicating its primary importance in conferring resistance.  Between patients, there was a notable lack of commonality in the specific sites conferring resistance, confirming the unusual nature of R5-tropic resistance.  We used coevolutionary and pos.-selection analyses to characterize the genotypic determinants of resistance and found that (i) there are complicated covariation networks, indicating frequent coevolutionary/compensatory changes in the context of protein structure; (ii) covarying sites under pos. selection are enriched in resistant viruses; (iii) CD4 binding sites form part of a unique covariation network independent of the V3 loop; and (iv) the covariation network formed between the V3 loop and other regions of gp120 and gp41 intersects sites involved in glycosylation and protein secretion.  These results demonstrate that while envelope sequence mutations are the key to conferring maraviroc resistance, the specific changes involved are context dependent and thus inherently unpredictable.  Sequences were deposited in GenBank under accession nos. KT452084 to KT452622.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDh62iRXiFIrVg90H21EOLACvtfcHk0lgMi4xgcIatrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslymtb%252FN&md5=ab7ed5de98f7b010383a1698fc4bb985</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FJVI.01384-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01384-15%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DFeyertag%26aufirst%3DF.%26aulast%3DMeehan%26aufirst%3DC.%2BJ.%26aulast%3DMcCormack%26aufirst%3DG.%2BP.%26aulast%3DTravers%26aufirst%3DS.%2BA.%26aulast%3DCraig%26aufirst%3DC.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DRobertson%26aufirst%3DD.%2BL.%26atitle%3DCharacterizing%2520the%2520diverse%2520mutational%2520pathways%2520associated%2520with%2520r5-tropic%2520maraviroc%2520resistance%253A%2520Hiv-1%2520that%2520uses%2520the%2520drug-bound%2520CCR5%2520coreceptor%26jtitle%3DJ.%2520Virol.%26date%3D2015%26volume%3D89%26spage%3D11457%26epage%3D11472%26doi%3D10.1128%2FJVI.01384-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rashad, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haftl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aneja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Chemical optimization of macrocyclic hiv-1 inactivators for improving potency and increasing the structural diversity at the triazole ring</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">7770</span>– <span class="NLM_lpage">7782</span>, <span class="refDoi"> DOI: 10.1039/C7OB01448A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1039%2FC7OB01448A" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=7770-7782&author=A.+A.+Rashadauthor=K.+Acharyaauthor=A.+Haftlauthor=R.+Anejaauthor=A.+Dickauthor=A.+P.+Holmesauthor=I.+Chaiken&title=Chemical+optimization+of+macrocyclic+hiv-1+inactivators+for+improving+potency+and+increasing+the+structural+diversity+at+the+triazole+ring&doi=10.1039%2FC7OB01448A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1039%2FC7OB01448A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7OB01448A%26sid%3Dliteratum%253Aachs%26aulast%3DRashad%26aufirst%3DA.%2BA.%26aulast%3DAcharya%26aufirst%3DK.%26aulast%3DHaftl%26aufirst%3DA.%26aulast%3DAneja%26aufirst%3DR.%26aulast%3DDick%26aufirst%3DA.%26aulast%3DHolmes%26aufirst%3DA.%2BP.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DChemical%2520optimization%2520of%2520macrocyclic%2520hiv-1%2520inactivators%2520for%2520improving%2520potency%2520and%2520increasing%2520the%2520structural%2520diversity%2520at%2520the%2520triazole%2520ring%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2017%26volume%3D15%26spage%3D7770%26epage%3D7782%26doi%3D10.1039%2FC7OB01448A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clercq, E.</span></span> <span> </span><span class="NLM_article-title">The bicyclam amd3100 story</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">587</span>, <span class="refDoi"> DOI: 10.1038/nrd1134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1038%2Fnrd1134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=12815382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1Oqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=581-587&author=E.+De%0AClercq&title=The+bicyclam+amd3100+story&doi=10.1038%2Fnrd1134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Timeline: The bicyclam AMD3100 story</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">581-587</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery and development of the bicyclam AMD3100 - a chemokine receptor antagonist - has highlighted the therapeutic potential of such compds. in HIV infection, inflammatory diseases, cancer and stem-cell mobilization.  Here, the author describes the development process of AMD3100, which began about 15 yr ago with the isolation of an impurity, and the basis for the clin. application of AMD3100 and its congeners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB-TkHJ79RrbVg90H21EOLACvtfcHk0liWYzoYUnszgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1Oqsr8%253D&md5=cf8344ba0e19da8ffaadfe8c9b57200c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnrd1134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1134%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520bicyclam%2520amd3100%2520story%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D581%26epage%3D587%26doi%3D10.1038%2Fnrd1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. Q.</span>; <span class="NLM_string-name">Cao, B.</span>; <span class="NLM_string-name">Xie, X.</span>; <span class="NLM_string-name">Wei, W.</span></span> <span> </span><span class="NLM_article-title">Imidazopyridines as CXCR4 Antagonists and Their Preparation, Pharmaceutical Compositions and Use In The Treatment Of Diseases</span>. <span class="NLM_patent">CN 102675305</span>, Sept 19, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=Y.+Q.+Long&author=B.+Cao&author=X.+Xie&author=W.+Wei&title=Imidazopyridines+as+CXCR4+Antagonists+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+In+The+Treatment+Of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DImidazopyridines%2520as%2520CXCR4%2520Antagonists%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520In%2520The%2520Treatment%2520Of%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="link1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'link1'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="link1_1"><span><span> </span><span class="NLM_article-title">Openeye
Scientific Software Home Page</span>. <a href="http://www.eyesopen.com" class="extLink">http://www.eyesopen.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Openeye%0AScientific+Software+Home+Page.+http%3A%2F%2Fwww.eyesopen.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=link1_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DOpeneye%250AScientific%2520Software%2520Home%2520Page" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madhavi
Sastry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adzhigirey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annabhimoju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+Madhavi%0ASastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+ligand+preparation%3A+Parameters%2C+protocols%2C+and+influence+on+virtual+screening+enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Madhavi Sastry, G.; Adzhigirey, Matvey; Day, Tyler; Annabhimoju, Ramakrishna; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-234</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepd. prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove at. clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addn., ligands must be prepd. to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system prepn. is generally accepted in the field, an extensive study of the prepn. steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in prepg. a system for virtual screening.  We first explore a large no. of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper prepn. and that neglecting certain steps of the prepn. process produces a systematic degrdn. in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the prepn. that impact database enrichment.  While the work presented here was performed with the Protein Prepn. Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruqN5nIOJtR7Vg90H21EOLACvtfcHk0liWYzoYUnszgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D&md5=259a6d547ef3e1310e091fb50fe8de16</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DMadhavi%2BSastry%26aufirst%3DG.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520ligand%2520preparation%253A%2520Parameters%252C%2520protocols%252C%2520and%2520influence%2520on%2520virtual%2520screening%2520enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashad, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klasse, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Recognition of hiv-inactivating peptide triazoles by the recombinant soluble env trimer, bg505 sosip.664</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1002/prot.25238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1002%2Fprot.25238" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2017&pages=843-851&author=K.+Acharyaauthor=A.+A.+Rashadauthor=F.+Moracaauthor=P.+J.+Klasseauthor=J.+P.+Mooreauthor=C.+Abramsauthor=I.+Chaiken&title=Recognition+of+hiv-inactivating+peptide+triazoles+by+the+recombinant+soluble+env+trimer%2C+bg505+sosip.664&doi=10.1002%2Fprot.25238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fprot.25238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.25238%26sid%3Dliteratum%253Aachs%26aulast%3DAcharya%26aufirst%3DK.%26aulast%3DRashad%26aufirst%3DA.%2BA.%26aulast%3DMoraca%26aufirst%3DF.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DAbrams%26aufirst%3DC.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DRecognition%2520of%2520hiv-inactivating%2520peptide%2520triazoles%2520by%2520the%2520recombinant%2520soluble%2520env%2520trimer%252C%2520bg505%2520sosip.664%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2017%26volume%3D85%26spage%3D843%26epage%3D851%26doi%3D10.1002%2Fprot.25238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R.</span>; <span class="NLM_string-name">Repasky, M.</span>; <span class="NLM_string-name">Zhou, Z.
Y.</span>; <span class="NLM_string-name">Abel, R.</span>; <span class="NLM_string-name">Krilov, G.</span>; <span class="NLM_string-name">Tubert-Brohman, I.</span>; <span class="NLM_string-name">Sherman, W.</span>; <span class="NLM_string-name">Farid, R.</span>; <span class="NLM_string-name">Friesner, R. A.</span></span><span> </span><span class="NLM_article-title">Evaluation of docking and scoring accuracy using a new version of schrodinger’s glide xp and induced fit docking (ifd) methodologies</span>. Presented at the 241st ACS National Meeting & Exposition, Anaheim, CA, March 27–31, <span class="NLM_year">2011</span>; Paper 93.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+Murphy&author=M.+Repasky&author=Z.%0AY.+Zhou&author=R.+Abel&author=G.+Krilov&author=I.+Tubert-Brohman&author=W.+Sherman&author=R.+Farid&author=R.+A.+Friesner&title=Evaluation+of+docking+and+scoring+accuracy+using+a+new+version+of+schrodinger%E2%80%99s+glide+xp+and+induced+fit+docking+%28ifd%29+methodologies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DR.%26atitle%3DEvaluation%2520of%2520docking%2520and%2520scoring%2520accuracy%2520using%2520a%2520new%2520version%2520of%2520schrodinger%25E2%2580%2599s%2520glide%2520xp%2520and%2520induced%2520fit%2520docking%2520%2528ifd%2529%2520methodologies%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korotvička, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deiana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kullberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Córdova, A.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis of maraviroc (uk-427,857)</span>. <i>Adv. Synth. Catal.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">2291</span>– <span class="NLM_lpage">2298</span>, <span class="refDoi"> DOI: 10.1002/adsc.201000287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1002%2Fadsc.201000287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFyhsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2010&pages=2291-2298&author=G.+L.+Zhaoauthor=S.+Linauthor=A.+Korotvi%C4%8Dkaauthor=L.+Deianaauthor=M.+Kullbergauthor=A.+C%C3%B3rdova&title=Asymmetric+synthesis+of+maraviroc+%28uk-427%2C857%29&doi=10.1002%2Fadsc.201000287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis of Maraviroc (UK-427,857)</span></div><div class="casAuthors">Zhao, Gui-Ling; Lin, Shuangzheng; Korotvicka, Ales; Deiana, Luca; Kullberg, Martin; Cordova, Armando</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Synthesis & Catalysis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2291-2298</span>CODEN:
                <span class="NLM_cas:coden">ASCAF7</span>;
        ISSN:<span class="NLM_cas:issn">1615-4150</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The asym. synthesis of Maraviroc (UK-427,857, I), a chemokine receptor 5 (CCR-5) receptor antagonist, is presented.  The key step involves an expeditious organocatalytic enantioselective assembly of the chiral β-amino aldehyde fragment via aza-Michael addn. of hydroxylamines to cinnamaldehydes.  The reactions were performed on a gram-scale and allow for the rapid construction of new Maraviroc analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr32V1A-BoeTLVg90H21EOLACvtfcHk0lgmzRWQsVGjpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFyhsL3L&md5=708d720f9f4ccf30357f552fa011919c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fadsc.201000287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadsc.201000287%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DG.%2BL.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DKorotvi%25C4%258Dka%26aufirst%3DA.%26aulast%3DDeiana%26aufirst%3DL.%26aulast%3DKullberg%26aufirst%3DM.%26aulast%3DC%25C3%25B3rdova%26aufirst%3DA.%26atitle%3DAsymmetric%2520synthesis%2520of%2520maraviroc%2520%2528uk-427%252C857%2529%26jtitle%3DAdv.%2520Synth.%2520Catal.%26date%3D2010%26volume%3D352%26spage%3D2291%26epage%3D2298%26doi%3D10.1002%2Fadsc.201000287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haycock-Lewandowski, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Åhman, J.</span></span> <span> </span><span class="NLM_article-title">Development of a bulk enabling route to maraviroc (uk-427,857), a ccr-5 receptor antagonist</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1094</span>– <span class="NLM_lpage">1103</span>, <span class="refDoi"> DOI: 10.1021/op8000614</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op8000614" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Sjt7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=1094-1103&author=S.+J.+Haycock-Lewandowskiauthor=A.+Wilderauthor=J.+%C3%85hman&title=Development+of+a+bulk+enabling+route+to+maraviroc+%28uk-427%2C857%29%2C+a+ccr-5+receptor+antagonist&doi=10.1021%2Fop8000614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Bulk Enabling Route to Maraviroc (UK-427,857), a CCR-5 Receptor Antagonist</span></div><div class="casAuthors">Haycock-Lewandowski, Sarah J.; Wilder, Alexander; Ahman, Jens</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1094-1103</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The bulk enabling synthesis of the CCR-5 receptor antagonist, Maraviroc (UK-427,857), was developed and is described.  Synthesis of the three key fragments, β-amino ester, 4,4-difluorohexanecarboxylic acid and 1,3,4-triazole-substituted tropane fragment are described.  Coupling strategies for these fragments are discussed and described, including synthetic challenges, protection strategies, impurity generation, and final scale-up of the developed route to Maraviroc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCJVxz_3HJqbVg90H21EOLACvtfcHk0lgmzRWQsVGjpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Sjt7nK&md5=2ab71c7866d3ac4bd7d9caa4cd0e0fea</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fop8000614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop8000614%26sid%3Dliteratum%253Aachs%26aulast%3DHaycock-Lewandowski%26aufirst%3DS.%2BJ.%26aulast%3DWilder%26aufirst%3DA.%26aulast%3D%25C3%2585hman%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520a%2520bulk%2520enabling%2520route%2520to%2520maraviroc%2520%2528uk-427%252C857%2529%252C%2520a%2520ccr-5%2520receptor%2520antagonist%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2008%26volume%3D12%26spage%3D1094%26epage%3D1103%26doi%3D10.1021%2Fop8000614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrilyuk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbas, C. F.,  3rd</span></span> <span> </span><span class="NLM_article-title">Preparation and activities of macromolecule conjugates of the CCR5 antagonist maraviroc</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1021/ml400370w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400370w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOntr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=133-137&author=S.+Asanoauthor=J.+Gavrilyukauthor=D.+R.+Burtonauthor=C.+F.+Barbas&title=Preparation+and+activities+of+macromolecule+conjugates+of+the+CCR5+antagonist+maraviroc&doi=10.1021%2Fml400370w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and activities of macromolecule conjugates of the CCR5 antagonist Maraviroc</span></div><div class="casAuthors">Asano, Shigehiro; Gavrilyuk, Julia; Burton, Dennis R.; Barbas, Carlos F., III</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-137</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CCR5 antagonists are among the most advanced approaches in HIV therapy and may also be relevant to treatment of graft-vs.-host disease and Staphylococcus aureus infection.  To expand the potential of the only approved CCR5 antagonist, Maraviroc, we studied derivs. that would enable functional linkage of Maraviroc to long-lived carriers.  Through targeted synthesis, we discovered an effective linkage site on Maraviroc and demonstrate the potential of these derivs. to prep. potent chem. programmed antibodies and PEGylated derivs.  The resulting compds. effectively neutralized a variety of HIV-1 isolates.  Both chem. programmed antibody and PEGylation approaches extend the neutralization activity of serum circulating Maraviroc.  Derivation of a successful conjugation strategy for Maraviroc should further enable its use in chem. programmed vaccines, novel bispecific antibodies, and topical microbicides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3dDcVML2YWbVg90H21EOLACvtfcHk0ljUJv3xSZZUIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOntr3P&md5=ea7c9d3c1c6161e1115a9a67de4bcce3</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fml400370w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400370w%26sid%3Dliteratum%253Aachs%26aulast%3DAsano%26aufirst%3DS.%26aulast%3DGavrilyuk%26aufirst%3DJ.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DBarbas%26aufirst%3DC.%2BF.%26atitle%3DPreparation%2520and%2520activities%2520of%2520macromolecule%2520conjugates%2520of%2520the%2520CCR5%2520antagonist%2520maraviroc%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D133%26epage%3D137%26doi%3D10.1021%2Fml400370w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiely, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutt, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culbertson, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucsh, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worth, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesheski, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogliotti, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sesnie, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mich, T. F.</span></span> <span> </span><span class="NLM_article-title">Quinolone antibacterials: Preparation and activity of bridged bicyclic analogues of the c7-piperazine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1021/jm00106a029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00106a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=656-663&author=J.+S.+Kielyauthor=M.+P.+Huttauthor=T.+P.+Culbertsonauthor=R.+A.+Bucshauthor=D.+F.+Worthauthor=L.+E.+Lesheskiauthor=R.+D.+Gogliottiauthor=J.+C.+Sesnieauthor=M.+Solomonauthor=T.+F.+Mich&title=Quinolone+antibacterials%3A+Preparation+and+activity+of+bridged+bicyclic+analogues+of+the+c7-piperazine&doi=10.1021%2Fjm00106a029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm00106a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00106a029%26sid%3Dliteratum%253Aachs%26aulast%3DKiely%26aufirst%3DJ.%2BS.%26aulast%3DHutt%26aufirst%3DM.%2BP.%26aulast%3DCulbertson%26aufirst%3DT.%2BP.%26aulast%3DBucsh%26aufirst%3DR.%2BA.%26aulast%3DWorth%26aufirst%3DD.%2BF.%26aulast%3DLesheski%26aufirst%3DL.%2BE.%26aulast%3DGogliotti%26aufirst%3DR.%2BD.%26aulast%3DSesnie%26aufirst%3DJ.%2BC.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DMich%26aufirst%3DT.%2BF.%26atitle%3DQuinolone%2520antibacterials%253A%2520Preparation%2520and%2520activity%2520of%2520bridged%2520bicyclic%2520analogues%2520of%2520the%2520c7-piperazine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D656%26epage%3D663%26doi%3D10.1021%2Fjm00106a029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel 2-methylpiperazine derivatives as potent CCR5 antagonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1168</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.12.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1016%2Fj.bmc.2014.12.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1157-1168&author=S.+Huauthor=Z.+Wangauthor=T.+Houauthor=X.+Maauthor=J.+Liauthor=T.+Liuauthor=X.+Xieauthor=Y.+Hu&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+2-methylpiperazine+derivatives+as+potent+CCR5+antagonists&doi=10.1016%2Fj.bmc.2014.12.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.12.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.12.052%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%25202-methylpiperazine%2520derivatives%2520as%2520potent%2520CCR5%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D1157%26epage%3D1168%26doi%3D10.1016%2Fj.bmc.2014.12.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bastian, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contarino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aneja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emileh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoxie, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Interactions of peptide triazole thiols with env gp120 induce irreversible breakdown and inactivation of hiv-1 virions</span>. <i>Retrovirology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">153</span>, <span class="refDoi"> DOI: 10.1186/1742-4690-10-153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1186%2F1742-4690-10-153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=24330857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFagurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=153&author=A.+R.+Bastianauthor=M.+Contarinoauthor=L.+D.+Baileyauthor=R.+Anejaauthor=D.+R.+Moreiraauthor=K.+Freedmanauthor=K.+McFaddenauthor=C.+Duffyauthor=A.+Emilehauthor=G.+Leslieauthor=J.+M.+Jacobsonauthor=J.+A.+Hoxieauthor=I.+Chaiken&title=Interactions+of+peptide+triazole+thiols+with+env+gp120+induce+irreversible+breakdown+and+inactivation+of+hiv-1+virions&doi=10.1186%2F1742-4690-10-153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of peptide triazole thiols with Env gp120 induce irreversible breakdown and inactivation of HIV-1 virions</span></div><div class="casAuthors">Bastian, Arangassery Rosemary; Contarino, Mark; Bailey, Lauren D.; Aneja, Rachna; Moreira, Diogo Rodrigo Magalhaes; Freedman, Kevin; McFadden, Karyn; Duffy, Caitlin; Emileh, Ali; Leslie, George; Jacobson, Jeffrey M.; Hoxie, James A.; Chaiken, Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Retrovirology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">153/1-153/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">RETRBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-4690</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: We examd. the underlying mechanism of action of the peptide triazole thiol, KR13 that has been shown previously to specifically bind gp120, block cell receptor site interactions and potently inhibit HIV-1 infectivity.  Results: KR13, the sulfhydryl blocked KR13b and its parent non-sulfhydryl peptide triazole, HNG156, induced gp120 shedding but only KR13 induced p24 capsid protein release.  The resulting virion post virolysis had an altered morphol., contained no gp120, but retained gp41 that bound to neutralizing gp41 antibodies.  Remarkably, HIV-1 p24 release by KR13 was inhibited by enfuvirtide, which blocks formation of the gp41 6-helix bundle during membrane fusion, while no inhibition of p24 release occurred for enfuvirtide-resistant virus.  KR13 thus appears to induce structural changes in gp41 normally assocd. with membrane fusion and cell entry.  The HIV-1 p24 release induced by KR13 was obsd. in several clades of HIV-1 as well as in fully infectious HIV-1 virions.  Conclusions: The antiviral activity of KR13 and its ability to inactivate virions prior to target cell engagement suggest that peptide triazole thiols could be highly effective in inhibiting HIV transmission across mucosal barriers and provide a novel probe to understand biochem. signals within envelope that are involved in membrane fusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJgYkvSx2m57Vg90H21EOLACvtfcHk0ljUJv3xSZZUIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFagurY%253D&md5=3a018d2f8f61818077c65af94c339267</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-10-153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-10-153%26sid%3Dliteratum%253Aachs%26aulast%3DBastian%26aufirst%3DA.%2BR.%26aulast%3DContarino%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DL.%2BD.%26aulast%3DAneja%26aufirst%3DR.%26aulast%3DMoreira%26aufirst%3DD.%2BR.%26aulast%3DFreedman%26aufirst%3DK.%26aulast%3DMcFadden%26aufirst%3DK.%26aulast%3DDuffy%26aufirst%3DC.%26aulast%3DEmileh%26aufirst%3DA.%26aulast%3DLeslie%26aufirst%3DG.%26aulast%3DJacobson%26aufirst%3DJ.%2BM.%26aulast%3DHoxie%26aufirst%3DJ.%2BA.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DInteractions%2520of%2520peptide%2520triazole%2520thiols%2520with%2520env%2520gp120%2520induce%2520irreversible%2520breakdown%2520and%2520inactivation%2520of%2520hiv-1%2520virions%26jtitle%3DRetrovirology%26date%3D2013%26volume%3D10%26spage%3D153%26doi%3D10.1186%2F1742-4690-10-153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantharaju</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umashankara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirrone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Garcia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shattock, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Antiviral breadth and combination potential of peptide triazole hiv-1 entry inhibitors</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1073</span>– <span class="NLM_lpage">1080</span>, <span class="refDoi"> DOI: 10.1128/AAC.05555-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FAAC.05555-11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=1073-1080&author=K.+McFaddenauthor=P.+Fletcherauthor=F.+Rossiauthor=+Kantharajuauthor=M.+Umashankaraauthor=V.+Pirroneauthor=S.+Rajagopalauthor=H.+Gopiauthor=F.+C.+Krebsauthor=J.+Martin-Garciaauthor=R.+J.+Shattockauthor=I.+Chaiken&title=Antiviral+breadth+and+combination+potential+of+peptide+triazole+hiv-1+entry+inhibitors&doi=10.1128%2FAAC.05555-11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1128%2FAAC.05555-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.05555-11%26sid%3Dliteratum%253Aachs%26aulast%3DMcFadden%26aufirst%3DK.%26aulast%3DFletcher%26aufirst%3DP.%26aulast%3DRossi%26aufirst%3DF.%26aulast%3DKantharaju%26aulast%3DUmashankara%26aufirst%3DM.%26aulast%3DPirrone%26aufirst%3DV.%26aulast%3DRajagopal%26aufirst%3DS.%26aulast%3DGopi%26aufirst%3DH.%26aulast%3DKrebs%26aufirst%3DF.%2BC.%26aulast%3DMartin-Garcia%26aufirst%3DJ.%26aulast%3DShattock%26aufirst%3DR.%2BJ.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DAntiviral%2520breadth%2520and%2520combination%2520potential%2520of%2520peptide%2520triazole%2520hiv-1%2520entry%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D1073%26epage%3D1080%26doi%3D10.1128%2FAAC.05555-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'link1':['link1_1'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lian‐Shun  Feng</span>, <span class="hlFld-ContribAuthor ">Man‐Jie  Zheng</span>, <span class="hlFld-ContribAuthor ">Feng  Zhao</span>, <span class="hlFld-ContribAuthor ">Duan  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,3‐Triazole hybrids with anti‐HIV‐1 activity. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2021,</strong> <em>354 </em>
                                    (1)
                                     , 2000163. <a href="https://doi.org/10.1002/ardp.202000163" title="DOI URL">https://doi.org/10.1002/ardp.202000163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.202000163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.202000163%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3D1%25252C2%25252C3%2525E2%252580%252590Triazole%252Bhybrids%252Bwith%252Banti%2525E2%252580%252590HIV%2525E2%252580%2525901%252Bactivity%26aulast%3DFeng%26aufirst%3DLian%25E2%2580%2590Shun%26date%3D2021%26date%3D2020%26volume%3D354%26issue%3D1%26spage%3D2000163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangyi  Jiang</span>, <span class="hlFld-ContribAuthor ">Ji  Yu</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Jacob  Kongsted</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular design opportunities presented by solvent‐exposed regions of target proteins. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (6)
                                     , 2194-2238. <a href="https://doi.org/10.1002/med.21581" title="DOI URL">https://doi.org/10.1002/med.21581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21581%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMolecular%252Bdesign%252Bopportunities%252Bpresented%252Bby%252Bsolvent%2525E2%252580%252590exposed%252Bregions%252Bof%252Btarget%252Bproteins%26aulast%3DJiang%26aufirst%3DXiangyi%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D6%26spage%3D2194%26epage%3D2238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Geometry of the gp120 protein showing the distance between the CD4-binding site and the released V3-loop tip (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QAD">2QAD</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Interaction maps of UM15 (left) docked within gp120 of the HIV-1 envelope (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NCO">4NCO</a>)<a onclick="showRef(event, 'ref25 ref28'); return false;" href="javascript:void(0);" class="ref ref25 ref28">(25,28)</a> and LJC240<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (right) docked onto the CCR5 structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MBS">4MBS</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The gray circles represent the solvated (solvent-exposed) moieties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Synthesis of the coreceptor inhibitor LJC240–COOH (<b>10</b>). Reagents and conditions: (a) NH<sub>2</sub>OH·HCl, NaHCO<sub>3</sub>, EtOH/H<sub>2</sub>O, rt; (b) Na, pentanol, reflux; (c) (Boc)<sub>2</sub>O, TEA, THF, rt; (d) 10% Pd/C, HCO<sub>2</sub>NH<sub>4</sub>, methanol, reflux; (e) 1-bromo-3-chloropropane, KI, TEA, DMF, rt; (f) 1-acetylpiperidine-4-carboxylic acid, SOCl<sub>2</sub>, TEA, DCM, rt; (g) <b>5</b>, KI, K<sub>2</sub>CO<sub>3</sub>, MeCN, reflux; (h) HCl, methanol, rt; (i) 4-(chlorosulfonyl)benzoic acid, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, rt.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Solid-phase synthesis of chimera <b>11</b>. A Liberty blue microwave synthesizer was used for the assembly of the L4–UM15 precursor segment. The latter was joined with the LJC240 free acid (<b>10</b>), which was followed by ferrocenyl triazole formation using a click reaction, leading to the final chimera (<b>11</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Neutralization of HIV-1 Env-pseudotyped viruses (A) Bal.01, (B) JRFL, (C) YU2, and (D) HxBc2, as examples of X4-tropic viruses, by the bifunctional chimera (red), UM15 (black), LJC240–L4 (blue), and a 1:1 mixture of UM15 and LJC240–L4 (green). ND indicates not determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Synergy-assay results between UM15 and LJC240–L4 against HIV-Bal.01. The IC<sub>50</sub> values (blue for LJC240–L4 and black for UM15) are the effective inhibitory concentrations of the individual components in the mixture. Chimera <b>11</b> (red) was also included in the experiment. (B) Isobologram representation of the UM15–LJC240–L4 combination. The blue line connects the IC<sub>50</sub> values of the two inhibitors; the red dot is the effective concentration of the noncovalent mixture (1:30 ratio which achieved 50% inhibition), whereas the green dot is the effective concentration of the covalent chimera, <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Efficacy of the chimeric inhibitor for gp120-protein–ligand binding determined by SPR gp120-competition analyses. (Left) Representative sensorgrams showing dose-dependent inhibition of monomeric-YU2-gp120 binding to the receptors CD4 and 17b by LJC240–L4–UM15. (Right) Dose–response curves derived from the sensorgrams of YU2-gp120-binding inhibition by LJC240–L4–UM15 and UM15 (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Capacity of the bifunctional chimera, LJC240–L4–UM15, to induce gp120 shedding similarly to UM15.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Evaluation of chimera <b>11</b> (red) and the individual components, UM15 (black) and LJC240–L4 (blue), against J1HX (A) and the CD4-independent J1HX mutant, N197S (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Dose-dependent CCR5 antagonism by the bifunctional chimera and the parent small-molecule inhibitors. (Top) Dose–response curves of the extent of the inhibition of RANTES (10 nM) stimulation of calcium mobilization measured for LJC240-containing compounds. Maraviroc was included as a control. (Bottom) Chemotaxis inhibition of CEM CCR5 cells to RANTES by LJC240–L4–UM15. One million CEM CCR5 cells were seeded in the apical chambers of 8 μm transwell inserts, and chemoattraction was induced using RANTES (10 ng/mL) in the presence or absence (control, No Chemokine) of the inhibitors maraviroc (MRVC); LJC240; LJC240–L4; or the peptide triazole chimera, LJC240–L4–UM15, at the IC<sub>50</sub> value for each compound. Data are presented as cells recovered in the basolateral chamber postincubation normalized to cells migrating to RANTES in the absence of inhibitor. Two-way ANOVA was used to compare the inhibitor-treated groups to the RANTES-only control group, and Student’s <i>t</i>-test was used to compare individual groups. Error bars represent means ± SEM; *<i>p</i> ≤ 0.05, **<i>p</i> ≤ 0.01. These data are representative of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/medium/jm-2018-004777_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Cytotoxicity evaluation of chimera <b>11</b> (left) and evaluation of chimera <b>11</b> against AMLV (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00477/20180608/images/large/jm-2018-004777_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00477&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06453" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06453" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 56 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilen, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilton, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doms, R. W.</span></span> <span> </span><span class="NLM_article-title">Hiv: Cell binding and entry</span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">a006866</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a006866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1101%2Fcshperspect.a006866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=22908191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlemtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a006866&author=C.+B.+Wilenauthor=J.+C.+Tiltonauthor=R.+W.+Doms&title=Hiv%3A+Cell+binding+and+entry&doi=10.1101%2Fcshperspect.a006866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">HIV: cell binding and entry</span></div><div class="casAuthors">Wilen, Craig B.; Tilton, John C.; Doms, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">a006866/1-a006866/13</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  The first step of the human immunodeficiency virus (HIV) replication cycle-binding and entry into the host cell-plays a major role in detg. viral tropism and the ability of HIV to degrade the human immune system.  HIV uses a complex series of steps to deliver its genome into the host cell cytoplasm while simultaneously evading the host immune response.  To infect cells, the HIV protein envelope (Env) binds to the primary cellular receptor CD4 and then to a cellular coreceptor.  This sequential binding triggers fusion of the viral and host cell membranes, initiating infection.  Revealing the mechanism of HIV entry has profound implications for viral tropism, transmission, pathogenesis, and therapeutic intervention.  Here, we provide an overview into the mechanism of HIV entry, provide historical context to key discoveries, discuss recent advances, and speculate on future directions in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTFIru0CcC0LVg90H21EOLACvtfcHk0ljrgQF-vCoh5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlemtL0%253D&md5=08e66975badc489e248c1ada616a86e7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006866%26sid%3Dliteratum%253Aachs%26aulast%3DWilen%26aufirst%3DC.%2BB.%26aulast%3DTilton%26aufirst%3DJ.%2BC.%26aulast%3DDoms%26aufirst%3DR.%2BW.%26atitle%3DHiv%253A%2520Cell%2520binding%2520and%2520entry%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da006866%26doi%3D10.1101%2Fcshperspect.a006866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macartney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickett, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Burchnell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armour, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros, M.</span></span> <span> </span><span class="NLM_article-title">Maraviroc (uk-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4721</span>– <span class="NLM_lpage">4732</span>, <span class="refDoi"> DOI: 10.1128/AAC.49.11.4721-4732.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FAAC.49.11.4721-4732.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=16251317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Siu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=4721-4732&author=P.+Dorrauthor=M.+Westbyauthor=S.+Dobbsauthor=P.+Griffinauthor=B.+Irvineauthor=M.+Macartneyauthor=J.+Moriauthor=G.+Rickettauthor=C.+Smith-Burchnellauthor=C.+Napierauthor=R.+Websterauthor=D.+Armourauthor=D.+Priceauthor=B.+Stammenauthor=A.+Woodauthor=M.+Perros&title=Maraviroc+%28uk-427%2C857%29%2C+a+potent%2C+orally+bioavailable%2C+and+selective+small-molecule+inhibitor+of+chemokine+receptor+CCR5+with+broad-spectrum+anti-human+immunodeficiency+virus+type+1+activity&doi=10.1128%2FAAC.49.11.4721-4732.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity</span></div><div class="casAuthors">Dorr, Patrick; Westby, Mike; Dobbs, Susan; Griffin, Paul; Irvine, Becky; Macartney, Malcolm; Mori, Julie; Rickett, Graham; Smith-Burchnell, Caroline; Napier, Carolyn; Webster, Rob; Armour, Duncan; Price, David; Stammen, Blanda; Wood, Anthony; Perros, Manos</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4721-4732</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Maraviroc (UK-427,857) is a selective CCR5 antagonist with potent antihuman immunodeficiency virus type 1 (HIV-1) activity and favorable pharmacol. properties.  Maraviroc is the product of a medicinal chem. effort initiated following identification of an imidazopyridine CCR5 ligand from a high-throughput screen of the Pfizer compd. file.  Maraviroc demonstrated potent antiviral activity against all CCR5-tropic HIV-1 viruses tested, including 43 primary isolates from various clades and diverse geog. origin (geometric mean 90% inhibitory concn. of 2.0 nM).  Maraviroc was active against 200 clin. derived HIV-1 envelope-recombinant pseudoviruses, 100 of which were derived from viruses resistant to existing drug classes.  There was little difference in the sensitivity of the 200 viruses to maraviroc, as illustrated by the biol. cutoff in this assay (= geometric mean plus two std. deviations [SD] of 1.7-fold).  The mechanism of action of maraviroc was established using cell-based assays, where it blocked binding of viral envelope, gp120, to CCR5 to prevent the membrane fusion events necessary for viral entry.  Maraviroc did not affect CCR5 cell surface levels or assocd. intracellular signaling, confirming it as a functional antagonist of CCR5.  Maraviroc has no detectable in vitro cytotoxicity and is highly selective for CCR5, as confirmed against a wide range of receptors and enzymes, including the hERG ion channel (50% inhibitory concn., > 10 μM), indicating potential for an excellent clin. safety profile.  Studies in preclin. in vitro and in vivo models predicted maraviroc to have human pharmacokinetics consistent with once- or twice-daily dosing following oral administration.  Clin. trials are ongoing to further investigate the potential of using maraviroc for the treatment of HIV-1 infection and AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN0Z8KdsHODrVg90H21EOLACvtfcHk0li02oGRiEGbfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Siu7rM&md5=561aea68490f7c6d3ec0f65676450155</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.11.4721-4732.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.11.4721-4732.2005%26sid%3Dliteratum%253Aachs%26aulast%3DDorr%26aufirst%3DP.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DDobbs%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DIrvine%26aufirst%3DB.%26aulast%3DMacartney%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DJ.%26aulast%3DRickett%26aufirst%3DG.%26aulast%3DSmith-Burchnell%26aufirst%3DC.%26aulast%3DNapier%26aufirst%3DC.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DArmour%26aufirst%3DD.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DStammen%26aufirst%3DB.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DPerros%26aufirst%3DM.%26atitle%3DMaraviroc%2520%2528uk-427%252C857%2529%252C%2520a%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520selective%2520small-molecule%2520inhibitor%2520of%2520chemokine%2520receptor%2520CCR5%2520with%2520broad-spectrum%2520anti-human%2520immunodeficiency%2520virus%2520type%25201%2520activity%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D4721%26epage%3D4732%26doi%3D10.1128%2FAAC.49.11.4721-4732.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman-Blum, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandres, J. C.</span></span> <span> </span><span class="NLM_article-title">Maraviroc: A CCR5-receptor antagonist for the treatment of hiv-1 infection</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1228</span>– <span class="NLM_lpage">1250</span>, <span class="refDoi"> DOI: 10.1016/S0149-2918(08)80048-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1016%2FS0149-2918%2808%2980048-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=18691983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVyitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=1228-1250&author=S.+S.+Lieberman-Blumauthor=H.+B.+Fungauthor=J.+C.+Bandres&title=Maraviroc%3A+A+CCR5-receptor+antagonist+for+the+treatment+of+hiv-1+infection&doi=10.1016%2FS0149-2918%2808%2980048-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection</span></div><div class="casAuthors">Lieberman-Blum, Sharon S.; Fung, Horatio B.; Bandres, Juan C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1228-1250</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Background: The emergence of viral resistance is one of the greatest challenges in the treatment of HIV infection.  Maraviroc is the first member of a new class of antiretroviral medications, the CCR5-receptor antagonists.  It is approved by the US Food and Drug Administration (FDA) for use in combination with other antiretroviral agents in treatment-experienced patients infected with multidrug-resistant, CCR5-tropic HIV-1.  Objective: This article provides an overview of the pharmacol., efficacy, and tolerability of maraviroc in the treatment of HIV-1 infection.  Methods: Relevant information was identified through a search of MEDLINE (Jan. 2000-May 2008) using the terms maraviroc, UK-427,857, and CCR5-receptor antagonist.  Also consulted were abstrs. from the International AIDS Society Conference, the Conference on Retroviruses and Opportunistic Infections, and other relevant scientific meetings.  Addnl. publications were found by searching the ref. lists of the identified articles and the FDA Web site.  Results: Maraviroc is a selective, reversible, small-mol. CCR5-receptor antagonist.  In vitro, it has potent anti-HIV-1 activity, with a mean 90% inhibitory concn. of 2.0 nmol/L.  It is widely distributed, with a Vd of ∼194 L.  Maraviroc is moderately metabolized in the liver (65.3%), primarily via the cytochrome P 450 3A4 isoenzyme.  It has an elimination t1/2 of 15.9 to 22.9 h.  Until more data are available, maraviroc should be avoided in patients with severe hepatic insufficiency; dose adjustment does not appear to be necessary on the basis of age, sex, or renal function.  In 2 Phase IIb/III studies, maraviroc 300 mg PO QD or BID was found to be more efficacious than placebo in reducing the viral load at 48 wk in treatment-experienced, CCR5-tropic HIV-1-infected patients receiving an optimized background regimen (difference vs placebo-QD arm: -0.89 log10 copies/mL [97.5% CI, -1.17 to -0.62]; BID arm: -1.05 log10 copies/mL [97.5% CI, -1.33 to -0.78]).  The proportion of patients with a viral load <50 copies/mL was 43.2% in the QD arm and 45.5% in the BID arm, compared with 16.7% in the placebo arm (P < 0.001, both treatment arms vs placebo).  In treatment-naive patients infected with CCR5-tropic virus only, maraviroc 300 mg PO BID was not noninferior to oral efavirenz 600 mg QD (difference = -4.2%; lower bound of the 1-sided 97.5% CI, -10.9 [predefined statistical cutoff for noninferiority, -10]).  Maraviroc was generally well tolerated in clin. trials.  The most frequently reported (≥5%) adverse events were upper respiratory tract infection (20.0%), cough (12.7%), pyrexia (12.0%), rash (9.6%), musculoskeletal complaints (8.7%), gastrointestinal and abdominal pain (8.2%), dizziness (8.2%), appetite disorders (7.3%), insomnia (7.0%), herpes infection (6.8%), sinusitis (6.3%), joint complaints (6.1%), bronchitis (5.9%), and constipation (5.4%).  The recommended dose of maraviroc differs based on concomitant medications, ranging from 150 to 600 mg BID.  Conclusion: When used in combination with other antiretroviral agents, maraviroc appears to be a promising agent for treatment-experienced patients infected with multidrug-resistant, CCR5-tropic HIV-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo73dWGTL6Me7Vg90H21EOLACvtfcHk0li02oGRiEGbfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVyitL0%253D&md5=f0923816dd986856a3dd6c3e11a3c45d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0149-2918%2808%2980048-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-2918%252808%252980048-3%26sid%3Dliteratum%253Aachs%26aulast%3DLieberman-Blum%26aufirst%3DS.%2BS.%26aulast%3DFung%26aufirst%3DH.%2BB.%26aulast%3DBandres%26aufirst%3DJ.%2BC.%26atitle%3DMaraviroc%253A%2520A%2520CCR5-receptor%2520antagonist%2520for%2520the%2520treatment%2520of%2520hiv-1%2520infection%26jtitle%3DClin.%2520Ther.%26date%3D2008%26volume%3D30%26spage%3D1228%26epage%3D1250%26doi%3D10.1016%2FS0149-2918%2808%2980048-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Este, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telenti, A.</span></span> <span> </span><span class="NLM_article-title">Hiv entry inhibitors</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>370</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(07)61052-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1016%2FS0140-6736%2807%2961052-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2007&pages=81-88&author=J.+A.+Esteauthor=A.+Telenti&title=Hiv+entry+inhibitors&doi=10.1016%2FS0140-6736%2807%2961052-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2807%2961052-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252807%252961052-6%26sid%3Dliteratum%253Aachs%26aulast%3DEste%26aufirst%3DJ.%2BA.%26aulast%3DTelenti%26aufirst%3DA.%26atitle%3DHiv%2520entry%2520inhibitors%26jtitle%3DLancet%26date%3D2007%26volume%3D370%26spage%3D81%26epage%3D88%26doi%3D10.1016%2FS0140-6736%2807%2961052-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yost, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquale, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahloff, E. G.</span></span> <span> </span><span class="NLM_article-title">Maraviroc: A coreceptor CCR5 antagonist for management of hiv infection</span>. <i>Am. J. Health-Syst. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.2146/ajhp080206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.2146%2Fajhp080206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=19336831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Gmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=715-726&author=R.+Yostauthor=T.+R.+Pasqualeauthor=E.+G.+Sahloff&title=Maraviroc%3A+A+coreceptor+CCR5+antagonist+for+management+of+hiv+infection&doi=10.2146%2Fajhp080206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Maraviroc: a coreceptor CCR5 antagonist for management of HIV infection</span></div><div class="casAuthors">Yost, Raymond; Pasquale, Timothy R.; Sahloff, Eric G.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Health-System Pharmacy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">715-726</span>CODEN:
                <span class="NLM_cas:coden">AHSPEK</span>;
        ISSN:<span class="NLM_cas:issn">1079-2082</span>.
    
            (<span class="NLM_cas:orgname">American Society of Health-System Pharmacists</span>)
        </div><div class="casAbstract">A review.  Purpose: The mechanism of action, pharmacol., pharmacokinetics, clin. efficacy, drug interactions, adverse effects, dosage and administration, cost, and role in therapy of maraviroc are reviewed.  Summary: Maraviroc is the first CCR5 coreceptor antagonist to receive marketing approval from the Food and Drug Administration (FDA) for the treatment of CCR5-tropic human immunodeficiency virus (HIV) infection as part of an optimized antiretroviral regimen in treatment-experienced patients.  As 50% or more of treatment-experienced patients may be infected with CXCR4-tropic virus, a tropism assay should be performed before initiating maraviroc therapy.  The majority of evidence supporting maraviroc's use comes from two studies of HIV-infected, treatment-experienced patients.  Pooled anal. from these two studies revealed that twice-daily maraviroc decreased HIV-1 RNA by 1.84 log copies/mL, compared with 0.78 log copy/mL with placebo.  Forty-six percent of subjects attained an HIV-1 RNA concn. of <50 copies/mL, compared with only 17% with placebo.  In a trial of treatment-naive HIV-infected individuals, maraviroc failed to show noninferiority to efavirenz.  Maraviroc is metabolized by cytochrome P 450 isoenzyme 3A4 and is subject to interactions with inhibitors and inducers of that isoenzyme, such as the protease inhibitors (except tipranavir), efavirenz, and rifampin.  Resistance has been reported with maraviroc, but specific mechanisms are still poorly understood.  The most common adverse effects reported with maraviroc were diarrhea, nausea, fatigue, and headache.  Conclusion: Available data support the use of maraviroc, the first CCR5 antagonist to receive FDA marketing approval, as part of an optimized antiretroviral regimen in treatment-experienced patients infected with CCR5-tropic HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfd1R_payHC7Vg90H21EOLACvtfcHk0li02oGRiEGbfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Gmsrw%253D&md5=7005b19eba32dd044a039532ade0d5bb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2146%2Fajhp080206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2146%252Fajhp080206%26sid%3Dliteratum%253Aachs%26aulast%3DYost%26aufirst%3DR.%26aulast%3DPasquale%26aufirst%3DT.%2BR.%26aulast%3DSahloff%26aufirst%3DE.%2BG.%26atitle%3DMaraviroc%253A%2520A%2520coreceptor%2520CCR5%2520antagonist%2520for%2520management%2520of%2520hiv%2520infection%26jtitle%3DAm.%2520J.%2520Health-Syst.%2520Pharm.%26date%3D2009%26volume%3D66%26spage%3D715%26epage%3D726%26doi%3D10.2146%2Fajhp080206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, M.
L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, N.</span></span> <span> </span><span class="NLM_article-title">Resistance to enfuvirtide, the first hiv fusion inhibitor</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">340</span>, <span class="refDoi"> DOI: 10.1093/jac/dkh330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1093%2Fjac%2Fdkh330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=15231762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1Wis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=333-340&author=M.%0AL.+Greenbergauthor=N.+Cammack&title=Resistance+to+enfuvirtide%2C+the+first+hiv+fusion+inhibitor&doi=10.1093%2Fjac%2Fdkh330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to enfuvirtide, the first HIV fusion inhibitor</span></div><div class="casAuthors">Greenberg, Michael L.; Cammack, Nick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">333-340</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Fusion inhibitors are a new class of antiretroviral drugs (ARVs) for the treatment of human immunodeficiency virus infection.  Enfuvirtide is the first in this class to reach market approval.  Fusion inhibitors block the last step in the three-step viral entry process consisting of attachment, co-receptor binding and fusion, thereby preventing viral capsid entry into the host cell.  Enfuvirtide has a unique mechanism of action and high viral target specificity, and in clin. trials has been shown to exhibit both high efficacy and low toxicity.  Enfuvirtide is a peptide mimetic of an essential region within viral envelope glycoprotein gp41 that functions by blocking gp41 structural rearrangements at a transitional pre-fusion conformation.  Although different clin. isolates show variation in susceptibility to enfuvirtide, primary resistance has not been obsd., and thus enfuvirtide-naive isolates remain clin. sensitive.  Acquired resistance centers round a 10 amino acid motif between residues 36 and 45 in gp41 that forms part of the binding site of enfuvirtide.  The 10 amino acid motif is crit. for viral fusion, and enfuvirtide-resistant mutants show poor replicative capacity compared with wild type.  Reversion to a wild-type, drug-sensitive state has been reported following enfuvirtide withdrawal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowrBuVp5AuRrVg90H21EOLACvtfcHk0ljL4NfvaqEiXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1Wis7k%253D&md5=0e61296ea9dcaa671883f5d4a37f34db</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkh330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkh330%26sid%3Dliteratum%253Aachs%26aulast%3DGreenberg%26aufirst%3DM.%2BL.%26aulast%3DCammack%26aufirst%3DN.%26atitle%3DResistance%2520to%2520enfuvirtide%252C%2520the%2520first%2520hiv%2520fusion%2520inhibitor%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2004%26volume%3D54%26spage%3D333%26epage%3D340%26doi%3D10.1093%2Fjac%2Fdkh330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eggink, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Taeye, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bontjer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klasse, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langedijk, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkhout, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, R. W.</span></span> <span> </span><span class="NLM_article-title">Hiv-1 escape from a peptidic anchor inhibitor through stabilization of the envelope glycoprotein spike</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">10587</span>– <span class="NLM_lpage">10599</span>, <span class="refDoi"> DOI: 10.1128/JVI.01616-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FJVI.01616-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=27654295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVWmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=10587-10599&author=D.+Egginkauthor=S.+W.+de+Taeyeauthor=I.+Bontjerauthor=P.+J.+Klasseauthor=J.+P.+Langedijkauthor=B.+Berkhoutauthor=R.+W.+Sanders&title=Hiv-1+escape+from+a+peptidic+anchor+inhibitor+through+stabilization+of+the+envelope+glycoprotein+spike&doi=10.1128%2FJVI.01616-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 escape from a peptidic anchor inhibitor through stabilization of the envelope glycoprotein spike</span></div><div class="casAuthors">Eggink, Dirk; de Taeye, Steven W.; Bontjer, Ilja; Klasse, Per Johan; Langedijk, Johannes P. M.; Berkhout, Ben; Sanders, Rogier W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10587-10599</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The trimeric HIV-1 envelope glycoprotein spike (Env) mediates viral entry into cells by using a spring-loaded mechanism that allows for the controlled insertion of the Env fusion peptide into the target membrane, followed by membrane fusion.  Env is the focus of vaccine research aimed at inducing protective immunity by antibodies as well as efforts to develop drugs that inhibit the viral entry process.  The mol. factors contributing to Env stability and decay need to be understood better in order to optimally design vaccines and therapeutics.  We generated viruses with resistance to VIR165, a peptidic inhibitor that binds the fusion peptide of the gp41 subunit and prevents its insertion into the target membrane.  Interestingly, a no. of escape viruses acquired substitutions in the C1 domain of the gp120 subunit (A60E, E64K, and H66R) that rendered these viruses dependent on the inhibitor.  These viruses could infect target cells only when VIR165 was present after CD4 binding.  Furthermore, the VIR165- dependent viruses were resistant to sol. CD4-induced Env destabilization and decay.  These data suggest that VIR165-dependent Env proteins are kinetically trapped in the unliganded state and require the drug to negotiate CD4-induced conformational changes.  These studies provide mechanistic insight into the action of the gp41 fusion peptide and its inhibitors and provide new ways to stabilize Env trimer vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyvuZVMr27jLVg90H21EOLACvtfcHk0ljL4NfvaqEiXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVWmsLo%253D&md5=03ee07cf829f06bef7415b47626271b4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FJVI.01616-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01616-16%26sid%3Dliteratum%253Aachs%26aulast%3DEggink%26aufirst%3DD.%26aulast%3Dde%2BTaeye%26aufirst%3DS.%2BW.%26aulast%3DBontjer%26aufirst%3DI.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DLangedijk%26aufirst%3DJ.%2BP.%26aulast%3DBerkhout%26aufirst%3DB.%26aulast%3DSanders%26aufirst%3DR.%2BW.%26atitle%3DHiv-1%2520escape%2520from%2520a%2520peptidic%2520anchor%2520inhibitor%2520through%2520stabilization%2520of%2520the%2520envelope%2520glycoprotein%2520spike%26jtitle%3DJ.%2520Virol.%26date%3D2016%26volume%3D90%26spage%3D10587%26epage%3D10599%26doi%3D10.1128%2FJVI.01616-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamamura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span> <span> </span><span class="NLM_article-title">Potent synergistic anti-human immunodeficiency virus (hiv) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-hiv drugs</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2111</span>– <span class="NLM_lpage">2119</span>, <span class="refDoi"> DOI: 10.1128/AAC.01299-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FAAC.01299-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=18378711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVaitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=2111-2119&author=H.+Nakataauthor=S.+M.+Steinbergauthor=Y.+Kohauthor=K.+Maedaauthor=Y.+Takaokaauthor=H.+Tamamuraauthor=N.+Fujiiauthor=H.+Mitsuya&title=Potent+synergistic+anti-human+immunodeficiency+virus+%28hiv%29+effects+using+combinations+of+the+CCR5+inhibitor+aplaviroc+with+other+anti-hiv+drugs&doi=10.1128%2FAAC.01299-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Potent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugs</span></div><div class="casAuthors">Nakata, Hirotomo; Steinberg, Seth M.; Koh, Yasuhiro; Maeda, Kenji; Takaoka, Yoshikazu; Tamamura, Hirokazu; Fujii, Nobutaka; Mitsuya, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2111-2119</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Aplaviroc (AVC), an exptl. CCR5 inhibitor, potently blocks in vitro the infection of R5-tropic human immunodeficiency virus type 1 (R5-HIV-1) at subnanomolar 50% inhibitory concns.  Although maraviroc is presently clin. available, further studies are required to det. the role of CCR5 inhibitors in combinations with other drugs.  Here we detd. anti-HIV-1 activity using combinations of AVC with various anti-HIV-1 agents, including four U.S. Food and Drug Administration-approved drugs, two CCR5 inhibitors (TAK779 and SCH-C) and two CXCR4 inhibitors (AMD3100 and TE14011).  Combination effects were defined as synergistic or antagonistic when the activity of drug A combined with B was statistically greater or less, resp., than the additive effects of drugs A and A combined and drugs B and B combined by using the Combo method, described in this paper, which provides (i) a flexible choice of interaction models and (ii) the use of nonparametric statistical methods.  Synergistic effects against R5-HIV-1Ba-L and a 50:50 mixt. of R5-HIV-1Ba-L and X4-HIV-1ERS104pre (HIV-1Ba-L/104pre) were seen when AVC was combined with zidovudine, nevirapine, indinavir, or enfuvirtide.  Mild synergism and additivity were obsd. when AVC was combined with TAK779 and SCH-C, resp.  We also obsd. more potent synergism against HIV-1Ba-L/104pre when AVC was combined with AMD3100 or TE14011.  The data demonstrate a tendency toward greater synergism with AVC plus either of the two CXCR4 inhibitors compared to the synergism obtained with combinations of AVC and other drugs, suggesting that the development of effective CXCR4 inhibitors may be important for increasing the efficacies of CCR5 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ZzHdzM1OULVg90H21EOLACvtfcHk0ljL4NfvaqEiXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVaitr4%253D&md5=afb4091cdb73b2f8568183da302a59fa</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FAAC.01299-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01299-07%26sid%3Dliteratum%253Aachs%26aulast%3DNakata%26aufirst%3DH.%26aulast%3DSteinberg%26aufirst%3DS.%2BM.%26aulast%3DKoh%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DTakaoka%26aufirst%3DY.%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DPotent%2520synergistic%2520anti-human%2520immunodeficiency%2520virus%2520%2528hiv%2529%2520effects%2520using%2520combinations%2520of%2520the%2520CCR5%2520inhibitor%2520aplaviroc%2520with%2520other%2520anti-hiv%2520drugs%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D2111%26epage%3D2119%26doi%3D10.1128%2FAAC.01299-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, M. S.</span></span> <span> </span><span class="NLM_article-title">Tak-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitro</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3483</span>– <span class="NLM_lpage">3485</span>, <span class="refDoi"> DOI: 10.1128/AAC.49.8.3483-3485.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FAAC.49.8.3483-3485.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=16048964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntFCgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=3483-3485&author=C.+L.+Tremblayauthor=F.+Giguelauthor=Y.+Guanauthor=T.+C.+Chouauthor=K.+Takashimaauthor=M.+S.+Hirsch&title=Tak-220%2C+a+novel+small-molecule+CCR5+antagonist%2C+has+favorable+anti-human+immunodeficiency+virus+interactions+with+other+antiretrovirals+in+vitro&doi=10.1128%2FAAC.49.8.3483-3485.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">TAK-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitro</span></div><div class="casAuthors">Tremblay, Cecile L.; Giguel, Francoise; Guan, Yongbiao; Chou, Ting-Chao; Takashima, Katsunori; Hirsch, Martin S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3483-3485</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">TAK-220 is a CCR5 antagonist, part of the new class of anti-human immunodeficiency virus type 1 (anti-HIV-1) entry inhibitors.  The authors evaluated the anti-HIV-1 interactions between TAK-220 and various antiretrovirals in vitro.  Synergy was obsd. with all drugs at the 90 and 95% inhibitory concns.  The favorable drug interactions obsd. suggest that further clin. evaluation is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQE1EHC3eXQ7Vg90H21EOLACvtfcHk0ljwSsbaG-zcsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntFCgsr4%253D&md5=6ca61dc2aed93ac6ac904a6eda731290</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.8.3483-3485.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.8.3483-3485.2005%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay%26aufirst%3DC.%2BL.%26aulast%3DGiguel%26aufirst%3DF.%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DChou%26aufirst%3DT.%2BC.%26aulast%3DTakashima%26aufirst%3DK.%26aulast%3DHirsch%26aufirst%3DM.%2BS.%26atitle%3DTak-220%252C%2520a%2520novel%2520small-molecule%2520CCR5%2520antagonist%252C%2520has%2520favorable%2520anti-human%2520immunodeficiency%2520virus%2520interactions%2520with%2520other%2520antiretrovirals%2520in%2520vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D3483%26epage%3D3485%26doi%3D10.1128%2FAAC.49.8.3483-3485.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baroudy, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, M. S.</span></span> <span> </span><span class="NLM_article-title">Anti-human immunodeficiency virus interactions of sch-c (sch 351125), a CCR5 antagonist, with other antiretroviral agents in vitro</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1336</span>– <span class="NLM_lpage">1339</span>, <span class="refDoi"> DOI: 10.1128/AAC.46.5.1336-1339.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FAAC.46.5.1336-1339.2002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=1336-1339&author=C.+L.+Tremblayauthor=F.+Giguelauthor=C.+Kollmannauthor=Y.+Guanauthor=T.+C.+Chouauthor=B.+M.+Baroudyauthor=M.+S.+Hirsch&title=Anti-human+immunodeficiency+virus+interactions+of+sch-c+%28sch+351125%29%2C+a+CCR5+antagonist%2C+with+other+antiretroviral+agents+in+vitro&doi=10.1128%2FAAC.46.5.1336-1339.2002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FAAC.46.5.1336-1339.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.46.5.1336-1339.2002%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay%26aufirst%3DC.%2BL.%26aulast%3DGiguel%26aufirst%3DF.%26aulast%3DKollmann%26aufirst%3DC.%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DChou%26aufirst%3DT.%2BC.%26aulast%3DBaroudy%26aufirst%3DB.%2BM.%26aulast%3DHirsch%26aufirst%3DM.%2BS.%26atitle%3DAnti-human%2520immunodeficiency%2520virus%2520interactions%2520of%2520sch-c%2520%2528sch%2520351125%2529%252C%2520a%2520CCR5%2520antagonist%252C%2520with%2520other%2520antiretroviral%2520agents%2520in%2520vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26spage%3D1336%26epage%3D1339%26doi%3D10.1128%2FAAC.46.5.1336-1339.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, M. S.</span></span> <span> </span><span class="NLM_article-title">Strong in vitro synergy between the fusion inhibitor t-20 and the CXCR4 blocker amd-3100</span>. <i>JAIDS, J. Acquired Immune Defic. Syndr.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1097/00126334-200010010-00001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1097%2F00126334-200010010-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=11103038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVekt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2000&pages=99-102&author=C.+L.+Tremblayauthor=C.+Kollmannauthor=F.+Giguelauthor=T.+C.+Chouauthor=M.+S.+Hirsch&title=Strong+in+vitro+synergy+between+the+fusion+inhibitor+t-20+and+the+CXCR4+blocker+amd-3100&doi=10.1097%2F00126334-200010010-00001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100</span></div><div class="casAuthors">Tremblay, Cecile L.; Kollmann, Christopher; Giguel, Francoise; Chou, Ting-Chao; Hirsch, Martin S.</div><div class="citationInfo"><span class="NLM_cas:title">JAIDS, Journal of Acquired Immune Deficiency Syndromes</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-102</span>CODEN:
                <span class="NLM_cas:coden">JJASFJ</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Attachment and entry of HIV-1 into CD4 cells involve a series of events in which different viral envelope proteins interact with specific cell receptors, culminating in fusion of viral and cell membranes.  AMD-3100 is a small mol. inhibitor of HIV-1 attachment to the CXCR4 chemokine receptor, and T-20 is a synthetic peptide corresponding to a region of HIV-1 gp41 that blocks fusion to cell membranes.  To evaluate the interaction between agents acting at 2 different steps of the entry process, the authors conducted in vitro studies of the combination of T-20 and AMD-3100 against an X4 HIV-1 isolate.  Single drugs or multiply dild. fixed ratio combinations of drugs were added to peripheral blood mononuclear cells infected with a clin. isolate, 14aPre.  Drug interactions were evaluated using the median-effect principle and the combination index technique.  The 50% inhibitory concn. (IC50) for T-20 was 0.10 μg/mL and for AMD-3100 was 0.19 μg/mL.  Synergy was obsd. between T-20 and AMD-3100 and this increased with higher inhibitory concns., with combination indexes ranging from 0.62 at IC50 to 0.02 at IC95.  Whether these synergistic interactions translate into clin. benefit will need to be addressed in the context of clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGnKF3mFZTbLVg90H21EOLACvtfcHk0ljwSsbaG-zcsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVekt7o%253D&md5=d618afa60b738f4d09a8a6fe7641db9f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1097%2F00126334-200010010-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00126334-200010010-00001%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay%26aufirst%3DC.%2BL.%26aulast%3DKollmann%26aufirst%3DC.%26aulast%3DGiguel%26aufirst%3DF.%26aulast%3DChou%26aufirst%3DT.%2BC.%26aulast%3DHirsch%26aufirst%3DM.%2BS.%26atitle%3DStrong%2520in%2520vitro%2520synergy%2520between%2520the%2520fusion%2520inhibitor%2520t-20%2520and%2520the%2520CXCR4%2520blocker%2520amd-3100%26jtitle%3DJAIDS%252C%2520J.%2520Acquired%2520Immune%2520Defic.%2520Syndr.%26date%3D2000%26volume%3D25%26spage%3D99%26epage%3D102%26doi%3D10.1097%2F00126334-200010010-00001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doms, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peiper, S. C.</span></span> <span> </span><span class="NLM_article-title">Unwelcomed guests with master keys: How hiv uses chemokine receptors for cellular entry</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>235</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1006/viro.1997.8703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1006%2Fviro.1997.8703" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1997&pages=179-190&author=R.+W.+Domsauthor=S.+C.+Peiper&title=Unwelcomed+guests+with+master+keys%3A+How+hiv+uses+chemokine+receptors+for+cellular+entry&doi=10.1006%2Fviro.1997.8703"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1006%2Fviro.1997.8703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fviro.1997.8703%26sid%3Dliteratum%253Aachs%26aulast%3DDoms%26aufirst%3DR.%2BW.%26aulast%3DPeiper%26aufirst%3DS.%2BC.%26atitle%3DUnwelcomed%2520guests%2520with%2520master%2520keys%253A%2520How%2520hiv%2520uses%2520chemokine%2520receptors%2520for%2520cellular%2520entry%26jtitle%3DVirology%26date%3D1997%26volume%3D235%26spage%3D179%26epage%3D190%26doi%3D10.1006%2Fviro.1997.8703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Efficient synthesis and identification of novel propane-1,3-diamino bridged CCR5 antagonists with variation on the basic center carrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">2827</span>– <span class="NLM_lpage">2840</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2010.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1016%2Fj.ejmech.2010.03.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=2827-2840&author=X.+Fanauthor=H.+S.+Zhangauthor=L.+Chenauthor=Y.+Q.+Long&title=Efficient+synthesis+and+identification+of+novel+propane-1%2C3-diamino+bridged+CCR5+antagonists+with+variation+on+the+basic+center+carrier&doi=10.1016%2Fj.ejmech.2010.03.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%2BS.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DEfficient%2520synthesis%2520and%2520identification%2520of%2520novel%2520propane-1%252C3-diamino%2520bridged%2520CCR5%2520antagonists%2520with%2520variation%2520on%2520the%2520basic%2520center%2520carrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D2827%26epage%3D2840%26doi%3D10.1016%2Fj.ejmech.2010.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Forward- and reverse-synthesis of piperazinopiperidine amide analogs: A general access to structurally diverse 4-piperazinopiperidine-based CCR5 antagonists</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2690</span>– <span class="NLM_lpage">2697</span>, <span class="refDoi"> DOI: 10.1039/b707175b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1039%2Fb707175b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=2690-2697&author=D.+Z.+Fengauthor=Y.+L.+Songauthor=X.+H.+Jiangauthor=L.+Chenauthor=Y.+Q.+Long&title=Forward-+and+reverse-synthesis+of+piperazinopiperidine+amide+analogs%3A+A+general+access+to+structurally+diverse+4-piperazinopiperidine-based+CCR5+antagonists&doi=10.1039%2Fb707175b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2Fb707175b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb707175b%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DD.%2BZ.%26aulast%3DSong%26aufirst%3DY.%2BL.%26aulast%3DJiang%26aufirst%3DX.%2BH.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DForward-%2520and%2520reverse-synthesis%2520of%2520piperazinopiperidine%2520amide%2520analogs%253A%2520A%2520general%2520access%2520to%2520structurally%2520diverse%25204-piperazinopiperidine-based%2520CCR5%2520antagonists%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2007%26volume%3D5%26spage%3D2690%26epage%3D2697%26doi%3D10.1039%2Fb707175b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. Q.</span>; <span class="NLM_string-name">Feng, D. Z.</span>; <span class="NLM_string-name">Chen, L.</span>; <span class="NLM_string-name">Chen, R.
H.</span></span> <span> </span><span class="NLM_article-title">1-(3-Amino-Propyl)-Piperidin-4-yl-Amides, Pharmaceutical Compositions, Processes For Their Preparation And Uses</span>. <span class="NLM_patent">WO2009052708A1</span>, April 30, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+Q.+Long&author=D.+Z.+Feng&author=L.+Chen&author=R.%0AH.+Chen&title=1-%283-Amino-Propyl%29-Piperidin-4-yl-Amides%2C+Pharmaceutical+Compositions%2C+Processes+For+Their+Preparation+And+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3D1-%25283-Amino-Propyl%2529-Piperidin-4-yl-Amides%252C%2520Pharmaceutical%2520Compositions%252C%2520Processes%2520For%2520Their%2520Preparation%2520And%2520Uses%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel (s)-alpha-phenyl-gamma-amino butanamide containing CCR5 antagonists via functionality inversion approach</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2219</span>– <span class="NLM_lpage">2223</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1016%2Fj.bmcl.2010.02.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2219-2223&author=H.+S.+Zhangauthor=D.+Z.+Fengauthor=L.+Chenauthor=Y.+Q.+Long&title=Discovery+of+novel+%28s%29-alpha-phenyl-gamma-amino+butanamide+containing+CCR5+antagonists+via+functionality+inversion+approach&doi=10.1016%2Fj.bmcl.2010.02.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BS.%26aulast%3DFeng%26aufirst%3DD.%2BZ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DDiscovery%2520of%2520novel%2520%2528s%2529-alpha-phenyl-gamma-amino%2520butanamide%2520containing%2520CCR5%2520antagonists%2520via%2520functionality%2520inversion%2520approach%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2219%26epage%3D2223%26doi%3D10.1016%2Fj.bmcl.2010.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span>; <span class="NLM_string-name">Long, Y.
Q.</span>; <span class="NLM_string-name">Wei, W.</span>; <span class="NLM_string-name">Xie, X.</span></span> <span> </span><span class="NLM_article-title">New Imidazopyridine Compound Useful In Pharmaceutical Composition and In Preparation Of Medicine For Treating Dieseases From Hiv Virus Infection, Rheumatoid Arthritis, Inflammation, and Cancer</span>. <span class="NLM_patent">CN 102675305 B</span>, March 08, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=B.+Cao&author=Y.%0AQ.+Long&author=W.+Wei&author=X.+Xie&title=New+Imidazopyridine+Compound+Useful+In+Pharmaceutical+Composition+and+In+Preparation+Of+Medicine+For+Treating+Dieseases+From+Hiv+Virus+Infection%2C+Rheumatoid+Arthritis%2C+Inflammation%2C+and+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DB.%26atitle%3DNew%2520Imidazopyridine%2520Compound%2520Useful%2520In%2520Pharmaceutical%2520Composition%2520and%2520In%2520Preparation%2520Of%2520Medicine%2520For%2520Treating%2520Dieseases%2520From%2520Hiv%2520Virus%2520Infection%252C%2520Rheumatoid%2520Arthritis%252C%2520Inflammation%252C%2520and%2520Cancer%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bastian, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantharaju</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contarino, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papazoglou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Cell-free hiv-1 virucidal action by modified peptide triazole inhibitors of env gp120</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1335</span>– <span class="NLM_lpage">1339</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1002%2Fcmdc.201100177" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1335-1339&author=A.+R.+Bastianauthor=+Kantharajuauthor=K.+McFaddenauthor=C.+Duffyauthor=S.+Rajagopalauthor=M.+R.+Contarinoauthor=E.+Papazoglouauthor=I.+Chaiken&title=Cell-free+hiv-1+virucidal+action+by+modified+peptide+triazole+inhibitors+of+env+gp120&doi=10.1002%2Fcmdc.201100177"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100177%26sid%3Dliteratum%253Aachs%26aulast%3DBastian%26aufirst%3DA.%2BR.%26aulast%3DKantharaju%26aulast%3DMcFadden%26aufirst%3DK.%26aulast%3DDuffy%26aufirst%3DC.%26aulast%3DRajagopal%26aufirst%3DS.%26aulast%3DContarino%26aufirst%3DM.%2BR.%26aulast%3DPapazoglou%26aufirst%3DE.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DCell-free%2520hiv-1%2520virucidal%2520action%2520by%2520modified%2520peptide%2520triazole%2520inhibitors%2520of%2520env%2520gp120%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1335%26epage%3D1339%26doi%3D10.1002%2Fcmdc.201100177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rashad, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyana Sundaram, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aneja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic envelope glycoprotein antagonists that irreversibly inactivate hiv-1 before host cell encounter</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7603</span>– <span class="NLM_lpage">7608</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7603-7608&author=A.+A.+Rashadauthor=R.+V.+Kalyana+Sundaramauthor=R.+Anejaauthor=C.+Duffyauthor=I.+Chaiken&title=Macrocyclic+envelope+glycoprotein+antagonists+that+irreversibly+inactivate+hiv-1+before+host+cell+encounter&doi=10.1021%2Facs.jmedchem.5b00935"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00935%26sid%3Dliteratum%253Aachs%26aulast%3DRashad%26aufirst%3DA.%2BA.%26aulast%3DKalyana%2BSundaram%26aufirst%3DR.%2BV.%26aulast%3DAneja%26aufirst%3DR.%26aulast%3DDuffy%26aufirst%3DC.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DMacrocyclic%2520envelope%2520glycoprotein%2520antagonists%2520that%2520irreversibly%2520inactivate%2520hiv-1%2520before%2520host%2520cell%2520encounter%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7603%26epage%3D7608%26doi%3D10.1021%2Facs.jmedchem.5b00935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aneja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashad, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyana Sundaram, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Peptide triazole inactivators of hiv-1 utilize a conserved two-cavity binding site at the junction of the inner and outer domains of env gp120</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3843</span>– <span class="NLM_lpage">3858</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00073</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00073" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3843-3858&author=R.+Anejaauthor=A.+A.+Rashadauthor=H.+Liauthor=R.+V.+Kalyana+Sundaramauthor=C.+Duffyauthor=L.+D.+Baileyauthor=I.+Chaiken&title=Peptide+triazole+inactivators+of+hiv-1+utilize+a+conserved+two-cavity+binding+site+at+the+junction+of+the+inner+and+outer+domains+of+env+gp120&doi=10.1021%2Facs.jmedchem.5b00073"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00073%26sid%3Dliteratum%253Aachs%26aulast%3DAneja%26aufirst%3DR.%26aulast%3DRashad%26aufirst%3DA.%2BA.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DKalyana%2BSundaram%26aufirst%3DR.%2BV.%26aulast%3DDuffy%26aufirst%3DC.%26aulast%3DBailey%26aufirst%3DL.%2BD.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DPeptide%2520triazole%2520inactivators%2520of%2520hiv-1%2520utilize%2520a%2520conserved%2520two-cavity%2520binding%2520site%2520at%2520the%2520junction%2520of%2520the%2520inner%2520and%2520outer%2520domains%2520of%2520env%2520gp120%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3843%26epage%3D3858%26doi%3D10.1021%2Facs.jmedchem.5b00073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gopi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umashankara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirrone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaLonde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuzer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zentner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocklin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jawanda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodroski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Structural determinants for affinity enhancement of a dual antagonist peptide entry inhibitor of human immunodeficiency virus type-1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2638</span>– <span class="NLM_lpage">2647</span>, <span class="refDoi"> DOI: 10.1021/jm070814r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070814r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2638-2647&author=H.+Gopiauthor=M.+Umashankaraauthor=V.+Pirroneauthor=J.+LaLondeauthor=N.+Madaniauthor=F.+Tuzerauthor=S.+Baxterauthor=I.+Zentnerauthor=S.+Cocklinauthor=N.+Jawandaauthor=S.+R.+Millerauthor=A.+Schonauthor=J.+C.+Kleinauthor=E.+Freireauthor=F.+C.+Krebsauthor=A.+B.+Smithauthor=J.+Sodroskiauthor=I.+Chaiken&title=Structural+determinants+for+affinity+enhancement+of+a+dual+antagonist+peptide+entry+inhibitor+of+human+immunodeficiency+virus+type-1&doi=10.1021%2Fjm070814r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm070814r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070814r%26sid%3Dliteratum%253Aachs%26aulast%3DGopi%26aufirst%3DH.%26aulast%3DUmashankara%26aufirst%3DM.%26aulast%3DPirrone%26aufirst%3DV.%26aulast%3DLaLonde%26aufirst%3DJ.%26aulast%3DMadani%26aufirst%3DN.%26aulast%3DTuzer%26aufirst%3DF.%26aulast%3DBaxter%26aufirst%3DS.%26aulast%3DZentner%26aufirst%3DI.%26aulast%3DCocklin%26aufirst%3DS.%26aulast%3DJawanda%26aufirst%3DN.%26aulast%3DMiller%26aufirst%3DS.%2BR.%26aulast%3DSchon%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DJ.%2BC.%26aulast%3DFreire%26aufirst%3DE.%26aulast%3DKrebs%26aufirst%3DF.%2BC.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DSodroski%26aufirst%3DJ.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DStructural%2520determinants%2520for%2520affinity%2520enhancement%2520of%2520a%2520dual%2520antagonist%2520peptide%2520entry%2520inhibitor%2520of%2520human%2520immunodeficiency%2520virus%2520type-1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2638%26epage%3D2647%26doi%3D10.1021%2Fjm070814r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gopi, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirupula, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I. M.</span></span> <span> </span><span class="NLM_article-title">Click chemistry on azidoproline: High-affinity dual antagonist for hiv-1 envelope glycoprotein gp120</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">54</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200500037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1002%2Fcmdc.200500037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=54-57&author=H.+N.+Gopiauthor=K.+C.+Tirupulaauthor=S.+Baxterauthor=S.+Ajithauthor=I.+M.+Chaiken&title=Click+chemistry+on+azidoproline%3A+High-affinity+dual+antagonist+for+hiv-1+envelope+glycoprotein+gp120&doi=10.1002%2Fcmdc.200500037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200500037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200500037%26sid%3Dliteratum%253Aachs%26aulast%3DGopi%26aufirst%3DH.%2BN.%26aulast%3DTirupula%26aufirst%3DK.%2BC.%26aulast%3DBaxter%26aufirst%3DS.%26aulast%3DAjith%26aufirst%3DS.%26aulast%3DChaiken%26aufirst%3DI.%2BM.%26atitle%3DClick%2520chemistry%2520on%2520azidoproline%253A%2520High-affinity%2520dual%2520antagonist%2520for%2520hiv-1%2520envelope%2520glycoprotein%2520gp120%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D54%26epage%3D57%26doi%3D10.1002%2Fcmdc.200500037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamanna, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aneja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubinski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigo
Moreira, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuzer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contarino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I. M.</span></span> <span> </span><span class="NLM_article-title">Non-natural peptide triazole antagonists of hiv-1 envelope gp120</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1002%2Fcmdc.201200422" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=322-328&author=K.+Kamannaauthor=R.+Anejaauthor=C.+Duffyauthor=P.+Kubinskiauthor=D.+Rodrigo%0AMoreiraauthor=L.+D.+Baileyauthor=K.+McFaddenauthor=A.+Schonauthor=A.+Holmesauthor=F.+Tuzerauthor=M.+Contarinoauthor=E.+Freireauthor=I.+M.+Chaiken&title=Non-natural+peptide+triazole+antagonists+of+hiv-1+envelope+gp120&doi=10.1002%2Fcmdc.201200422"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200422%26sid%3Dliteratum%253Aachs%26aulast%3DKamanna%26aufirst%3DK.%26aulast%3DAneja%26aufirst%3DR.%26aulast%3DDuffy%26aufirst%3DC.%26aulast%3DKubinski%26aufirst%3DP.%26aulast%3DRodrigo%2BMoreira%26aufirst%3DD.%26aulast%3DBailey%26aufirst%3DL.%2BD.%26aulast%3DMcFadden%26aufirst%3DK.%26aulast%3DSchon%26aufirst%3DA.%26aulast%3DHolmes%26aufirst%3DA.%26aulast%3DTuzer%26aufirst%3DF.%26aulast%3DContarino%26aufirst%3DM.%26aulast%3DFreire%26aufirst%3DE.%26aulast%3DChaiken%26aufirst%3DI.%2BM.%26atitle%3DNon-natural%2520peptide%2520triazole%2520antagonists%2520of%2520hiv-1%2520envelope%2520gp120%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D322%26epage%3D328%26doi%3D10.1002%2Fcmdc.201200422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Umashankara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zentner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuzer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriakose, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contarino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalonde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freire, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">The active core in a triazole peptide dual-site antagonist of hiv-1 gp120</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1871</span>– <span class="NLM_lpage">1879</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1002%2Fcmdc.201000222" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1871-1879&author=M.+Umashankaraauthor=K.+McFaddenauthor=I.+Zentnerauthor=A.+Schonauthor=S.+Rajagopalauthor=F.+Tuzerauthor=S.+A.+Kuriakoseauthor=M.+Contarinoauthor=J.+Lalondeauthor=E.+Freireauthor=I.+Chaiken&title=The+active+core+in+a+triazole+peptide+dual-site+antagonist+of+hiv-1+gp120&doi=10.1002%2Fcmdc.201000222"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000222%26sid%3Dliteratum%253Aachs%26aulast%3DUmashankara%26aufirst%3DM.%26aulast%3DMcFadden%26aufirst%3DK.%26aulast%3DZentner%26aufirst%3DI.%26aulast%3DSchon%26aufirst%3DA.%26aulast%3DRajagopal%26aufirst%3DS.%26aulast%3DTuzer%26aufirst%3DF.%26aulast%3DKuriakose%26aufirst%3DS.%2BA.%26aulast%3DContarino%26aufirst%3DM.%26aulast%3DLalonde%26aufirst%3DJ.%26aulast%3DFreire%26aufirst%3DE.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DThe%2520active%2520core%2520in%2520a%2520triazole%2520peptide%2520dual-site%2520antagonist%2520of%2520hiv-1%2520gp120%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1871%26epage%3D1879%26doi%3D10.1002%2Fcmdc.201000222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanfield, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyumkis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deller, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klasse, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a soluble cleaved hiv-1 envelope trimer</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">1477</span>– <span class="NLM_lpage">1483</span>, <span class="refDoi"> DOI: 10.1126/science.1245625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1126%2Fscience.1245625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=24179159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFemu7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=1477-1483&author=J.+P.+Julienauthor=A.+Cupoauthor=D.+Sokauthor=R.+L.+Stanfieldauthor=D.+Lyumkisauthor=M.+C.+Dellerauthor=P.+J.+Klasseauthor=D.+R.+Burtonauthor=R.+W.+Sandersauthor=J.+P.+Mooreauthor=A.+B.+Wardauthor=I.+A.+Wilson&title=Crystal+structure+of+a+soluble+cleaved+hiv-1+envelope+trimer&doi=10.1126%2Fscience.1245625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer</span></div><div class="casAuthors">Julien, Jean-Philippe; Cupo, Albert; Sok, Devin; Stanfield, Robyn L.; Lyumkis, Dmitry; Deller, Marc C.; Klasse, Per-Johan; Burton, Dennis R.; Sanders, Rogier W.; Moore, John P.; Ward, Andrew B.; Wilson, Ian A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">6165</span>),
    <span class="NLM_cas:pages">1477-1483</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">HIV-1 entry into CD4+ target cells is mediated by cleaved envelope glycoprotein (Env) trimers that have been challenging to characterize structurally.  Here, we describe the crystal structure at 4.7 angstroms of a sol., cleaved Env trimer that is stabilized and antigenically near-native (termed the BG505 SOSIP.664 gp140 trimer) in complex with a potent broadly neutralizing antibody, PGT122.  The structure shows a prefusion state of gp41, the interaction between the component gp120 and gp41 subunits, and how a close assocn. between the gp120 V1/V2/V3 loops stabilizes the trimer apex around the threefold axis.  The complete epitope of PGT122 on the trimer involves gp120 V1, V3, and several surrounding glycans.  This trimer structure advances our understanding of how Env functions and is presented to the immune system, and provides a blueprint for structure-based vaccine design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYmAaUYZVlYbVg90H21EOLACvtfcHk0lhRnjtRWGzgFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFemu7zI&md5=30ec4fffcf1264eb668261f1640d7609</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscience.1245625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1245625%26sid%3Dliteratum%253Aachs%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DCupo%26aufirst%3DA.%26aulast%3DSok%26aufirst%3DD.%26aulast%3DStanfield%26aufirst%3DR.%2BL.%26aulast%3DLyumkis%26aufirst%3DD.%26aulast%3DDeller%26aufirst%3DM.%2BC.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DSanders%26aufirst%3DR.%2BW.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520a%2520soluble%2520cleaved%2520hiv-1%2520envelope%2520trimer%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D1477%26epage%3D1483%26doi%3D10.1126%2Fscience.1245625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenalti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span> <span> </span><span class="NLM_article-title">Structure of the CCR5 chemokine receptor-hiv entry inhibitor maraviroc complex</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">1387</span>– <span class="NLM_lpage">1390</span>, <span class="refDoi"> DOI: 10.1126/science.1241475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1126%2Fscience.1241475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=24030490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2013&pages=1387-1390&author=Q.+Tanauthor=Y.+Zhuauthor=J.+Liauthor=Z.+Chenauthor=G.+W.+Hanauthor=I.+Kufarevaauthor=T.+Liauthor=L.+Maauthor=G.+Fenaltiauthor=J.+Liauthor=W.+Zhangauthor=X.+Xieauthor=H.+Yangauthor=H.+Jiangauthor=V.+Cherezovauthor=H.+Liuauthor=R.+C.+Stevensauthor=Q.+Zhaoauthor=B.+Wu&title=Structure+of+the+CCR5+chemokine+receptor-hiv+entry+inhibitor+maraviroc+complex&doi=10.1126%2Fscience.1241475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex</span></div><div class="casAuthors">Tan, Qiuxiang; Zhu, Ya; Li, Jian; Chen, Zhuxi; Han, Gye Won; Kufareva, Irina; Li, Tingting; Ma, Limin; Fenalti, Gustavo; Li, Jing; Zhang, Wenru; Xie, Xin; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Liu, Hong; Stevens, Raymond C.; Zhao, Qiang; Wu, Beili</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6152</span>),
    <span class="NLM_cas:pages">1387-1390</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The CCR5 chemokine receptor acts as a co-receptor for HIV-1 viral entry.  Here we report the 2.7 angstrom-resoln. crystal structure of human CCR5 bound to the marketed HIV drug maraviroc.  The structure reveals a ligand-binding site that is distinct from the proposed major recognition sites for chemokines and the viral glycoprotein gp120, providing insights into the mechanism of allosteric inhibition of chemokine signaling and viral entry.  A comparison between CCR5 and CXCR4 crystal structures, along with models of co-receptor-gp120-V3 complexes, suggests that different charge distributions and steric hindrances caused by residue substitutions may be major determinants of HIV-1 co-receptor selectivity.  These high-resoln. insights into CCR5 can enable structure-based drug discovery for the treatment of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt5VKeO5Hmb7Vg90H21EOLACvtfcHk0lgc8VAvrFQ3BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCmu7vJ&md5=730ee5644a2a144cd49cd0e9a15eba2e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscience.1241475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1241475%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DB.%26atitle%3DStructure%2520of%2520the%2520CCR5%2520chemokine%2520receptor-hiv%2520entry%2520inhibitor%2520maraviroc%2520complex%26jtitle%3DScience%26date%3D2013%26volume%3D341%26spage%3D1387%26epage%3D1390%26doi%3D10.1126%2Fscience.1241475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanfield, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodroski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bewley, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, P. D.</span></span> <span> </span><span class="NLM_article-title">Structures of the CCR5 n terminus and of a tyrosine-sulfated antibody with hiv-1 gp120 and CD4</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">1930</span>– <span class="NLM_lpage">1934</span>, <span class="refDoi"> DOI: 10.1126/science.1145373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1126%2Fscience.1145373" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=1930-1934&author=C.+C.+Huangauthor=S.+N.+Lamauthor=P.+Acharyaauthor=M.+Tangauthor=S.+H.+Xiangauthor=S.+S.+Hussanauthor=R.+L.+Stanfieldauthor=J.+Robinsonauthor=J.+Sodroskiauthor=I.+A.+Wilsonauthor=R.+Wyattauthor=C.+A.+Bewleyauthor=P.+D.+Kwong&title=Structures+of+the+CCR5+n+terminus+and+of+a+tyrosine-sulfated+antibody+with+hiv-1+gp120+and+CD4&doi=10.1126%2Fscience.1145373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscience.1145373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1145373%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DLam%26aufirst%3DS.%2BN.%26aulast%3DAcharya%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DS.%2BH.%26aulast%3DHussan%26aufirst%3DS.%2BS.%26aulast%3DStanfield%26aufirst%3DR.%2BL.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DSodroski%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DWyatt%26aufirst%3DR.%26aulast%3DBewley%26aufirst%3DC.%2BA.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26atitle%3DStructures%2520of%2520the%2520CCR5%2520n%2520terminus%2520and%2520of%2520a%2520tyrosine-sulfated%2520antibody%2520with%2520hiv-1%2520gp120%2520and%2520CD4%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D1930%26epage%3D1934%26doi%3D10.1126%2Fscience.1145373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moraca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melillo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. B.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, C. F.</span></span> <span> </span><span class="NLM_article-title">Computational evaluation of hiv-1 gp120 conformations of soluble trimeric gp140 structures as targets for de novo docking of first- and second-generation small-molecule cd4 mimics</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2069</span>– <span class="NLM_lpage">2079</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.6b00393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.6b00393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOrt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2016&pages=2069-2079&author=F.+Moracaauthor=K.+Acharyaauthor=B.+Melilloauthor=A.+B.+Smithauthor=I.+Chaikenauthor=C.+F.+Abrams&title=Computational+evaluation+of+hiv-1+gp120+conformations+of+soluble+trimeric+gp140+structures+as+targets+for+de+novo+docking+of+first-+and+second-generation+small-molecule+cd4+mimics&doi=10.1021%2Facs.jcim.6b00393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Computational Evaluation of HIV-1 gp120 Conformations of Soluble Trimeric gp140 Structures as Targets for de Novo Docking of First- and Second-Generation Small-Molecule CD4 Mimics</span></div><div class="casAuthors">Moraca, Francesca; Acharya, Kriti; Melillo, Bruno; Smith, Amos B.; Chaiken, Irwin; Abrams, Cameron F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2069-2079</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. CD4 mimics (SMCM's) bind to the gp120 subunit of the HIV-1 envelope glycoprotein (Env) and have been optimized to block cell infection in vitro.  The lack of the V1/2 and V3 loops and the presence of the β2/3 and β20/21 strands (bridging sheet) in the available structures of the monomeric gp120 core may limit its applicability as a target for further synthetic optimization of SMCM potency and/or breadth.  Here, we employ a combination of binding-site search, docking, estn. of protein-ligand interaction energy, all-atom mol. dynamics, and ELISA-based CD4-binding competition assays to create, characterize, and rationalize models of first- and second-generation of SMCM's bound to the distinct, trimeric BG505 SOSIP.664 structures 4NCO and 4TVP contg. V1/2 and V3 loops with no bridging sheet.  We demonstrate that the in silico neutralization of the highly conserved D368 is necessary to obtain the correct orientation of SMCM in their binding site when docking against the monomeric gp120 core.  The computational results correlate with IC50's measured in CD4 binding competition ELISA and with KD's measured on gp120 core monomer.  This supports the hypothesis that the 4NCO trimeric structure represents a viable target for further SMCM's optimization with advantages over both the 4TVP trimer and gp120 core monomer.  Finally, the docking protocol has been optimized to screen compds. that can clearly interact with the highly conserved residue D368, increasing the likelihood of future optimizations to arrive at SMCM's with a broader spectrum of activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp155xyNFo1YLVg90H21EOLACvtfcHk0lgc8VAvrFQ3BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOrt73P&md5=4fe4c0ee8faa7f3bdd9b018f1cfa2f74</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.6b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.6b00393%26sid%3Dliteratum%253Aachs%26aulast%3DMoraca%26aufirst%3DF.%26aulast%3DAcharya%26aufirst%3DK.%26aulast%3DMelillo%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DChaiken%26aufirst%3DI.%26aulast%3DAbrams%26aufirst%3DC.%2BF.%26atitle%3DComputational%2520evaluation%2520of%2520hiv-1%2520gp120%2520conformations%2520of%2520soluble%2520trimeric%2520gp140%2520structures%2520as%2520targets%2520for%2520de%2520novo%2520docking%2520of%2520first-%2520and%2520second-generation%2520small-molecule%2520cd4%2520mimics%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2016%26volume%3D56%26spage%3D2069%26epage%3D2079%26doi%3D10.1021%2Facs.jcim.6b00393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tallarida, R. J.</span></span> <span> </span><span class="NLM_article-title">An overview of drug combination analysis with isobolograms</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>319</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.104117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1124%2Fjpet.106.104117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=16670349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCksL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=1-7&author=R.+J.+Tallarida&title=An+overview+of+drug+combination+analysis+with+isobolograms&doi=10.1124%2Fjpet.106.104117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of drug combination analysis with isobolograms</span></div><div class="casAuthors">Tallarida, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review with refs.  Drugs given in combination may produce effects that are greater than or less than the effect predicted from their individual potencies.  The historical basis for predicting the effect of a combination is based on the concept of dose equivalence; i.e., an equally ED (a) of one will add to the dose (b) of the other in the combination situation.  For drugs with a const. relative potency, this leads to linear additive isoboles (a-b curves of const. effect), whereas a varying potency ratio produces nonlinear additive isoboles.  Detn. of the additive isobole is a necessary procedure for assessing both synergistic and antagonistic interactions of the combination.  This review discusses both variable and const. relative potency situations and provides the math. formulas needed to distinguish these cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFzemT-mANgrVg90H21EOLACvtfcHk0ligAUQaCJrEsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCksL%252FO&md5=dc5254bd4348e2704599f41947f273fc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.104117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.104117%26sid%3Dliteratum%253Aachs%26aulast%3DTallarida%26aufirst%3DR.%2BJ.%26atitle%3DAn%2520overview%2520of%2520drug%2520combination%2520analysis%2520with%2520isobolograms%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D1%26epage%3D7%26doi%3D10.1124%2Fjpet.106.104117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emileh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuzer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umashankara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalonde, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bewley, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I. M.</span></span> <span> </span><span class="NLM_article-title">A model of peptide triazole entry inhibitor binding to hiv-1 gp120 and the mechanism of bridging sheet disruption</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2245</span>– <span class="NLM_lpage">2261</span>, <span class="refDoi"> DOI: 10.1021/bi400166b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi400166b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=2245-2261&author=A.+Emilehauthor=F.+Tuzerauthor=H.+Yehauthor=M.+Umashankaraauthor=D.+R.+Moreiraauthor=J.+M.+Lalondeauthor=C.+A.+Bewleyauthor=C.+F.+Abramsauthor=I.+M.+Chaiken&title=A+model+of+peptide+triazole+entry+inhibitor+binding+to+hiv-1+gp120+and+the+mechanism+of+bridging+sheet+disruption&doi=10.1021%2Fbi400166b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fbi400166b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400166b%26sid%3Dliteratum%253Aachs%26aulast%3DEmileh%26aufirst%3DA.%26aulast%3DTuzer%26aufirst%3DF.%26aulast%3DYeh%26aufirst%3DH.%26aulast%3DUmashankara%26aufirst%3DM.%26aulast%3DMoreira%26aufirst%3DD.%2BR.%26aulast%3DLalonde%26aufirst%3DJ.%2BM.%26aulast%3DBewley%26aufirst%3DC.%2BA.%26aulast%3DAbrams%26aufirst%3DC.%2BF.%26aulast%3DChaiken%26aufirst%3DI.%2BM.%26atitle%3DA%2520model%2520of%2520peptide%2520triazole%2520entry%2520inhibitor%2520binding%2520to%2520hiv-1%2520gp120%2520and%2520the%2520mechanism%2520of%2520bridging%2520sheet%2520disruption%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D2245%26epage%3D2261%26doi%3D10.1021%2Fbi400166b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tuzer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamanna, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zentner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaLonde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contarino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodroski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Hiv-1 env gp120 structural determinants for peptide triazole dual receptor site antagonism</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1002/prot.24184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1002%2Fprot.24184" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=271-290&author=F.+Tuzerauthor=N.+Madaniauthor=K.+Kamannaauthor=I.+Zentnerauthor=J.+LaLondeauthor=A.+Holmesauthor=E.+Uptonauthor=S.+Rajagopalauthor=K.+McFaddenauthor=M.+Contarinoauthor=J.+Sodroskiauthor=I.+Chaiken&title=Hiv-1+env+gp120+structural+determinants+for+peptide+triazole+dual+receptor+site+antagonism&doi=10.1002%2Fprot.24184"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fprot.24184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.24184%26sid%3Dliteratum%253Aachs%26aulast%3DTuzer%26aufirst%3DF.%26aulast%3DMadani%26aufirst%3DN.%26aulast%3DKamanna%26aufirst%3DK.%26aulast%3DZentner%26aufirst%3DI.%26aulast%3DLaLonde%26aufirst%3DJ.%26aulast%3DHolmes%26aufirst%3DA.%26aulast%3DUpton%26aufirst%3DE.%26aulast%3DRajagopal%26aufirst%3DS.%26aulast%3DMcFadden%26aufirst%3DK.%26aulast%3DContarino%26aufirst%3DM.%26aulast%3DSodroski%26aufirst%3DJ.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DHiv-1%2520env%2520gp120%2520structural%2520determinants%2520for%2520peptide%2520triazole%2520dual%2520receptor%2520site%2520antagonism%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2013%26volume%3D81%26spage%3D271%26epage%3D290%26doi%3D10.1002%2Fprot.24184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolchinsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiprilov, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodroski, J.</span></span> <span> </span><span class="NLM_article-title">Loss of a single n-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 v1/v2 variable loops</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">3435</span>– <span class="NLM_lpage">3443</span>, <span class="refDoi"> DOI: 10.1128/JVI.75.7.3435-3443.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FJVI.75.7.3435-3443.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=11238869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVGiu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2001&pages=3435-3443&author=P.+Kolchinskyauthor=E.+Kiprilovauthor=P.+Bartleyauthor=R.+Rubinsteinauthor=J.+Sodroski&title=Loss+of+a+single+n-linked+glycan+allows+CD4-independent+human+immunodeficiency+virus+type+1+infection+by+altering+the+position+of+the+gp120+v1%2Fv2+variable+loops&doi=10.1128%2FJVI.75.7.3435-3443.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops</span></div><div class="casAuthors">Kolchinsky, Peter; Kiprilov, Enko; Bartley, Peter; Rubinstein, Roee; Sodroski, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3435-3443</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The gp120 envelope glycoprotein of primary human immunodeficiency virus type 1 (HIV-1) promotes virus entry by sequentially binding CD4 and the CCR5 chemokine receptor on the target cell.  Previously, we adapted a primary HIV-1 isolate, ADA, to replicate in CD4-neg. canine cells expressing human CCR5.  The gp120 changes responsible for CD4-independent replication were limited to the V2 loop-V1/V2 stem.  Here we show that elimination of a single glycosylation site at asparagine 197 in the V1/V2 stem is sufficient for CD4-independent gp120 binding to CCR5 and for HIV-1 entry into CD4-neg. cells expressing CCR5.  Deletion of the V1/V2 loops also allowed CD4-independent viral entry and gp120 binding to CCR5.  The binding of the wild-type ADA gp120 to CCR5 was less dependent upon CD4 at 4°C than at 37°C.  In the absence of the V1/V2 loops, neither removal of the N-linked carbohydrate at asparagine 197 nor lowering of the temp. increased the CD4-independent phenotypes.  A CCR5-binding conformation of gp120, achieved by CD4 interaction or by modification of temp., glycosylation, or variable loops, was preferentially recognized by the monoclonal antibody 48d.  These results suggest that the CCR5-binding region of gp120 is occluded by the V1/V2 variable loops, the position of which can be modulated by temp., CD4 binding, or an N-linked glycan in the V1/V2 stem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Zyjp5wv_V7Vg90H21EOLACvtfcHk0ligAUQaCJrEsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVGiu7Y%253D&md5=247af9cce61ae5e742fa4116cf5747c9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FJVI.75.7.3435-3443.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.75.7.3435-3443.2001%26sid%3Dliteratum%253Aachs%26aulast%3DKolchinsky%26aufirst%3DP.%26aulast%3DKiprilov%26aufirst%3DE.%26aulast%3DBartley%26aufirst%3DP.%26aulast%3DRubinstein%26aufirst%3DR.%26aulast%3DSodroski%26aufirst%3DJ.%26atitle%3DLoss%2520of%2520a%2520single%2520n-linked%2520glycan%2520allows%2520CD4-independent%2520human%2520immunodeficiency%2520virus%2520type%25201%2520infection%2520by%2520altering%2520the%2520position%2520of%2520the%2520gp120%2520v1%252Fv2%2520variable%2520loops%26jtitle%3DJ.%2520Virol%26date%3D2001%26volume%3D75%26spage%3D3435%26epage%3D3443%26doi%3D10.1128%2FJVI.75.7.3435-3443.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pancera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiev, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofek, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart-Jones, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailer, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louder, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumba, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascola, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munro, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mothes, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connors, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, P. D.</span></span> <span> </span><span class="NLM_article-title">Structure and immune recognition of trimeric pre-fusion hiv-1 env</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>514</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1038/nature13808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1038%2Fnature13808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=25296255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSmurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=514&publication_year=2014&pages=455-461&author=M.+Panceraauthor=T.+Zhouauthor=A.+Druzauthor=I.+S.+Georgievauthor=C.+Sotoauthor=J.+Gormanauthor=J.+Huangauthor=P.+Acharyaauthor=G.+Y.+Chuangauthor=G.+Ofekauthor=G.+B.+Stewart-Jonesauthor=J.+Stuckeyauthor=R.+T.+Bailerauthor=M.+G.+Joyceauthor=M.+K.+Louderauthor=N.+Tumbaauthor=Y.+Yangauthor=B.+Zhangauthor=M.+S.+Cohenauthor=B.+F.+Haynesauthor=J.+R.+Mascolaauthor=L.+Morrisauthor=J.+B.+Munroauthor=S.+C.+Blanchardauthor=W.+Mothesauthor=M.+Connorsauthor=P.+D.+Kwong&title=Structure+and+immune+recognition+of+trimeric+pre-fusion+hiv-1+env&doi=10.1038%2Fnature13808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and immune recognition of trimeric pre-fusion HIV-1 Env</span></div><div class="casAuthors">Pancera, Marie; Zhou, Tongqing; Druz, Aliaksandr; Georgiev, Ivelin S.; Soto, Cinque; Gorman, Jason; Huang, Jinghe; Acharya, Priyamvada; Chuang, Gwo-Yu; Ofek, Gilad; Stewart-Jones, Guillaume B. E.; Stuckey, Jonathan; Bailer, Robert T.; Joyce, M. Gordon; Louder, Mark K.; Tumba, Nancy; Yang, Yongping; Zhang, Baoshan; Cohen, Myron S.; Haynes, Barton F.; Mascola, John R.; Morris, Lynn; Munro, James B.; Blanchard, Scott C.; Mothes, Walther; Connors, Mark; Kwong, Peter D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">514</span>
        (<span class="NLM_cas:issue">7523</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human immunodeficiency virus type 1 (HIV-1) envelope (Env) spike, comprising three gp120 and three gp41 subunits, is a conformational machine that facilitates HIV-1 entry by rearranging from a mature unliganded state, through receptor-bound intermediates, to a post-fusion state.  As the sole viral antigen on the HIV-1 virion surface, Env is both the target of neutralizing antibodies and a focus of vaccine efforts.  Here we report the structure at 3.5 Å resoln. for an HIV-1 Env trimer captured in a mature closed state by antibodies PGT122 and 35O22.  This structure reveals the pre-fusion conformation of gp41, indicates rearrangements needed for fusion activation, and defines parameters of immune evasion and immune recognition.  Pre-fusion gp41 encircles amino- and carboxy-terminal strands of gp120 with four helixes that form a membrane-proximal collar, fastened by insertion of a fusion peptide-proximal methionine into a gp41-tryptophan clasp.  Spike rearrangements required for entry involve opening the clasp and expelling the termini.  N-linked glycosylation and sequence-variable regions cover the pre-fusion closed spike; we used chronic cohorts to map the prevalence and location of effective HIV-1-neutralizing responses, which were distinguished by their recognition of N-linked glycan and tolerance for epitope-sequence variation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-_ounjxrWarVg90H21EOLACvtfcHk0lhZldAUk990VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSmurnE&md5=2bfc5d3cc8a8577a33ac5f31adbb9015</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnature13808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13808%26sid%3Dliteratum%253Aachs%26aulast%3DPancera%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DDruz%26aufirst%3DA.%26aulast%3DGeorgiev%26aufirst%3DI.%2BS.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DGorman%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DAcharya%26aufirst%3DP.%26aulast%3DChuang%26aufirst%3DG.%2BY.%26aulast%3DOfek%26aufirst%3DG.%26aulast%3DStewart-Jones%26aufirst%3DG.%2BB.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DBailer%26aufirst%3DR.%2BT.%26aulast%3DJoyce%26aufirst%3DM.%2BG.%26aulast%3DLouder%26aufirst%3DM.%2BK.%26aulast%3DTumba%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DCohen%26aufirst%3DM.%2BS.%26aulast%3DHaynes%26aufirst%3DB.%2BF.%26aulast%3DMascola%26aufirst%3DJ.%2BR.%26aulast%3DMorris%26aufirst%3DL.%26aulast%3DMunro%26aufirst%3DJ.%2BB.%26aulast%3DBlanchard%26aufirst%3DS.%2BC.%26aulast%3DMothes%26aufirst%3DW.%26aulast%3DConnors%26aufirst%3DM.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26atitle%3DStructure%2520and%2520immune%2520recognition%2520of%2520trimeric%2520pre-fusion%2520hiv-1%2520env%26jtitle%3DNature%26date%3D2014%26volume%3D514%26spage%3D455%26epage%3D461%26doi%3D10.1038%2Fnature13808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borsi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchinat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarti, N.</span></span> <span> </span><span class="NLM_article-title">Entropic contribution to the linking coefficient in fragment based drug design: A case study</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4285</span>– <span class="NLM_lpage">4289</span>, <span class="refDoi"> DOI: 10.1021/jm901723z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901723z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFChsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4285-4289&author=V.+Borsiauthor=V.+Calderoneauthor=M.+Fragaiauthor=C.+Luchinatauthor=N.+Sarti&title=Entropic+contribution+to+the+linking+coefficient+in+fragment+based+drug+design%3A+A+case+study&doi=10.1021%2Fjm901723z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Entropic Contribution to the Linking Coefficient in Fragment Based Drug Design: A Case Study</span></div><div class="casAuthors">Borsi, Valentina; Calderone, Vito; Fragai, Marco; Luchinat, Claudio; Sarti, Niko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4285-4289</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">For several drug leads obtained by tethering weak binding ligands, the dissocn. const. is smaller than the product of those of the individual fragments by a factor named the linking coeff., E.  This favorable contribution is attributed to the entropic gain that is realized when two weak binding ligands are tethered.  Here we show a case study where the linking coeff. is strikingly small (E = 2.1 × 10-3 M-1) and its totally entropic nature is demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzdSoYwKSiDbVg90H21EOLACvtfcHk0lhfClLIXxoIWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFChsb4%253D&md5=3f33ad95e5443545871184726ba43e4a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm901723z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901723z%26sid%3Dliteratum%253Aachs%26aulast%3DBorsi%26aufirst%3DV.%26aulast%3DCalderone%26aufirst%3DV.%26aulast%3DFragai%26aufirst%3DM.%26aulast%3DLuchinat%26aufirst%3DC.%26aulast%3DSarti%26aufirst%3DN.%26atitle%3DEntropic%2520contribution%2520to%2520the%2520linking%2520coefficient%2520in%2520fragment%2520based%2520drug%2520design%253A%2520A%2520case%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4285%26epage%3D4289%26doi%3D10.1021%2Fjm901723z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopetzki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jekle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubenrauch, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlothauer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilek, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ries, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankuratri, S.</span></span> <span> </span><span class="NLM_article-title">CD4-anchoring hiv-1 fusion inhibitor with enhanced potency and in vivo stability</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">5175</span>– <span class="NLM_lpage">5185</span>, <span class="refDoi"> DOI: 10.1074/jbc.M808745200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1074%2Fjbc.M808745200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=5175-5185&author=C.+Jiauthor=E.+Kopetzkiauthor=A.+Jekleauthor=K.+G.+Stubenrauchauthor=X.+Liuauthor=J.+Zhangauthor=E.+Raoauthor=T.+Schlothauerauthor=S.+Fischerauthor=N.+Cammackauthor=G.+Heilekauthor=S.+Riesauthor=S.+Sankuratri&title=CD4-anchoring+hiv-1+fusion+inhibitor+with+enhanced+potency+and+in+vivo+stability&doi=10.1074%2Fjbc.M808745200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M808745200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M808745200%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DC.%26aulast%3DKopetzki%26aufirst%3DE.%26aulast%3DJekle%26aufirst%3DA.%26aulast%3DStubenrauch%26aufirst%3DK.%2BG.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DE.%26aulast%3DSchlothauer%26aufirst%3DT.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DHeilek%26aufirst%3DG.%26aulast%3DRies%26aufirst%3DS.%26aulast%3DSankuratri%26aufirst%3DS.%26atitle%3DCD4-anchoring%2520hiv-1%2520fusion%2520inhibitor%2520with%2520enhanced%2520potency%2520and%2520in%2520vivo%2520stability%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D5175%26epage%3D5185%26doi%3D10.1074%2Fjbc.M808745200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kagiampakis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharibi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankowski, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alatas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LiWang, P. J.</span></span> <span> </span><span class="NLM_article-title">Potent strategy to inhibit hiv-1 by binding both gp120 and gp41</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1128/AAC.00376-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FAAC.00376-10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=264-275&author=I.+Kagiampakisauthor=A.+Gharibiauthor=M.+K.+Mankowskiauthor=B.+A.+Snyderauthor=R.+G.+Ptakauthor=K.+Alatasauthor=P.+J.+LiWang&title=Potent+strategy+to+inhibit+hiv-1+by+binding+both+gp120+and+gp41&doi=10.1128%2FAAC.00376-10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1128%2FAAC.00376-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00376-10%26sid%3Dliteratum%253Aachs%26aulast%3DKagiampakis%26aufirst%3DI.%26aulast%3DGharibi%26aufirst%3DA.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DSnyder%26aufirst%3DB.%2BA.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DAlatas%26aufirst%3DK.%26aulast%3DLiWang%26aufirst%3DP.%2BJ.%26atitle%3DPotent%2520strategy%2520to%2520inhibit%2520hiv-1%2520by%2520binding%2520both%2520gp120%2520and%2520gp41%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D264%26epage%3D275%26doi%3D10.1128%2FAAC.00376-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopetzki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jekle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankuratri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilek, G.</span></span> <span> </span><span class="NLM_article-title">Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of hiv-1</span>. <i>Virol. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">56</span>, <span class="refDoi"> DOI: 10.1186/1743-422X-5-56</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1186%2F1743-422X-5-56" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=18452606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A280%3ADC%252BD1czktlOrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=56&author=E.+Kopetzkiauthor=A.+Jekleauthor=C.+Jiauthor=E.+Raoauthor=J.+Zhangauthor=S.+Fischerauthor=N.+Cammackauthor=S.+Sankuratriauthor=G.+Heilek&title=Closing+two+doors+of+viral+entry%3A+Intramolecular+combination+of+a+coreceptor-+and+fusion+inhibitor+of+hiv-1&doi=10.1186%2F1743-422X-5-56"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Closing two doors of viral entry: intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1</span></div><div class="casAuthors">Kopetzki Erhard; Jekle Andreas; Ji Changhua; Rao Eileen; Zhang Jun; Fischer Stephan; Cammack Nick; Sankuratri Surya; Heilek Gabrielle</div><div class="citationInfo"><span class="NLM_cas:title">Virology journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We describe a novel strategy in which two inhibitors of HIV viral entry were incorporated into a single molecule.  This bifunctional fusion inhibitor consists of an antibody blocking the binding of HIV to its co-receptor CCR5, and a covalently linked peptide which blocks envelope mediated virus-cell fusion.  This novel bifunctional molecule is highly active on CCR5- and X4-tropic viruses in a single cycle assay and a reporter cell line with IC50 values of 0.03-0.05 nM.  We demonstrated that both inhibitors contribute to the antiviral activity.  In the natural host peripheral blood mononuclear cells (PBMC) the inhibition of CXCR4-tropic viruses is dependant on the co-expression of CCR5 and CXCR4 receptors.  This bifunctional inhibitor may offer potential for improved pharmacokinetic parameters for a fusion inhibitor in humans and the combination of two active antiviral agents in one molecule may provide better durability in controlling the emergence of resistant viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQRY3cZ5prrYbGbPKh4T9eAfW6udTcc2ebd0YdgMxHFurntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czktlOrsg%253D%253D&md5=757aadc315dcc9f4b4a2bdff7f7c2e6d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1186%2F1743-422X-5-56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1743-422X-5-56%26sid%3Dliteratum%253Aachs%26aulast%3DKopetzki%26aufirst%3DE.%26aulast%3DJekle%26aufirst%3DA.%26aulast%3DJi%26aufirst%3DC.%26aulast%3DRao%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DSankuratri%26aufirst%3DS.%26aulast%3DHeilek%26aufirst%3DG.%26atitle%3DClosing%2520two%2520doors%2520of%2520viral%2520entry%253A%2520Intramolecular%2520combination%2520of%2520a%2520coreceptor-%2520and%2520fusion%2520inhibitor%2520of%2520hiv-1%26jtitle%3DVirol.%2520J.%26date%3D2008%26volume%3D5%26spage%3D56%26doi%3D10.1186%2F1743-422X-5-56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parajuli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashad, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I. M.</span></span> <span> </span><span class="NLM_article-title">Lytic inactivation of human immunodeficiency virus by dual engagement of gp120 and gp41 domains in the virus env protein trimer</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6100</span>– <span class="NLM_lpage">6114</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.6b00570</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.6b00570" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1GrurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=6100-6114&author=B.+Parajuliauthor=K.+Acharyaauthor=R.+Yuauthor=B.+Ngoauthor=A.+A.+Rashadauthor=C.+F.+Abramsauthor=I.+M.+Chaiken&title=Lytic+inactivation+of+human+immunodeficiency+virus+by+dual+engagement+of+gp120+and+gp41+domains+in+the+virus+env+protein+trimer&doi=10.1021%2Facs.biochem.6b00570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Lytic inactivation of human immunodeficiency virus by dual engagement of gp120 and gp41 domains in the virus Env protein trimer</span></div><div class="casAuthors">Parajuli, Bibek; Acharya, Kriti; Yu, Reina; Ngo, Brendon; Rashad, Adel A.; Abrams, Cameron F.; Chaiken, Irwin M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">6100-6114</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors recently reported the discovery of a recombinant chimera, denoted DAVEI (dual-acting virucidal entry inhibitor), which was able to selectively cause specific and potent lytic inactivation of both pseudotyped and fully infectious human immunodeficiency virus (HIV-1) virions.  The chimera was composed of the lectin cyanovirin-N (CVN) fused to the 20-residue membrane-proximal external region (MPER) of HIV-1 gp41.  Because the Env gp120-binding CVN domain on its own is not lytic, the authors sought here to det. how the MPER(DAVEI) domain is able to endow the chimera with virolytic activity.  The authors used a protein engineering strategy to identify mol. determinants of MPER(DAVEI) that were important for function.  Recombinant mutagenesis and truncation demonstrated that the MPER(DAVEI) domain could be significantly minimized without loss of function.  The dependence of lysis on specific MPER sequences of DAVEI, detn. of minimal linker length, and competition by a simplified MPER surrogate peptide suggested that the MPER domain of DAVEI interacts with the Env spike trimer, likely with the gp41 region.  This conclusion was further supported by observations from binding of the biotinylated MPER surrogate peptide to Env protein expressed on cells, monoclonal antibody competition, a direct binding ELISA on viruses with varying nos. of trimeric spikes on their surfaces, and comparison of maximal interdomain spacing in DAVEI to that in high-resoln. structures of Env.  The finding that MPER(DAVEI) in CVN-MPER linker sequences could be minimized without loss of virolytic function provides an improved exptl. path for constructing size-minimized DAVEI chimeras and mol. tools for detg. how simultaneous engagement of gp120 and gp41 by these chimeras can disrupt the metastable virus Env spike.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBDfNfVUqtC7Vg90H21EOLACvtfcHk0lj7usxNBV5GFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1GrurjK&md5=649cf20617e6d9aa6ad8ba33e87a4266</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.6b00570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.6b00570%26sid%3Dliteratum%253Aachs%26aulast%3DParajuli%26aufirst%3DB.%26aulast%3DAcharya%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DNgo%26aufirst%3DB.%26aulast%3DRashad%26aufirst%3DA.%2BA.%26aulast%3DAbrams%26aufirst%3DC.%2BF.%26aulast%3DChaiken%26aufirst%3DI.%2BM.%26atitle%3DLytic%2520inactivation%2520of%2520human%2520immunodeficiency%2520virus%2520by%2520dual%2520engagement%2520of%2520gp120%2520and%2520gp41%2520domains%2520in%2520the%2520virus%2520env%2520protein%2520trimer%26jtitle%3DBiochemistry%26date%3D2016%26volume%3D55%26spage%3D6100%26epage%3D6114%26doi%3D10.1021%2Facs.biochem.6b00570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quinlan, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebrahimi, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farzan, M.</span></span> <span> </span><span class="NLM_article-title">A double-mimetic peptide efficiently neutralizes hiv-1 by bridging the CD4- and coreceptor-binding sites of gp120</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">3353</span>– <span class="NLM_lpage">3358</span>, <span class="refDoi"> DOI: 10.1128/JVI.03800-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FJVI.03800-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=24390333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVOqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2014&pages=3353-3358&author=B.+D.+Quinlanauthor=V.+R.+Joshiauthor=M.+R.+Gardnerauthor=K.+H.+Ebrahimiauthor=M.+Farzan&title=A+double-mimetic+peptide+efficiently+neutralizes+hiv-1+by+bridging+the+CD4-+and+coreceptor-binding+sites+of+gp120&doi=10.1128%2FJVI.03800-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A double-mimetic peptide efficiently neutralizes HIV-1 by bridging the CD4- and coreceptor-binding sites of gp120</span></div><div class="casAuthors">Quinlan, Brian D.; Joshi, Vinita R.; Gardner, Matthew R.; Ebrahimi, Kourosh H.; Farzan, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3353-3358, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The HIV-1 envelope glycoprotein binds cooperatively to its cellular receptor CD4 and a coreceptor, principally CXCR4 or CCR5.  The authors have previously improved a natural amino-acid form of a scorpion toxin-derived CD4-mimetic peptide and in parallel generated sulfopeptide mimetics of the CCR5 amino terminus.  Here the authors show that some fusions of these CCR5- and CD4-mimetic peptides, expressed as immunoadhesins, neutralize HIV-1 more efficiently than CD4-Fc or equimolar mixts. of immunoadhesin forms of each peptide.  Specifically, double-mimetic peptides with linkers of 11 amino acids or greater, and with the CCR5-mimetic component preceding the CD4-mimetic component, were more efficient than constructs with shorter linkers or in a reverse orientation.  The potency of these constructs derives from (i) their ability to simultaneously and cooperatively bind the CD4- and CCR5-binding sites of a single gp120 monomer of the HIV-1 envelope glycoprotein trimer and (ii) the ability of the CCR5-mimetic component to prevent the CD4-mimetic peptide from promoting infection when cellular CD4 is limiting.  Thus, there is a significant advantage to simultaneously targeting both conserved regions of the HIV-1 envelope glycoprotein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr88wqaM8jg0bVg90H21EOLACvtfcHk0lj7usxNBV5GFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVOqsrY%253D&md5=f28889bd475cb5d560782ee46d44a0a7</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1128%2FJVI.03800-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.03800-13%26sid%3Dliteratum%253Aachs%26aulast%3DQuinlan%26aufirst%3DB.%2BD.%26aulast%3DJoshi%26aufirst%3DV.%2BR.%26aulast%3DGardner%26aufirst%3DM.%2BR.%26aulast%3DEbrahimi%26aufirst%3DK.%2BH.%26aulast%3DFarzan%26aufirst%3DM.%26atitle%3DA%2520double-mimetic%2520peptide%2520efficiently%2520neutralizes%2520hiv-1%2520by%2520bridging%2520the%2520CD4-%2520and%2520coreceptor-binding%2520sites%2520of%2520gp120%26jtitle%3DJ.%2520Virol%26date%3D2014%26volume%3D88%26spage%3D3353%26epage%3D3358%26doi%3D10.1128%2FJVI.03800-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankowski, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liwang, P. J.</span></span> <span> </span><span class="NLM_article-title">Highly potent chimeric inhibitors targeting two steps of hiv cell entry</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">28370</span>– <span class="NLM_lpage">28381</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.234799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1074%2Fjbc.M111.234799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=21659523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsl2msb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=28370-28381&author=B.+Zhaoauthor=M.+K.+Mankowskiauthor=B.+A.+Snyderauthor=R.+G.+Ptakauthor=P.+J.+Liwang&title=Highly+potent+chimeric+inhibitors+targeting+two+steps+of+hiv+cell+entry&doi=10.1074%2Fjbc.M111.234799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry</span></div><div class="casAuthors">Zhao, Bo; Mankowski, Marie K.; Snyder, Beth A.; Ptak, Roger G.; LiWang, Patricia J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">28370-28381, S28370/1-S28370/5</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Blocking HIV-1 cell entry has long been a major goal of anti-HIV drug development.  Here, we report a successful design of two highly potent chimeric HIV entry inhibitors composed of one CCR5-targeting RANTES (regulated on activation normal T cell expressed and secreted) variant (5P12-RANTES or 5P14-RANTES (Gaertner, H., Cerini, F., Escola, J. M., Kuenzi, G., Melotti, A., Offord, R., Rossitto-Borlat, I., Nedellec, R., Salkowitz, J., Gorochov, G., Mosier, D., and Hartley, O. (2008) PROC: Natl. Acad. Sci. U.S.A. 105, 17706-17711)) linked to a gp41 fusion inhibitor, C37.  Chimeric inhibitors 5P12-linker-C37 and 5P14-linker-C37 showed extremely high antiviral potency in single cycle and replication-competent viral assays against R5-tropic viruses, with IC50 values as low as 0.004 nM.  This inhibition was somewhat strain-dependent and was up to 100-fold better than the RANTES variant alone or in combination with unlinked C37.  The chimeric inhibitors also fully retained the antiviral activity of C37 against X4-tropic viruses, and this inhibition can be further enhanced significantly if the target cell co-expresses CCR5 receptor.  On human peripheral blood mononuclear cells, the inhibitors showed very strong inhibition against R5-tropic Ba-L strain and X4-tropic IIIB strain, with IC50 values as low as 0.015 and 0.44 nM, which are 45- and 16-fold better than the parent inhibitors, resp.  A clear delivery mechanism requiring a covalent linkage between the two segments of the chimera was obsd. and characterized.  Furthermore, the two chimeric inhibitors are fully recombinant and are easily produced at low cost.  These attributes make them excellent candidates for anti-HIV microbicides.  The results of this study also suggest a potent approach for optimizing existing HIV entry inhibitors or designing new inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_mgPhkmOu-bVg90H21EOLACvtfcHk0lj7usxNBV5GFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsl2msb4%253D&md5=b8599136ca194462a3332b9b8b91495d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.234799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.234799%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DSnyder%26aufirst%3DB.%2BA.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DLiwang%26aufirst%3DP.%2BJ.%26atitle%3DHighly%2520potent%2520chimeric%2520inhibitors%2520targeting%2520two%2520steps%2520of%2520hiv%2520cell%2520entry%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D28370%26epage%3D28381%26doi%3D10.1074%2Fjbc.M111.234799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Munoz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyrhaug, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vega, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Fernandez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santiago, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frade, J. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellado, M.</span></span> <span> </span><span class="NLM_article-title">CCR5/CD4/CXCR4 oligomerization prevents hiv-1 gp120iiib binding to the cell surface</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">E1960</span>– <span class="NLM_lpage">E1969</span>, <span class="refDoi"> DOI: 10.1073/pnas.1322887111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1073%2Fpnas.1322887111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=24778234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntFGisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E1960-E1969&author=L.+Martinez-Munozauthor=R.+Barrosoauthor=S.+Y.+Dyrhaugauthor=G.+Navarroauthor=P.+Lucasauthor=S.+F.+Sorianoauthor=B.+Vegaauthor=C.+Costasauthor=M.+A.+Munoz-Fernandezauthor=C.+Santiagoauthor=J.+M.+R.+Fradeauthor=R.+Francoauthor=M.+Mellado&title=CCR5%2FCD4%2FCXCR4+oligomerization+prevents+hiv-1+gp120iiib+binding+to+the+cell+surface&doi=10.1073%2Fpnas.1322887111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">CCR5/CD4/CXCR4 oligomerization prevents HIV-1 gp120IIIB binding to the cell surface</span></div><div class="casAuthors">Martinez-Munoz, Laura; Barroso, Ruben; Dyrhaug, Sunniva Y.; Navarro, Gemma; Lucas, Pilar; Soriano, Silvia F.; Vega, Beatriz; Costas, Coloma; Munoz-Fernandez, M. Angeles; Santiago, Cesar; Rodriguez Frade, Jose Miguel; Franco, Rafael; Mellado, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">E1960-E1969</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">CCR5 and CXCR4, the resp. cell surface coreceptors of R5 and X4 HIV-1 strains, both form heterodimers with CD4, the principal HIV-1 receptor.  Using several resonance energy transfer techniques, the authors detd. that CD4, CXCR4, and CCR5 formed heterotrimers, and that CCR5 coexpression altered the conformation of both CXCR4/CXCR4 homodimers and CD4/CXCR4 heterodimers.  As a result, binding of the HIV-1 envelope protein gp120IIIB to the CD4/CXCR4/CCR5 heterooligomer was negligible, and the gp120-induced cytoskeletal rearrangements necessary for HIV-1 entry were prevented.  CCR5 reduced HIV-1 envelope-induced CD4/CXCR4-mediated cell-cell fusion.  In nucleofected Jurkat CD4 cells and primary human CD4+ T cells, CCR5 expression led to a redn. in X4 HIV-1 infectivity.  These findings can help to understand why X4 HIV-1 strains infection affect T-cell types differently during AIDS development and indicate that receptor oligomerization might be a target for previously unidentified therapeutic approaches for AIDS intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQPlvOBqnKq7Vg90H21EOLACvtfcHk0lg35D0MRKAk5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntFGisrg%253D&md5=c701d21034823dd22e9cf14cc1839a38</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1322887111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1322887111%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Munoz%26aufirst%3DL.%26aulast%3DBarroso%26aufirst%3DR.%26aulast%3DDyrhaug%26aufirst%3DS.%2BY.%26aulast%3DNavarro%26aufirst%3DG.%26aulast%3DLucas%26aufirst%3DP.%26aulast%3DSoriano%26aufirst%3DS.%2BF.%26aulast%3DVega%26aufirst%3DB.%26aulast%3DCostas%26aufirst%3DC.%26aulast%3DMunoz-Fernandez%26aufirst%3DM.%2BA.%26aulast%3DSantiago%26aufirst%3DC.%26aulast%3DFrade%26aufirst%3DJ.%2BM.%2BR.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DMellado%26aufirst%3DM.%26atitle%3DCCR5%252FCD4%252FCXCR4%2520oligomerization%2520prevents%2520hiv-1%2520gp120iiib%2520binding%2520to%2520the%2520cell%2520surface%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3DE1960%26epage%3DE1969%26doi%3D10.1073%2Fpnas.1322887111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feyertag, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meehan, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travers, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, D. L.</span></span> <span> </span><span class="NLM_article-title">Characterizing the diverse mutational pathways associated with r5-tropic maraviroc resistance: Hiv-1 that uses the drug-bound CCR5 coreceptor</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">11457</span>– <span class="NLM_lpage">11472</span>, <span class="refDoi"> DOI: 10.1128/JVI.01384-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FJVI.01384-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=26339063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslymtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=11457-11472&author=X.+Jiangauthor=F.+Feyertagauthor=C.+J.+Meehanauthor=G.+P.+McCormackauthor=S.+A.+Traversauthor=C.+Craigauthor=M.+Westbyauthor=M.+Lewisauthor=D.+L.+Robertson&title=Characterizing+the+diverse+mutational+pathways+associated+with+r5-tropic+maraviroc+resistance%3A+Hiv-1+that+uses+the+drug-bound+CCR5+coreceptor&doi=10.1128%2FJVI.01384-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Characterizing the diverse mutational pathways associated with R5-tropic maraviroc resistance: HIV-1 that uses the drug-bound CCR5 coreceptor</span></div><div class="casAuthors">Jiang, Xiaowei; Feyertag, Felix; Meehan, Conor J.; McCormack, Grace P.; Travers, Simon A.; Craig, Charles; Westby, Mike; Lewis, Marilyn; Robertson, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">11457-11472</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Entry inhibitors represent a potent class of antiretroviral drugs that target a host cell protein, CCR5, an HIV-1 entry coreceptor, and not viral protein.  Lack of sensitivity can occur due to preexisting virus that uses the CXCR4 coreceptor, while true resistance occurs through viral adaptation to use a drug-bound CCR5 coreceptor.  To understand this R5 resistance pathway, we analyzed >500 envelope protein sequences and phenotypes from viruses of 20 patients from the clin. trials MOTIVATE 1 and 2, in which treatment-experienced patients received maraviroc plus optimized background therapy.  The resistant viral population was phylogenetically distinct and assocd. with a genetic bottleneck in each patient, consistent with de novo emergence of resistance.  Recombination anal. showed that the C2-V3-C3 region tends to genotypically correspond to the recombinant's phenotype, indicating its primary importance in conferring resistance.  Between patients, there was a notable lack of commonality in the specific sites conferring resistance, confirming the unusual nature of R5-tropic resistance.  We used coevolutionary and pos.-selection analyses to characterize the genotypic determinants of resistance and found that (i) there are complicated covariation networks, indicating frequent coevolutionary/compensatory changes in the context of protein structure; (ii) covarying sites under pos. selection are enriched in resistant viruses; (iii) CD4 binding sites form part of a unique covariation network independent of the V3 loop; and (iv) the covariation network formed between the V3 loop and other regions of gp120 and gp41 intersects sites involved in glycosylation and protein secretion.  These results demonstrate that while envelope sequence mutations are the key to conferring maraviroc resistance, the specific changes involved are context dependent and thus inherently unpredictable.  Sequences were deposited in GenBank under accession nos. KT452084 to KT452622.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDh62iRXiFIrVg90H21EOLACvtfcHk0lg35D0MRKAk5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslymtb%252FN&md5=ab7ed5de98f7b010383a1698fc4bb985</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FJVI.01384-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01384-15%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DFeyertag%26aufirst%3DF.%26aulast%3DMeehan%26aufirst%3DC.%2BJ.%26aulast%3DMcCormack%26aufirst%3DG.%2BP.%26aulast%3DTravers%26aufirst%3DS.%2BA.%26aulast%3DCraig%26aufirst%3DC.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DRobertson%26aufirst%3DD.%2BL.%26atitle%3DCharacterizing%2520the%2520diverse%2520mutational%2520pathways%2520associated%2520with%2520r5-tropic%2520maraviroc%2520resistance%253A%2520Hiv-1%2520that%2520uses%2520the%2520drug-bound%2520CCR5%2520coreceptor%26jtitle%3DJ.%2520Virol.%26date%3D2015%26volume%3D89%26spage%3D11457%26epage%3D11472%26doi%3D10.1128%2FJVI.01384-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rashad, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haftl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aneja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Chemical optimization of macrocyclic hiv-1 inactivators for improving potency and increasing the structural diversity at the triazole ring</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">7770</span>– <span class="NLM_lpage">7782</span>, <span class="refDoi"> DOI: 10.1039/C7OB01448A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1039%2FC7OB01448A" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=7770-7782&author=A.+A.+Rashadauthor=K.+Acharyaauthor=A.+Haftlauthor=R.+Anejaauthor=A.+Dickauthor=A.+P.+Holmesauthor=I.+Chaiken&title=Chemical+optimization+of+macrocyclic+hiv-1+inactivators+for+improving+potency+and+increasing+the+structural+diversity+at+the+triazole+ring&doi=10.1039%2FC7OB01448A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1039%2FC7OB01448A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7OB01448A%26sid%3Dliteratum%253Aachs%26aulast%3DRashad%26aufirst%3DA.%2BA.%26aulast%3DAcharya%26aufirst%3DK.%26aulast%3DHaftl%26aufirst%3DA.%26aulast%3DAneja%26aufirst%3DR.%26aulast%3DDick%26aufirst%3DA.%26aulast%3DHolmes%26aufirst%3DA.%2BP.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DChemical%2520optimization%2520of%2520macrocyclic%2520hiv-1%2520inactivators%2520for%2520improving%2520potency%2520and%2520increasing%2520the%2520structural%2520diversity%2520at%2520the%2520triazole%2520ring%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2017%26volume%3D15%26spage%3D7770%26epage%3D7782%26doi%3D10.1039%2FC7OB01448A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clercq, E.</span></span> <span> </span><span class="NLM_article-title">The bicyclam amd3100 story</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">587</span>, <span class="refDoi"> DOI: 10.1038/nrd1134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1038%2Fnrd1134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=12815382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1Oqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=581-587&author=E.+De%0AClercq&title=The+bicyclam+amd3100+story&doi=10.1038%2Fnrd1134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Timeline: The bicyclam AMD3100 story</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">581-587</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery and development of the bicyclam AMD3100 - a chemokine receptor antagonist - has highlighted the therapeutic potential of such compds. in HIV infection, inflammatory diseases, cancer and stem-cell mobilization.  Here, the author describes the development process of AMD3100, which began about 15 yr ago with the isolation of an impurity, and the basis for the clin. application of AMD3100 and its congeners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB-TkHJ79RrbVg90H21EOLACvtfcHk0lgzENqzmzY7gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1Oqsr8%253D&md5=cf8344ba0e19da8ffaadfe8c9b57200c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnrd1134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1134%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520bicyclam%2520amd3100%2520story%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D581%26epage%3D587%26doi%3D10.1038%2Fnrd1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. Q.</span>; <span class="NLM_string-name">Cao, B.</span>; <span class="NLM_string-name">Xie, X.</span>; <span class="NLM_string-name">Wei, W.</span></span> <span> </span><span class="NLM_article-title">Imidazopyridines as CXCR4 Antagonists and Their Preparation, Pharmaceutical Compositions and Use In The Treatment Of Diseases</span>. <span class="NLM_patent">CN 102675305</span>, Sept 19, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=Y.+Q.+Long&author=B.+Cao&author=X.+Xie&author=W.+Wei&title=Imidazopyridines+as+CXCR4+Antagonists+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+In+The+Treatment+Of+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DImidazopyridines%2520as%2520CXCR4%2520Antagonists%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520In%2520The%2520Treatment%2520Of%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-link1"><div class="reference"><strong class="refLabel"><a href="#link1" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-link1_1"><span><span> </span><span class="NLM_article-title">Openeye
Scientific Software Home Page</span>. <a href="http://www.eyesopen.com" class="extLink">http://www.eyesopen.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Openeye%0AScientific+Software+Home+Page.+http%3A%2F%2Fwww.eyesopen.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=link1_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DOpeneye%250AScientific%2520Software%2520Home%2520Page" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madhavi
Sastry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adzhigirey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annabhimoju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+Madhavi%0ASastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+ligand+preparation%3A+Parameters%2C+protocols%2C+and+influence+on+virtual+screening+enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Madhavi Sastry, G.; Adzhigirey, Matvey; Day, Tyler; Annabhimoju, Ramakrishna; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-234</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepd. prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove at. clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addn., ligands must be prepd. to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system prepn. is generally accepted in the field, an extensive study of the prepn. steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in prepg. a system for virtual screening.  We first explore a large no. of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper prepn. and that neglecting certain steps of the prepn. process produces a systematic degrdn. in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the prepn. that impact database enrichment.  While the work presented here was performed with the Protein Prepn. Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruqN5nIOJtR7Vg90H21EOLACvtfcHk0lgzENqzmzY7gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D&md5=259a6d547ef3e1310e091fb50fe8de16</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DMadhavi%2BSastry%26aufirst%3DG.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520ligand%2520preparation%253A%2520Parameters%252C%2520protocols%252C%2520and%2520influence%2520on%2520virtual%2520screening%2520enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashad, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klasse, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Recognition of hiv-inactivating peptide triazoles by the recombinant soluble env trimer, bg505 sosip.664</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1002/prot.25238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1002%2Fprot.25238" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2017&pages=843-851&author=K.+Acharyaauthor=A.+A.+Rashadauthor=F.+Moracaauthor=P.+J.+Klasseauthor=J.+P.+Mooreauthor=C.+Abramsauthor=I.+Chaiken&title=Recognition+of+hiv-inactivating+peptide+triazoles+by+the+recombinant+soluble+env+trimer%2C+bg505+sosip.664&doi=10.1002%2Fprot.25238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fprot.25238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.25238%26sid%3Dliteratum%253Aachs%26aulast%3DAcharya%26aufirst%3DK.%26aulast%3DRashad%26aufirst%3DA.%2BA.%26aulast%3DMoraca%26aufirst%3DF.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DAbrams%26aufirst%3DC.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DRecognition%2520of%2520hiv-inactivating%2520peptide%2520triazoles%2520by%2520the%2520recombinant%2520soluble%2520env%2520trimer%252C%2520bg505%2520sosip.664%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2017%26volume%3D85%26spage%3D843%26epage%3D851%26doi%3D10.1002%2Fprot.25238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R.</span>; <span class="NLM_string-name">Repasky, M.</span>; <span class="NLM_string-name">Zhou, Z.
Y.</span>; <span class="NLM_string-name">Abel, R.</span>; <span class="NLM_string-name">Krilov, G.</span>; <span class="NLM_string-name">Tubert-Brohman, I.</span>; <span class="NLM_string-name">Sherman, W.</span>; <span class="NLM_string-name">Farid, R.</span>; <span class="NLM_string-name">Friesner, R. A.</span></span><span> </span><span class="NLM_article-title">Evaluation of docking and scoring accuracy using a new version of schrodinger’s glide xp and induced fit docking (ifd) methodologies</span>. Presented at the 241st ACS National Meeting & Exposition, Anaheim, CA, March 27–31, <span class="NLM_year">2011</span>; Paper 93.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+Murphy&author=M.+Repasky&author=Z.%0AY.+Zhou&author=R.+Abel&author=G.+Krilov&author=I.+Tubert-Brohman&author=W.+Sherman&author=R.+Farid&author=R.+A.+Friesner&title=Evaluation+of+docking+and+scoring+accuracy+using+a+new+version+of+schrodinger%E2%80%99s+glide+xp+and+induced+fit+docking+%28ifd%29+methodologies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DR.%26atitle%3DEvaluation%2520of%2520docking%2520and%2520scoring%2520accuracy%2520using%2520a%2520new%2520version%2520of%2520schrodinger%25E2%2580%2599s%2520glide%2520xp%2520and%2520induced%2520fit%2520docking%2520%2528ifd%2529%2520methodologies%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korotvička, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deiana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kullberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Córdova, A.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis of maraviroc (uk-427,857)</span>. <i>Adv. Synth. Catal.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">2291</span>– <span class="NLM_lpage">2298</span>, <span class="refDoi"> DOI: 10.1002/adsc.201000287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1002%2Fadsc.201000287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFyhsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2010&pages=2291-2298&author=G.+L.+Zhaoauthor=S.+Linauthor=A.+Korotvi%C4%8Dkaauthor=L.+Deianaauthor=M.+Kullbergauthor=A.+C%C3%B3rdova&title=Asymmetric+synthesis+of+maraviroc+%28uk-427%2C857%29&doi=10.1002%2Fadsc.201000287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis of Maraviroc (UK-427,857)</span></div><div class="casAuthors">Zhao, Gui-Ling; Lin, Shuangzheng; Korotvicka, Ales; Deiana, Luca; Kullberg, Martin; Cordova, Armando</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Synthesis & Catalysis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2291-2298</span>CODEN:
                <span class="NLM_cas:coden">ASCAF7</span>;
        ISSN:<span class="NLM_cas:issn">1615-4150</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The asym. synthesis of Maraviroc (UK-427,857, I), a chemokine receptor 5 (CCR-5) receptor antagonist, is presented.  The key step involves an expeditious organocatalytic enantioselective assembly of the chiral β-amino aldehyde fragment via aza-Michael addn. of hydroxylamines to cinnamaldehydes.  The reactions were performed on a gram-scale and allow for the rapid construction of new Maraviroc analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr32V1A-BoeTLVg90H21EOLACvtfcHk0lgeJGSQvG6OGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFyhsL3L&md5=708d720f9f4ccf30357f552fa011919c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fadsc.201000287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadsc.201000287%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DG.%2BL.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DKorotvi%25C4%258Dka%26aufirst%3DA.%26aulast%3DDeiana%26aufirst%3DL.%26aulast%3DKullberg%26aufirst%3DM.%26aulast%3DC%25C3%25B3rdova%26aufirst%3DA.%26atitle%3DAsymmetric%2520synthesis%2520of%2520maraviroc%2520%2528uk-427%252C857%2529%26jtitle%3DAdv.%2520Synth.%2520Catal.%26date%3D2010%26volume%3D352%26spage%3D2291%26epage%3D2298%26doi%3D10.1002%2Fadsc.201000287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haycock-Lewandowski, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Åhman, J.</span></span> <span> </span><span class="NLM_article-title">Development of a bulk enabling route to maraviroc (uk-427,857), a ccr-5 receptor antagonist</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1094</span>– <span class="NLM_lpage">1103</span>, <span class="refDoi"> DOI: 10.1021/op8000614</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op8000614" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Sjt7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=1094-1103&author=S.+J.+Haycock-Lewandowskiauthor=A.+Wilderauthor=J.+%C3%85hman&title=Development+of+a+bulk+enabling+route+to+maraviroc+%28uk-427%2C857%29%2C+a+ccr-5+receptor+antagonist&doi=10.1021%2Fop8000614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Bulk Enabling Route to Maraviroc (UK-427,857), a CCR-5 Receptor Antagonist</span></div><div class="casAuthors">Haycock-Lewandowski, Sarah J.; Wilder, Alexander; Ahman, Jens</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1094-1103</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The bulk enabling synthesis of the CCR-5 receptor antagonist, Maraviroc (UK-427,857), was developed and is described.  Synthesis of the three key fragments, β-amino ester, 4,4-difluorohexanecarboxylic acid and 1,3,4-triazole-substituted tropane fragment are described.  Coupling strategies for these fragments are discussed and described, including synthetic challenges, protection strategies, impurity generation, and final scale-up of the developed route to Maraviroc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCJVxz_3HJqbVg90H21EOLACvtfcHk0lgeJGSQvG6OGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Sjt7nK&md5=2ab71c7866d3ac4bd7d9caa4cd0e0fea</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fop8000614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop8000614%26sid%3Dliteratum%253Aachs%26aulast%3DHaycock-Lewandowski%26aufirst%3DS.%2BJ.%26aulast%3DWilder%26aufirst%3DA.%26aulast%3D%25C3%2585hman%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520a%2520bulk%2520enabling%2520route%2520to%2520maraviroc%2520%2528uk-427%252C857%2529%252C%2520a%2520ccr-5%2520receptor%2520antagonist%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2008%26volume%3D12%26spage%3D1094%26epage%3D1103%26doi%3D10.1021%2Fop8000614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrilyuk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbas, C. F.,  3rd</span></span> <span> </span><span class="NLM_article-title">Preparation and activities of macromolecule conjugates of the CCR5 antagonist maraviroc</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1021/ml400370w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400370w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOntr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=133-137&author=S.+Asanoauthor=J.+Gavrilyukauthor=D.+R.+Burtonauthor=C.+F.+Barbas&title=Preparation+and+activities+of+macromolecule+conjugates+of+the+CCR5+antagonist+maraviroc&doi=10.1021%2Fml400370w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and activities of macromolecule conjugates of the CCR5 antagonist Maraviroc</span></div><div class="casAuthors">Asano, Shigehiro; Gavrilyuk, Julia; Burton, Dennis R.; Barbas, Carlos F., III</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-137</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CCR5 antagonists are among the most advanced approaches in HIV therapy and may also be relevant to treatment of graft-vs.-host disease and Staphylococcus aureus infection.  To expand the potential of the only approved CCR5 antagonist, Maraviroc, we studied derivs. that would enable functional linkage of Maraviroc to long-lived carriers.  Through targeted synthesis, we discovered an effective linkage site on Maraviroc and demonstrate the potential of these derivs. to prep. potent chem. programmed antibodies and PEGylated derivs.  The resulting compds. effectively neutralized a variety of HIV-1 isolates.  Both chem. programmed antibody and PEGylation approaches extend the neutralization activity of serum circulating Maraviroc.  Derivation of a successful conjugation strategy for Maraviroc should further enable its use in chem. programmed vaccines, novel bispecific antibodies, and topical microbicides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3dDcVML2YWbVg90H21EOLACvtfcHk0lgeJGSQvG6OGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOntr3P&md5=ea7c9d3c1c6161e1115a9a67de4bcce3</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fml400370w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400370w%26sid%3Dliteratum%253Aachs%26aulast%3DAsano%26aufirst%3DS.%26aulast%3DGavrilyuk%26aufirst%3DJ.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DBarbas%26aufirst%3DC.%2BF.%26atitle%3DPreparation%2520and%2520activities%2520of%2520macromolecule%2520conjugates%2520of%2520the%2520CCR5%2520antagonist%2520maraviroc%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D133%26epage%3D137%26doi%3D10.1021%2Fml400370w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiely, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutt, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culbertson, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucsh, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worth, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesheski, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogliotti, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sesnie, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mich, T. F.</span></span> <span> </span><span class="NLM_article-title">Quinolone antibacterials: Preparation and activity of bridged bicyclic analogues of the c7-piperazine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1021/jm00106a029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00106a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=656-663&author=J.+S.+Kielyauthor=M.+P.+Huttauthor=T.+P.+Culbertsonauthor=R.+A.+Bucshauthor=D.+F.+Worthauthor=L.+E.+Lesheskiauthor=R.+D.+Gogliottiauthor=J.+C.+Sesnieauthor=M.+Solomonauthor=T.+F.+Mich&title=Quinolone+antibacterials%3A+Preparation+and+activity+of+bridged+bicyclic+analogues+of+the+c7-piperazine&doi=10.1021%2Fjm00106a029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm00106a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00106a029%26sid%3Dliteratum%253Aachs%26aulast%3DKiely%26aufirst%3DJ.%2BS.%26aulast%3DHutt%26aufirst%3DM.%2BP.%26aulast%3DCulbertson%26aufirst%3DT.%2BP.%26aulast%3DBucsh%26aufirst%3DR.%2BA.%26aulast%3DWorth%26aufirst%3DD.%2BF.%26aulast%3DLesheski%26aufirst%3DL.%2BE.%26aulast%3DGogliotti%26aufirst%3DR.%2BD.%26aulast%3DSesnie%26aufirst%3DJ.%2BC.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DMich%26aufirst%3DT.%2BF.%26atitle%3DQuinolone%2520antibacterials%253A%2520Preparation%2520and%2520activity%2520of%2520bridged%2520bicyclic%2520analogues%2520of%2520the%2520c7-piperazine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D656%26epage%3D663%26doi%3D10.1021%2Fjm00106a029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel 2-methylpiperazine derivatives as potent CCR5 antagonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1168</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.12.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1016%2Fj.bmc.2014.12.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1157-1168&author=S.+Huauthor=Z.+Wangauthor=T.+Houauthor=X.+Maauthor=J.+Liauthor=T.+Liuauthor=X.+Xieauthor=Y.+Hu&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+2-methylpiperazine+derivatives+as+potent+CCR5+antagonists&doi=10.1016%2Fj.bmc.2014.12.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.12.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.12.052%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%25202-methylpiperazine%2520derivatives%2520as%2520potent%2520CCR5%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D1157%26epage%3D1168%26doi%3D10.1016%2Fj.bmc.2014.12.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bastian, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contarino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aneja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emileh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoxie, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Interactions of peptide triazole thiols with env gp120 induce irreversible breakdown and inactivation of hiv-1 virions</span>. <i>Retrovirology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">153</span>, <span class="refDoi"> DOI: 10.1186/1742-4690-10-153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1186%2F1742-4690-10-153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=24330857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFagurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=153&author=A.+R.+Bastianauthor=M.+Contarinoauthor=L.+D.+Baileyauthor=R.+Anejaauthor=D.+R.+Moreiraauthor=K.+Freedmanauthor=K.+McFaddenauthor=C.+Duffyauthor=A.+Emilehauthor=G.+Leslieauthor=J.+M.+Jacobsonauthor=J.+A.+Hoxieauthor=I.+Chaiken&title=Interactions+of+peptide+triazole+thiols+with+env+gp120+induce+irreversible+breakdown+and+inactivation+of+hiv-1+virions&doi=10.1186%2F1742-4690-10-153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of peptide triazole thiols with Env gp120 induce irreversible breakdown and inactivation of HIV-1 virions</span></div><div class="casAuthors">Bastian, Arangassery Rosemary; Contarino, Mark; Bailey, Lauren D.; Aneja, Rachna; Moreira, Diogo Rodrigo Magalhaes; Freedman, Kevin; McFadden, Karyn; Duffy, Caitlin; Emileh, Ali; Leslie, George; Jacobson, Jeffrey M.; Hoxie, James A.; Chaiken, Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Retrovirology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">153/1-153/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">RETRBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-4690</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: We examd. the underlying mechanism of action of the peptide triazole thiol, KR13 that has been shown previously to specifically bind gp120, block cell receptor site interactions and potently inhibit HIV-1 infectivity.  Results: KR13, the sulfhydryl blocked KR13b and its parent non-sulfhydryl peptide triazole, HNG156, induced gp120 shedding but only KR13 induced p24 capsid protein release.  The resulting virion post virolysis had an altered morphol., contained no gp120, but retained gp41 that bound to neutralizing gp41 antibodies.  Remarkably, HIV-1 p24 release by KR13 was inhibited by enfuvirtide, which blocks formation of the gp41 6-helix bundle during membrane fusion, while no inhibition of p24 release occurred for enfuvirtide-resistant virus.  KR13 thus appears to induce structural changes in gp41 normally assocd. with membrane fusion and cell entry.  The HIV-1 p24 release induced by KR13 was obsd. in several clades of HIV-1 as well as in fully infectious HIV-1 virions.  Conclusions: The antiviral activity of KR13 and its ability to inactivate virions prior to target cell engagement suggest that peptide triazole thiols could be highly effective in inhibiting HIV transmission across mucosal barriers and provide a novel probe to understand biochem. signals within envelope that are involved in membrane fusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJgYkvSx2m57Vg90H21EOLACvtfcHk0ljkNwmjV6lt4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFagurY%253D&md5=3a018d2f8f61818077c65af94c339267</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-10-153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-10-153%26sid%3Dliteratum%253Aachs%26aulast%3DBastian%26aufirst%3DA.%2BR.%26aulast%3DContarino%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DL.%2BD.%26aulast%3DAneja%26aufirst%3DR.%26aulast%3DMoreira%26aufirst%3DD.%2BR.%26aulast%3DFreedman%26aufirst%3DK.%26aulast%3DMcFadden%26aufirst%3DK.%26aulast%3DDuffy%26aufirst%3DC.%26aulast%3DEmileh%26aufirst%3DA.%26aulast%3DLeslie%26aufirst%3DG.%26aulast%3DJacobson%26aufirst%3DJ.%2BM.%26aulast%3DHoxie%26aufirst%3DJ.%2BA.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DInteractions%2520of%2520peptide%2520triazole%2520thiols%2520with%2520env%2520gp120%2520induce%2520irreversible%2520breakdown%2520and%2520inactivation%2520of%2520hiv-1%2520virions%26jtitle%3DRetrovirology%26date%3D2013%26volume%3D10%26spage%3D153%26doi%3D10.1186%2F1742-4690-10-153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McFadden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantharaju</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umashankara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirrone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krebs, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Garcia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shattock, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaiken, I.</span></span> <span> </span><span class="NLM_article-title">Antiviral breadth and combination potential of peptide triazole hiv-1 entry inhibitors</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1073</span>– <span class="NLM_lpage">1080</span>, <span class="refDoi"> DOI: 10.1128/AAC.05555-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;key=10.1128%2FAAC.05555-11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=1073-1080&author=K.+McFaddenauthor=P.+Fletcherauthor=F.+Rossiauthor=+Kantharajuauthor=M.+Umashankaraauthor=V.+Pirroneauthor=S.+Rajagopalauthor=H.+Gopiauthor=F.+C.+Krebsauthor=J.+Martin-Garciaauthor=R.+J.+Shattockauthor=I.+Chaiken&title=Antiviral+breadth+and+combination+potential+of+peptide+triazole+hiv-1+entry+inhibitors&doi=10.1128%2FAAC.05555-11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1128%2FAAC.05555-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.05555-11%26sid%3Dliteratum%253Aachs%26aulast%3DMcFadden%26aufirst%3DK.%26aulast%3DFletcher%26aufirst%3DP.%26aulast%3DRossi%26aufirst%3DF.%26aulast%3DKantharaju%26aulast%3DUmashankara%26aufirst%3DM.%26aulast%3DPirrone%26aufirst%3DV.%26aulast%3DRajagopal%26aufirst%3DS.%26aulast%3DGopi%26aufirst%3DH.%26aulast%3DKrebs%26aufirst%3DF.%2BC.%26aulast%3DMartin-Garcia%26aufirst%3DJ.%26aulast%3DShattock%26aufirst%3DR.%2BJ.%26aulast%3DChaiken%26aufirst%3DI.%26atitle%3DAntiviral%2520breadth%2520and%2520combination%2520potential%2520of%2520peptide%2520triazole%2520hiv-1%2520entry%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D1073%26epage%3D1080%26doi%3D10.1128%2FAAC.05555-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QAD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QAD','PDB','2QAD'); return false;">PDB: 2QAD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NCO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NCO','PDB','4NCO'); return false;">PDB: 4NCO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MBS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MBS','PDB','4MBS'); return false;">PDB: 4MBS</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i44"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00477">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_53200"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00477">10.1021/acs.jmedchem.8b00477</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">UM15–SOSIP (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00477/suppl_file/jm8b00477_si_001.pdb">PDB</a>)</p></li><li><p class="inline">LJC240–CCR5 complex (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00477/suppl_file/jm8b00477_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Molecular-formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00477/suppl_file/jm8b00477_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00477/suppl_file/jm8b00477_si_001.pdb">jm8b00477_si_001.pdb (571.37 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00477/suppl_file/jm8b00477_si_002.pdb">jm8b00477_si_002.pdb (459.4 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00477/suppl_file/jm8b00477_si_003.csv">jm8b00477_si_003.csv (0.93 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00477&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-11%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00477%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00477" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67993c6a5cc31991","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
